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CHAPTER 1 
DNA damage, repair 
and human hereditary disease 
AN INTRODUCTION 
In its long nucleotide-chains, the DNA double helix contains the genetic infor-
mation for ten thousands of proteins. The DNA molecule, however, is subject to 
constant change. In order to l11ailltaill its integrity, several luechallisms that 
cope with DNA damage, inflicted byvarious naturally occurring and man-made 
agents, have evolved. Individuals with the rare genetic disease xeroderma 
pigmentosum demonstrate the importance of DNA repair systems. These pa-
tients carry a defect in proteins that are involved in the removal ofUV-induced 
damage from the DNA, which results in sun-sensitivity and the frequent occur-
rence of skin cancers, Hence, studies on DNA repair and human repah' disorders 
such as xeroderma pigmentosum help our understanding of the origin of can-
cer and processes like aging. This introduction briefly reviews our current 
knowledge of different types of DNA damage and DNA repair processes, with an 
emphasis on the nucleotide excision repair pathway. Xeroderma pigmentosum 
and other human repair disorders are dealt with later in the chapter. 
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DNA damage and consequences 
Numerous endogenous and environmental agents call react with DNA and pro~ 
duce a wide variety of DNA lesions. Major DNA lesions together with the corre-
sponding repair mechanisms are listed in Table I. 
Origin 
endoge1lollS 
DNA synthesis 
(incorporation incorrect or 
damaged base or slippage) 
DNA recombination 
Reacth'c metabolites 
(e.g. oxygen radicals) 
etn'irOl1mellta/ 
UV-light 
Ionizing radiation 
Cross~linking agents 
(e.g. mitomycin C, 
cisplatin) 
Alkylating agents 
Aromatic compounds 
DNA lesion 
mismatches 
base alterations (oxidation 
and alh.·ylation), loss of bases 
and strand breaks 
c}'clobutane pyrimidine 
dimers, 6-4 photoproducts 
single and double strand 
breaks, loss of bases, base 
alterations 
intra- and inter-strand 
cross-links 
alkylated bases 
bulkr adducts 
Table 1 Major DNA lesions (adapted from Friedberg eta/1995) 
Repair pathway 
mismatch repair 
base excision repair 
recombinalional repair 
end-joining 
nucleotide excision repair 
photoreactivation 
recombinational repair 
end joining 
base excision repair 
recombinational repair 
nucleotide excision repair 
DNA-alkyltransferases 
base excision repair 
nucleotide excision repair 
nucleotide excision repair 
The most C01111110n natural environmental genotoxic agent is the UV component 
of sunlight. UV links neighboring pyrimidine bases on a DNA strand. As these 
dimers distort the DNA double helix, they can block essential cellular processes 
like replication and transcription. DNA lesions can also have altered base-pairing 
properties. Unless removed, inappropriate or mispaired bases nlay bring about 
-10-
permanent alterations in the genetic code. Sequence alterations can consist of base 
pair substitutions, deletions and insertions. Such Inutations can change gene ex-
pression or alter the structure andlor function of encoded proteins resulting in 
disturbed cell growth. lvIoreover, an accmnulation of mutations in somatic cells 
plays an important role in the developIllent of cancer and aging. \"'hen mutations 
occur in germ line cells, they may even give rise to hereditary disease. 
H is clear that removal of DNA damage is of vital importance to the cell in order to 
keep its normal function and to prevent it frOllllllalignant transformation. The 
following section describes different repair processes that give cells the ability to 
survive DNA damage. 
DNA repair mechanisms 
DNA repair mechanisms are many and varied. The present section briefly summa-
rizes the different DNA repair pathways known to date. For an extensive overview, 
the reader is referred to Friedberg et 01 (1995). 
Reversal of DNA damage 
The simplest way to remove certain types of DNA damage is through direct re-
versal in a single-enzyme reaction. Alkyltransferases simply extract the alkyl group 
fi'0111 alkylated bases that is transferred to an internal cysteine residue, thereby in-
activating themselves (Teo el 011984). Photolyases, on the other hand, revert UV-
induced dimers in a light-dependent reaction called photo-reactivation (Sancar 
1990, Yasui and Eeker 1998). Photolyases specific for cyclobutane pyrimidine 
dimers are wide-spread among prokaryotes and eukaryotes, fl:om bacteria and 
fungi up to vertebrates and even aplacental mammals, but they have not been 
found in placental mammals (Yasui et 0/1994). Photolyases for 6-4 photoproducts 
have also been found in various species, including Drosophila, Xenopus and plants 
(Todo el nl 1993). Only recently, two genes with homology to the class of 6-4 
photolyases and blue-light receptors have been identified in man. However, no 
overt photolyase activity has been demonstrated for these genes yet (Todo el nl 
1996, van der Spek eln11996, Yasui and Eeker 1998). 
Double-strand break repair 
More complex processes are required for the repair of double-strand breaks 
(DSBs) (Fig. 1). Strand breaks result fi'om exposure to ionizing radiation and cer-
tain cheillicals but are also naturally occurring intermediates in cellular processes 
like V(D)J-recombination and meiosis. Besides the simple rejoining of 
nonhomologous ends, that may not be error-fi'ee (ehu 1997, Kanaar and 
Hoeijmakers 1997), DSBs can be restored through homology-dependent recombi-
nation that can occur by homologous recombination repair or single-strand an-
nealing (SSA). 
Recombination is initiated by a 5' -?J'exonuclease that generates long single-
stranded 3' tails (White and Haber 1990, Sugawara and Haber 1992). In homologous 
recombination, one of these tails invades a hOlll0logous DNA duplex. The donor 
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sequence can serve as a template for new DNA s)olthesis, The daughter strand an-
neals with another single-stranded tail on the other side of the break. In this way, a 
recombination intenncdiate is fanned with two crossover points also known as 
Holliday junctions, Resolution of the Holliday junction restores the exact sequence 
into two recombinant DNA molecules, with or without crossing-over. 
DSB 
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llIl23' I I I 
1 
,S-ill 
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Fig. 1 }·,'Iodel for double-strand break repair in yeast. In the case of homolo-
gous recombination, the homologous DNA molecule is indicated in 
gray. For the single-strand annealing pathway, these gray areas represent 
repeats within the same DNA double helix. Arrows indicate new DNA 
synthesis. For further details see Chapter 6. 
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In the alternative SSA pathway, degradation from the breakpoint continues until a 
relatively short region of homology is found (e.g. within repeats) (Sugawara and 
Haber 1992). Subsequent annealing of the single-stranded complementary strands 
produces an intermediate with non-hOIllologous 3) ends that must be removed 
before new DNA synthesis and ligation can take place (Fishman-lobell and Haber 
1992, Yao et nI1997). Repair of a DSB via single-strand annealing is accompanied 
by a deletion and can also involve a translocation. 
Postreplication repair 
In case the DNA replication machinery encounters a lesion, DNA synthesis can 
restart downstream of the lesion, leaving a gap. These single-strand gaps opposite 
lesions in the newly replicated DNA strand can be filled in by postreplicative repair. 
The process, also known as daughter strand gap repair, involves homologous pair-
ing and strand exchange with the undamaged sister molecule (Friedberg et al 
1995). At present, little is known about the proteins involved and their role in this 
process. Another way to pass by a lesion in the DNA template is translesion synthe-
sis, which is less accurate and therefore error-prone (Paz-Elizur et al 1996). The 
remaining damage will be repaired via one of the other repair processes mentioned 
here. 
Mismatch repair 
Mismatch repair corrects misincorporation errors after DNA synthesis and acts on 
mispaired bases that occur in recombination intermediates. In Escherichia coli, the 
MutS dimer specifically binds to mispairs (Grilley et a11989) (Fig. 2). Subsequent 
binding of Mutl activates MutH that makes a single-strand incision, which can be 
on either side of the mismatch (Au etaI1992). The repair proteins select the newly 
synthesized DNA strand, as it remains temporarily unmethylated. Subsequent ex-
cision initiates at the nick and proceeds towards the mismatch depending on the 
concerted action of MutS, Mutl, the UvrD helicase and an exonuclease activity 
(Grilley et al 1993). The reaction is completed by resynthesis over several hundred 
bases. A similar process takes place in eukaryotes utilizing proteins highly homolo-
gous to MutS and MutL. However, in eukaryotes, l11islnatch recognition involves 
heterodimeric protein complexes rather than the MutS and Mutl homodimers 
employed by E. coli, e.g. MSH2 forms a complex with either MSH3 or MSH6 (all 
MutS homologs) (Drummond etal 1995, Palombo ef n11995, Palombo et nI1996). 
These complexes have different but overlapping substrate specificities. Whereas 
the human MSH2-MSH6 dimer binds to single base mispairs and loops of one or 
two bases, the MSH2-lvlSH3 dimer prefers larger looped structures (Modrich 
1994, Alani 1996, Johnson et a11996, Marsischky et nI1996). The mechanism that 
discriminates between the newly synthesized strand and the template strand is 
unknown, but does not involve herni-methylation as in E. coli. Mutations in the 
encoding human genes are associated with hereditary nonpolyposis colorectal 
cancer (HNPCC) (Modrich 1994, Fishel and Kolodner 1995). 
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Mismatch 
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Fig. 2 A'1odel for mismatch repair in E. coli. 
Base excision repair 
Base excision repair (BER) protects the cell against the effects of various types of 
endogenously generated small types of DNA base damage, BER is also important to 
eliminate similar lesions produced by ionizing radiation and alkylating agents (see 
Table I). Different DNA glycosylases with partially overlapping substrate specificity 
remove modified bases by cleavage of the base-sugar bond leaving an abasic site (Fig. 
3), Subsequently, the sugar residue is removed by an AP-endonuclease or AP-lyase 
activity and the one-nucleotide gap is filled-in by DNA polymerase ~ and DNA ligase 
IV in eukaryotes. Occasionally, longer repair patches of2 to 10 residues are observed 
(Matsumoto eta11994, Frosina etaI1996). It is likely that these longer patches result 
fr01n repair synthesis associated with strand displacement in the 5)---13) direction. 
The produced 'flap' structure would be a substrate for the flap endonuclease FEN-1 
(Harrington and Lieber 1994a, Klungland and Lindahl 1997). 
;.1 I II : I I I I I I II I I I I I~: 1 Glycosylase 
\ AP site 
1111 ; I I I \I 11111 I II 
I AP endonuclease t or AP lyase 
DTI,IIIIIIIIIIIII 
I 
DNA polymerase /3, DNA ligase III 
andXRCCt 
111111111111111111 
Single nucleotide inserted 
Fig. 3 ~.fodel for base excision repair. 
Nucleotide excision repair 
\. 
DNA polymerase p or S 
andPCNA ~ 
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FEN-1 and DNA ligase r 
IIII"IIII~IIIIII 
2 to 10 nuc/eotides inserted 
after strand displacement 
Another excision repair process is the nucleotide excision repair pathway (NER). 
The major difference between NER and BER is the way the damage is removed. 
Basically, NER cuts out the damage as part of an oligonucleotide fragment, while 
BER excises only one nucleotide. NER will be described in more detail in the next 
section as the XPF and ERCC1 proteins engaged in NER are the main subject of the 
present thesis. 
An alternative DNA excision repair pathway for UV-Iesions 
In most organisms NER is thought to be a major pathway for the repair of UV-
induced damage. In addition to NER, photo-reactivation and in some species BER 
are also involved in UV-damage repair (i.e. CPD-specific DNA glycosylases have 
been identified in bacteriophage T4 and bacterium MicrococC/is luteus) (Dodson et 
011994). Recently, an alternative nucleotide excision repair pathway for the re-
moval of UV photoproducts has been identified in ScJlizosocc/wrolllyces pOlllbe and 
the fIlamentous fungus Neurospora crasso (Doetsch 1995, Freyer et 011995, Yajima 
et 011995). It involves a new type of nicking activity, named the S. pOlllbe DNA 
endonuclease (SPDE). The enzyme makes an incision immediately 5' to the dimer 
(Bowman et 011994, Freyer et 011995). Following incision, either a 3'endonuclease 
or a 5' ~3'exonuclease (perhaps the yeast FEN-l homolog) may proceed with the 
repair reaction. The latter would explain the reduced repair of UV-induced dimers 
found in an UV-sensitive S. pOlllbe fell-l mutant (McCready ef a11993, Murray ef al 
1994). Subsequent resynthesis and ligation may involve proteins shared with other 
repair systems (Murray ef aI1994). 
For a long time it was thought that the different repair pathways would operate 
independent from onc another. However, a number of repair proteins appear to be 
involved in multiple processes, providing a way to regulate the different ways of 
repair. This issue is addressed in Chapter 6. 
Nucleotide excision repair 
Nucleotide excision repair is currently the most intensively studied repair process. 
Although NER has a very broad substrate-specificity, it is primarily involved in the 
removal of UV-induced damage from the DNA. The repair reaction sequentially 
involves: recognition of the damage, DNA unwinding, incision of the damaged 
strand on both sides of the lesion, excision of an oligonucleotide containing the 
damage, and gap-filling DNA synthesis. NER has been maintained during evolu-
tion. The process is the most simple in bacteria. In E. coli only three proteins 
-UvrA, UvrB, and UvrC- arc required for the incision reaction. UvrA forms a 
dimer that in a complex with UvrB is responsible for damage recognition (Mazur 
and Grossman 1991, IVIyles and Sancar 1991). Subsequent binding ofUvrB to the 
damaged site induces a conformational change in the DNA helL". As a result, the 
UvrA molecules dissociate allowing UvrC to bind (Moolenaar ef al 1995). Both 
incisions occur in this UvrBC-DNA complex (Lin and Sancar 1992, Moolenaar ef 
aI1995). Then the UvrD heliease releases the approximately 13 bases long oligonu-
cleotide containing the lesion, DNA polymerase I fIlls the gap, and finally DNA 
ligase seals the repair patch. The NER processes in yeast and mammalian cells are 
very much alike. Therefore, the present chapter, as most of the thesis, will focus on 
NER in mammalian cells. 
The mechanism afmammalian NER 
The process in 111ammals is far more complex than in bacteria. No less than 15 
proteins are required for dual incision. Most of the encoding genes have been iso-
lated through transfection of repair-deficient rodent mutant cell lines and recov-
ery of the excision repair cross complementing (ERCC) human genes. Nearly all 
ERCC proteins subsequently appeared to be involved in the human repair disor-
ders xeroderma pigmentosum (XP) and Cockayne s)11drome (CS), and are there-
fore called XP and CS factors, respectively. Two genes have been isolated using the 
XP cells themselves: XPA and xpc. Others have been cloned using the protein se-
quences of homologs in yeast. Interesting features of the XP and ERCC factors 
('!able 2) that take part in the different steps ofNER (Fig. 4) are summarized in the 
following section. 
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Lesion recognition 
Removal of the DNA lesion requires its recognition first. Three proteins preferen-
tially bind damaged DNA ill vitro and are probably reqnired for the initiation of 
the repair reaction. The XPC protein strongly binds (UV-damaged) DNA 
(Drapkin et n11994, Masntani et n11994, Reardon et nI1996). XPA recognizes vari-
ous lesions, including UV-induced 6-4 photoproducts (Robins et n11991, Jones 
and Wood 1993, Asahina et nI1994), whereas the UV-DDB protein (for UV-dam-
aged DNA binding) specifically binds to 6-4 photoproducts (Treiber et n11992, 
Protic and Levine 1993, Reardon et nI1993a), but also cyclobutane pyrimidine 
dimers and cisplatin adducts (Chu and Chang 1988, Chu and Chang 1990). 
The XPC protein exists in a complex with the human homolog of the SnccharolllY-
ces cerel'isine repair protein Rad23, HHR23B, that enhances XPC-dependent exci-
sion repair ill I'itro (Sugasawa et aI1996). There is strong evidence that XPC binds 
the damaged site first (Sugasawa etnI1998). 
The XPA protein can interact with several repair factors that modulate its binding 
properties. For instance, XPA binds to the Replication protein A, RPA (Matsuda et 
n11995, Saijo et nI1996). This trim eric single-stranded DNA-binding protein is 
required for both the incision reaction as well as repair synthesis (Covedey et nl 
1992, Aboussekhra et n11995, Mu et nI1995). RPA stimulates the interaction of 
XPA with yet another repair protein, ERCC1 (Li et n11994, Park and Sanear 1994, 
Li et n11995b, Saijo et nI1996). ERCC1 resides in a complex with the XPF protein. 
Together they form an endonuclease that is responsible for one of the incisions 
around the lesion (Chapter 3). Like the homologous proteins in S. cerel'isine, XPA 
may bind the ERCC1-XPF complex with even higher affinity than either subunit 
alone (Guzder etnI1996). Both RPA and ERCCI enhance the preference ofXPA 
for damaged DNA (He et n11995, Li et nl 1995a, Nagai et nI1995), whereas its 
binding to darnaged DNA, in turn, stimulates the interaction with the basal tran-
scription factor TFJIH (Park et a11995b, Nocentini et nI1997). RPA, on the other 
hand, can bind to the endonuclease XPG (He et nI1995), possibly XPF (Bessho etal 
1997b), and UV-DDB (Otrin et nI1997). Small amounts of UV-DDB stimulate 
NER ill I,itro (Aboussekhra et n11995, Mu et nI1995), possibly via this specific 
interaction with RPA. 
Taken together, data strongly suggest that the XPC-HHR23B and pre-assembled 
XPA-RPA complexes bind to the damaged site and recruit the factors required for 
dual incision. However, it is also possible that a complex consisting ofTFIIH, XPA 
and RPA acts as one entity after initial damage detection by XPC-HHR23B. 
DNA unwinding 
During NER the DNA is opened over a region of at least 25 bases with help of 
TFJIH, a large protein complex that participates both in initiation of basal tran-
scription and in NER (Evans et n11997a, Wood 1997). The XPB and XPD proteins 
are subunits of the TFIIH factor and their helicase activities (with opposite polar-
ity) are probably required for local unwinding of the DNA double helix (Schaeffer 
eta11993, Drapkin et n11994, Humbert et n11994, Schaeffer et n11994, van Vuuren 
et nI1994). XPC-HHR23B may assist this strand separation by interacting with 
TFIII-I (Drapkin et n11994), However, the need for XPC depends on the DNA 
structure, as for the removal of lesions in a partially unwound DNA substrate the 
XPG-HHR23B complex is not required O'v!u etn11996, Mu and Sanear 1997, Mu et 
n11997b), Binding of RPA to the non-damaged strand may prevent incision of the 
strand (that serves as a template for repair synthesis) and stabilize the open struc-
ture (Kim eta11992, Seroussi and Lavi 1993), 
Global genome repair 
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Fig. 4 i\.Jodcl for nucleotide excision repair in mammalian cells. 
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Dual incision 
TFIIH and RPA can both bind to XPG, the protein that probably proceeds with the 
repair reaction (Mu ef 11/1995, Habraken el 11/1996, Iyer el al 1996, de Laat el al 
1998b). XPG makes the first incision while it cuts the damaged DNA strand on the 
3' side of the lesion (O'Donovan el a11994a, Matsunaga el 1111995, Mu el aI1996). 
Next, the ERCCI-XPF complex makes the incision on the opposite side (Mu el III 
1996). Both endonucleases specifically cut near junctions of unpaired and duplex 
DNA in a structure-dependent way (Chapter 3, O'Donovan el aI1994a). Recent 
results indicate that RPA helps to position the 3' and 5' incisions (de Laat el al 
1998b), which could explain the finding that with certain substrates, RPA stimu-
lates the structure-specific incision ofERCCI-XPF (Matsunaga el 1111996, Bessho 
eIIl/1997b). 
Excision 
Whereas the cleavage positions vary with the type of adduct, the excised oligomers 
are more or less constant in length. Incision 2 to 9 phosphodiester bonds away 
hom the lesion on the 3' side and 16 to 25 bonds away on the 5' side releases a 24 to 
32-nucleotide-Iong fragment ill vitro (Huang el III 1992, Svoboda el al 1993, 
Matsunaga el a11995, Moggs elaI1996). It is not known which protein(s) displace 
the lesion-containing strand, but both the excised fragment and the gapped DNA 
molecule remain bound to one or more components of the repair complex (Mu el 
a11995, Mu ef III 1996). XPG can bind to the proliferating cell nuclear antigen 
PCNA (Gary el a/1997). This interaction stimulates repair, though is not essential 
to the incision reaction. It probably stimulates the release of the protein assembly 
and/or links excision with subsequent repair s)Ollhesis (Nichols and Sancar 1992). 
Gapjilling 
DNA polymerase /) and/or £ fills in the resulting single-stranded gap using the 
complementary strand as a template. The polymerase is supported by proteins 
known to be involved in DNA replication: RPA, PCNA and Replication factor C 
(RF-C) (Miura el aI1992, Nichols and Sanear 1992, Shivji el aI1992, Aboussekhra 
el a11995, Wood and Shivji 1997). RF-C is needed to load PCNA onto the DNA 
(Podust el aI1994). PCNA may be required for the initiation of repair synthesis 
and/or subsequent turnover of the repair complex. It may also stimulate polymer-
ase activity. The single-strand breaks are rejoined by DNA ligase I sealing the repair 
patch. 
Human prolein ERCC 
(complex) prolein 
XPA 
RPA p70 
p32 
pl4 
XPC 
HHR23B 
HHR23A 
A'PE UV~DDBl 
UV~DDB2 
TFIIH XPB 3 
(core) XPD 2 
pS24 
p62 
p44 
p34 
TTDA 
XPG 5 
ERCCI 
XPF 4 
(XPF) II 
CSA 8 
CSB 6 
7 
9 
lO 
I identified in database (our unpublished 
obsentation) 
2 complex of three subunits 
3 allelic with SSL2 
Table 2 Eukaryotic NER factors 
Homologs 
S. cerev;siae S. pOll/be other 
Radl4 D>.'VaDmc 
RPA2 
Rad4 Xl)CDmc 
Rad23 
Rad23 
Rad2S3 ERCC3sp" XPB llm<' 
Rad3 Radl5 XPoDme 
Tib2 
Tibl 
Ssll 
TIM 
Rad2 Rad13 
RadlO SwilO5 
Radl Radl66 Mei_9f)mt' 
1:lu538,\'(( 
Radl Radl6 Mei_9 Dmt' 
Mus38,\'cT 
Rad28 
Rad26 
Rad7 
Radl6 
MMSl9 
4 previously known as p41 
5 aUelic with Rad23 (Hang et (11996) 
6 allelic with Swi9, RadIO. and Rad20 
(Schmidt et (11989) 
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Protein activity 
damage recognition 
ssDNA binding 
damage recognition! 
ssDNA binding 
damage recognitionl 
ssDNA binding 
3' ~5'hdicase 
5'-43'helicase 
3' structure-specific 
endonuclease 
5' structure-specific 
endonuclease 
ds DNA-dependent ATPase 
ATP-dependent 
DNA damage sensor 
Sp.:J S.pombe 
Dmr D. melallog(/ster 
Ncr Neurospora cm5Sa 
Sensitivity Additional 
human/rodent mutant function 
uv mitom},cinC 
++ +/-
DNA replication 
recombination 
+ 
+ 
++ +/- basal transcription 
++ +/-
++ ± 
++ +++ single-strand annealing 
++ +++ 
+ + 
+ 
+ 
+ ± 
+ 
+ + 
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Transcription.coupled repair 
The basal transcription factor TFIIH is involved in both transcription and NER. A 
number of lesions, when present in actively transcribed genes, are repaired more 
efficiently than lesions in the rest of the genome via a process known as transcrip-
tion-coupled repair (TC-I\TER). Repair is probably initiated by a stalled RNA 
polymerase II (Hanawalt 1994) (Fig. 4). The CS factors, CSA and CSB, arc specifi-
cally involved in TC-NER. They probably support the assembly of the repair com-
plex at the site of arrested transcription. Several interactions have been reported 
that may be relevant to this process, including CSB-RNA polymerase II (van Gool 
et 011997), CSB-CSA and CSB-XPG (Iyer et 011996), CSB-CSA-TFIIH (Henning 
et 011995) and CSB with DNA and XPA (Selby and Sancar 1997). 
The XPC protein, on the other hand, is specifically involved in the repair of the 
rCluaining of the genome. Because of the condense chromatin structure, these re-
gions are normally inaccessible. It is likely that XPC increases the accessibility of 
the damaged site for other repair proteins as XPC seems not to be required for 
repair of already partially unwound DNA structures (Mu et 01 1996, Mu and 
Sancar 1997, Mu et 01 1997b). XPC may take the role of RNA polymerase II during 
global genome repair (Sugasawa et 011998). 
Complexity 
The exact composition of the preincision complex is not known. According to Mu 
et 01 (1997b) the smallest DNA-protein complex detected ill vitro is formed in the 
presence of the purified XPA, RPA, XPC-HHR23B, and TFIIH factors. Recent 
studies, however, revealed the presence of a DNA-XPC-HHR23B pre-incision fac-
tor, which appeared to be the first factor to bind to a lesion (Sugasawa etoI1998). 
The isolation of a factor that consists of the yeast XPA, XPF and ERCCI homologs 
suggests that the preincision complex is formed at the damaged site by sequential 
assembly of the different repair proteins (Guzder et 01 1995, Guzder et 011996, 
Habraken et 011996). Other results, however, suggest the existence of a preformed 
'repairosome'. Two forms of yeast TFIIH have been isolated as large complexes. The 
factor probably active in transcription is associated with a kinase activity, whereas 
the factor involved in repair seems to include repair proteins instead of the kinase 
(Svejstrup eto11995, Mu eto11996, He and Ingles 1997). 
Defects in NER can result in three genetic disorders: xeroderma pigmentosUIll, 
Cockayne syndrome and PIElDS, the photosensitive form of trichothiodystrophy 
(TTD), which are shortly described in the ne,,1' section. For a recent overview, the 
reader is referred to Bootsma etol (1998). 
Human NER·deficient disorders 
Xeroderma pigmentosum 
XP is a rare, autosomal recessive disease. In the Netherlands, one in 200,000 indi-
viduals suffers fron1 XP. Characteristics of XP are sun-sensitivity, dry appearance 
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of the skin (xeroderma), pigmentation abnormalities (pigmenloslIlII), a more than 
two thousand fold increased incidence of skin cancer) and in SOIl1C cases neurologi-
cal disease due to accelerated neurodegeneration. Cell fusion experiments estab-
lished seven NER-deficient complementation groups, XP-A through XP-G, and a 
so-called variant group (XP-V) that is thought to be defective in postreplication 
repair (Table 3) (Vermeulen et a11991). 
While XP has a worldwide distribution, XP-A is most common in Japan and in the 
Mediterranean countries. :Mutations in the XPA gene usually give rise to a severe 
phenotype associated with neurological abnormalities, though leaky mutations 
have been reported (Mimaki et a11996, States and Myrand 1996). Among the Japa-
nese group A patients three different IllutatiollS prevail. T'wo arc nonsense u1uta-
tions that produce truncated proteins. These give rise to a less severe phenotype 
than the splice mutation responsible for a complete lack of XPA protein. XP-B is 
extremely rare. At present, only five patients (from three independent families) 
have been assigned to this cOlllplementation group. Two mutations in the XPB 
gene originate in an XP phenotype combined with the severe characteristics of the 
CS repair disorder, whereas a third mutation gives rise to features of the third NER 
syndrome, TTD (Weeda et aI1997b). The XPB gene encodes a subunit of the basal 
transcription factor TFIIH. 
The XPC protein is the damage recognition factor (Sugasawa et aI1998). Interest-
ingly, XP-C cells are only defective in genome-overall repair, suggesting that XPC 
might be specifically involved in repair of transcriptionally inactive DNA. XP-C 
patients normally have no neurological complications (Kraemer et a11987, Cleaver 
and Kraemer 1989), although one exceptional case has been reported with 
neurodegeneration in later life (Robbins etaI1993). 
Unlike XP-C, XP-D is fi'equently associated with neurological abnormalities. The 
XPD gene product -like XPB- is a subunit of the TFIlH factor. Mutations in XPD 
result in classical XP, combined XP-CS or ITO. The molecular defect causing XP-E is 
still unclear. Some XP-E individuals lack the DNA-binding activity of one of the two 
subunits of the UV-DDB complex. The protein can stimulate, but is not essential to 
the NER reaction ill vilro. This might explain the relatively mild clinical symptoms 
and a high residual cellular repair activity characteristic of XP-E (Wood 1997). 
Likewise, XP-F patients have a relatively mild clinical phenotype. XP-F patients 
hardly experience sensitivity to sunlight. Fifty percent of the XP patients assigned 
to a complementation group belong to group A or C, contrasting the only eleven 
cases (five percent) with XP-F (Cleaver and Kraemer 1989). In the past ten years, 
we have come across at least fourteen additional cases with XP-F. In only two out of 
the eighteen reported XP-F individuals, neurological symptoms developed later in 
life (Chapter 4, Moriwaki et aI1993). 
Patients belonging to complementation group G are in general more severely af-
fected and like in XP groups Band D there is extensive clinical heterogeneity. Low 
levels of repair and a XP phenotype are the consequence of subtle mutations that 
inactivate the XPG endonuclease. In those cases where mutations result in a tnlIl-
cated XPG protein, additional CS features are found (Nouspikel el aI1997). Some of 
the features of the different complementation groups are summarized in Table 3. 
Group Freq UV UDS' Skin Neurological Features 
sens (%) cancer abnormalities 
XP-A high +++ 2-5 + present 
XP-B low2 ++ 10-40 +/- variable XP-CSorTTD 
XP-C high + 15-30 + absent genome overall 
repair-deficient 
XP-D in. ++ 15-50 +/- variable XP, XP-CS, or T1'D 
XP-E low ± 40-50 +/- absent 
XP-F low + 15-30 +/- mild repair low hut long-lasting 
XP-G low ++ 2-25 +/- variable XPorXP-CS 
XP-V high +/± normal +/- absent postreplication repair 
deficient 
CS-A in. + normal severe TC-NER-deficient 
CS-B high + normal - severe TC-NER-deficient 
TTD-A low3 + 10 mild 
UV' 10w.4 + normal - absent CS-like 
I Unscheduled DNA synthesis as percentage of repair synthesis in normal cells 
2 3 families 
3 1 family 
-12 families 
Table 3 l\TER-deficicllt complementation groups 
Trichothiodystrophy 
PlElDS is the acronym for the photosensitive form ofTTD, which is further char-
acterized by ichthyosis (scaling of the skin), (sulfur-deficient) brittle hair, impaired 
intelligence, decreased fertility) and short stature. ''''hile acute sun-sensitivity is as-
sociated with PIBlDS, other skin problems typical of XP are not, for instance skin 
cancer has never been reported in TTD patients. Ivlolecular defects have been as-
signed to the XPD and )CPB genes and to a still unidentified gene, TTDA (Stefanini 
et a11993a, 1993b, Vermeulen et aI1994b). The XPB, XPD, and probably TTDA 
proteins are associated with the basal transcription factor TFIIH (Schaeffer et al 
1993, Drapkin et a11994, Schaeffer et a11994, Vermeulen et aI1994b). Since fea-
lllres like brittle hair are not easily explained by a NER defect alone, they are as-
sumed to result from a subtle defect in the transcription function of TFIIH 
(Vermeulen et aI1994b). 
Cockayne syndrome 
Cockayne syndrome patients have an aged appearance due to a dry and sometimes 
scaly skin, thin hair, and diminished subcutaneous tissue. The neurological and 
developmental complaints associated with CS arc similar to those found in TTD. 
Growth retardation and skeletal abnormalities generally begin within the first year 
of life (reviewed by Nance and Berry 1992). The mean age of death in reported 
patients is about 12 years, although a few affected individuals have lived into their 
late teens and twenties. Cells from CS patients (without additional XP) are specifi-
cally defective in the transcription-coupled repair process (Venema et a11990, van 
Hoffen et aI1993). CS can result from mutations in at least five genes (Lehmann 
1995). Classical CS is associated with mutations in the CSB or CSA genes (Troelstra 
ef a11992b, Henning et aI1995). Individuals with an exceptional combined XF-CS 
phenotype carry mutations in the XPD, XPB, or XPG gene (Vermeulen ef a11993, 
Vermeulen et a11994a, Broughton et aI1995). Mutations in these genes can affect 
the repair and/or transcription initiation function ofTFIIH. Features typical of 
CS, like cataract) hearing loss, dental caries, and poor development, are thought to 
be the result of a subtle transcription defect. 
Notably, several of the CS and TTD features are also found in individuals with 
COFS and CAMFAK syndrome (CS-like), Tal' syndrome and Amish brittle hair 
syndrome (TTD-like), and other candidate 'transcription syndromes' (Bootsma 
and Hoeijmakers 1993, Vermeulen et aI1994b). 
Fig. 5 Xeroderma pigmcntosulll, Cockayne syndrome. and PIBIDS patient 
(from left to right), Courtesy of Lehmann and lvIcCuaig. 
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Outline ofthe thesis 
The aim of the study presented in the present thesis was to unravel the identity and 
role of the ERCCl-containing protein complex in DNA repair. Chapter 2 presents 
the results of a mutational analysis revealing the different domains important for 
ERCCl activity. Chapter 3 reports on the isolation and identification of the com-
plex partner of ERCCl as the protein involved in xeroderma pigmentosum group 
F. The proteins together form a structure-specific endonuclease. The identification 
ofXP-F mutations in a Dutch patient (Chapter 4) and the mutual interaction do-
mains in ERCCl and XPF (Chapter 5) provided a molecular basis for the clinical 
phenotype. Finally, the role of the ERCCl-xeroderma pigmentosum group F com-
plex in DNA repair is discussed in Chapter 6. 
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CHAPTER 2 
Mutational analysis of the human nucleotide 
excision repair gene ERCCl 
Anneke M. Sijbers 
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Hanny Odijk 
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Nucleic Acids Res 24: 3370-3380 (1996) 
The human DNA repair protein ERCClresides in a complex together with the 
ERCC4, ERCCll, and XP-F correcting activities, thought to perform the 
5' strand incision during NER. Its yeast counterpart, Radl-RadiO, has an ad-
ditional engagement in a mitotic recombination pathway, probably required 
for repair of DNA cross-links. Mutational analysis revealed that the poorly 
conserved N-terminal 91 amino acids of ERCCI are dispensable for both re-
pair functions in contrast to a deletion of only four residues from the C-termi-
nus. A database search revealed a strongly conserved motif in this C-terminus 
sharing sequence homology with many DNA break-processing proteins, indi-
cating that this part is primarily required for the presumed stl'llcture-specific 
endonuclease activity of ERCCI. Most missense mutations in the centralre-
gion give rise to an unstable protein (complex). Accordingly, we found that 
free ERCCI is very rapidly degraded, suggesting that protein-protein interac-
tions provide stability. Survival experiments show that the removal of cross-
links requires less ERCCI than UV repair. This suggests that the ERCCI-de-
pendent step in cross-link repair occurs outside the context of NER and pro-
vides an explanation for the phenotype of the human repair syndrome xero-
derma pigmentosum group F. 
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Introduction 
Repair of damaged DNA prevents accumulation of lesions that give rise to muta-
tions, chromosomal instability, carcinogenesis or cell death. A wide variety of DNA 
lesions caused by exposure to UV-light and numerous chemical agents is removed 
via the NER pathway. This repair process involves specific damage recognition, 
dual incision of the damaged strand, followed by lesion removal, gap-fIlling and 
finally strand ligation (for a recent review see Hoeijmakers 1994). Most of the pro-
teins engaged in NER have been identified by making use ofUV-sensitive mntant 
rodent cells (ERCCI throngh ERCC11) and cells derived from patients suffering 
from xeroderma pigmentosum (XP-A through XP-G), Cockayne syndrome (CS-A 
and CS-B) or trichothiodystrophy (TTD-A). XPA protein is thought to play an 
important role in the damage recognition step as it specifically binds to damaged 
DNA (Robins el 011991, Jones and Wood 1993, Asahina el 011994) and interacts 
with several other repair proteins including the RPA heterotrimer (He elo11995, 
Matsuda el 011995), XPG (He el 011995), the basal transcription factor TFIIH 
(PaJ'k eloI1995b), and the ERCCI complex (Li el 011994, Park and Sancar 1994, Li 
el 011995b, Nagai el 011995). Following damage recognition the helicase activities 
ofXPB and XPD (Sung el 011993a, Roy eloI1994), present in the TFIlH complex 
(Schaeffer elo11993, Drapkin el 011994, Schaeffer eloI1994), are thought to con-
vert the damaged site into a substrate for XPG and the ERCCI complex, likely to be 
responsible for dual strand incision around the lesion. Further action of RPA, 
PCNA, RF-C, DNA polymerase 0 and/or £, and ligase are needed to complete the 
full NER reaction (Shivji eloI1995). 
Although ERCCI was the first human NER gene cloned (Westervcld eloI1984), 
infonnation on its enzymatic function is still very limited. The protein exists in a 
complex together with the ERCC4, ERCC11 and XP-F correcting activities 
(Biggerstaff el 011993, Reardon ef 01 1993b, van Vuuren el 0/1993). Largely due to 
the difficulty of purifying it to homogeneity (van Vuuren elol 1995), the exact 
composition of the complex has not yet been fully resolved, although recently a 
heterodimeric ERCCI complex was reported (Park ef 011995a). By homology with 
its S. cerel'isioe counterpart RadIO (van Duin ef 011986), which associates with the 
Radl protein (Bailly el 011992, Bardwell el 011992), the ERCCI complex is ex-
pected to mediate endonucleolytic incision at the 5' side of the lesion (Sung el 01 
1993b, Tomkinson ef 01 1993, Bardwell el 01 1994, Tomkinson el "I 1994, 
lVlatsunaga et 0/1995). The nature of this putative activity, however, remains to be 
established. The domain ofERCCI involved in the transient interaction with XPA 
eA'tends from residues 93 to 120 (Li el 011994), in a region that is strongly con-
served in RadIO (van Duin el 011986). Further, on the basis of this conservation, 
the area could be involved in the association with the human homolog of Radl 
(Bardwell ef 011992), ERCC4 and 11 and/or XPF. 
-28 -
Beyond the central region, towards the C-terminus, significant homology with the 
C-terminus of the E. coliNER protein UvrC is observed (see Fig. 9). This domain is 
conserved in the S. pombe ERCCI homolog SwilO (Rodel et alI992), but absent in 
RadIO from S. cerel'isiae (van Duin et alI988). Both homologs have an additional 
function in a l11itotic recombination pathway. In S. cerevisiae this pathway involves 
recombination between direct repeats (Klein 1988, Schiestl and Prakash 1988, 
Schiestl and Prakash 1990) in which RadI is required for removal of 
nonhomologous sequences from the 3' ends of recombining DNA (Fishman-
Lobell and Haber 1992, Saffran et al1994, Ivanov and Haber 1995). In S. pombe 
this pathway entails mating-type switching (Gutz and Schmidt 1985). The mam-
malian ERCCI complex may have such a function as well. This idea is supported 
by the extreme hypersensitivity to DNA cross-linking agents that is unique to 
ERCCI- and ERCC4-deficient rodent mutants (Busch et al 1989). Interstrand 
cross-links probably require recombination for their elimination. In order to ob-
tain more information on the significance of various ERCCI domains for both the 
NER and recombination functions, we have constructed ERCCI cDNAs with spe-
cific mutations and measured their ability to correct the mutagen-hypersensitivity 
of rodent ERCCI-mutant 43-3B. 
Results 
To identify the regions in ERCCI essential for its function in NER and cross-link 
repair, mutated ERCCI cDNAs were assayed for correction of the rodent group 1 
mutant 43-3B. Like other mutants in this complementation group and in group 4, 
this UV-sensitive cell line also exhibits an extreme sensitivity to cross-linking 
agents such as mitomycin C (MMC) and cisplatin. The latter feature is not dis-
played by other lTV-sensitive NER-deficient complementation groups and prob-
ably reflects the role of ERCCI in recombination needed for elimination of 
interstrand cross-links. The requirement ofERCCI for UV resistance corresponds 
with its function in NER. Stably transfected neomycin-resistant mass populations 
were examined for their responses to UV irradiation and MMC. To validate the 
findings two separate cDNAs for each mutation were tested. Since a negative result 
can have trivial reasons we studied in addition, when indicated, individual clones 
which were verified to contain one or Inore copies of intact ll1utated or wild type 
ERCCI cDNA. Transfcction to Chinese hamster 43-3B cells of a wild type human 
ERCCI cDNA (encoding 297 residues) almost fully complements both repair de-
fects of these cells (see Fig. I and 2). 
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Construct ERCC1 protein 
homology with: Rad10 UvrC 
Swi10 
pSVL5E 11 j///////I 1297 
peD3C 31M 1/ / / / / / /1 
ATG69 691 1///////1 
ATG83 8311///////1 
ATG92 921V/ / / ///1 
ATG103 103V / / / / / /1 
peDEAst V / / / / //11214 
peDE72 17//////1 I :0273 
STOP285 V//////I 1285 
peDEBgl V//////I 11287 
STOP290 V//////I 1290 
STOP291 j/ //// //1 1291 
STOP292 1///////1 1292 
STOP293 V//////I 1293 
pUCPROMH-1 V / / ////1 1297 
peDEMP2 1///////1, 1299 
AY 
HYBRID V//////I I UvrC 1291 
Hg. 1 Schematic representation of ERCCi deletion mutants and their correct-
ing abilities. +, correction; int, intermediate correction; -, no correc-
tion of the 43-3B mutant phenotype; nd, not determined; >I, dominant 
negative when oycrexpressed in wildtypc cells. Numbers in brackets, 
number of amino acid residues. The hatched region illustrates the most 
strongly conserwd sequence between EReCl and RadIO and the black 
regions indicate nonsense sequences. In peDEn, EReCI is lacking exon 
VIII, whereas in pcDE1{P2 an extra alanine and tyrosine (AY) are in-
serted distal from residue 208. For several mutants the CFA was deter-
mined as described by Westen'eld et til (1984). 
N-terminal deletion mutants ofERCCl 
Phenotype 
MMCR UVR 
+ + 
+ + 
+ nd 
+ nd 
+ + 
nd 
+ int 
+ + 
nd 
Construct pcD3C encoding a truncated ERCCI protein lacking the first 54 amino 
acids (Fig. I) has been shown to confer MMC resistance on 43-3B cells (van Duin 
et aI1986). We have further shortened the protein by constructing ERCCl cDNAs 
containing the start codon at amino acid positions 69, 83, 92, and 103 (Fig. 1), 
preceded by an optimal translation initiation sequence. 
Whereas the constructs ATG69, ATG83, and ATG92 all corrected both the UVand 
MMC sensitivity of recipient cells, ATG 103 could not do so (see Fig. 2A and B for 
the ATG92 and ATG103 mutants, for others data not shown). We conclude that an 
N-tenninal deletion of 91 residues comprising almost one third of the protein 
does not interfere with its repair functions. 
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It was not possible to verify the effect of the ATG92 and ATG 103 mutations at the 
protein level by imIl1unoblot analysis as our affinity-purified ERCCI antiserum 
mainly recognizes epitopes in the N-terminus of the protein. Therefore, it remains 
uncertain whether a deletion of 102 amino acids results in an unstable protein or 
interferes with the protein activity itself. 
A B 
100 100 
10 10 
ro 
> .~ 
J 0.1 
'CHOOJ UJ ~43·3B 
* 0.1 0.01 epSVL5E 
... ATG92 
.6.I'\TG103 
0 2 4 6 8 0 2 4 6 
UV (J/m2) MMC("M) 
100 
ro 
> .~ 943-3B 
J .pUCPROMH.l 
UJ epSVL5E 
* 0.1 _STOP293 
DSTOP292 
oHY8RID 
0 2 4 6 8 0 2 4 6 0 2 
UV (J/m2) MMC("M) Cisplatin (~Ig!m!) 
C 0 E 
Fig. 2 Survival of 'B-3B transfectants containing N-termillal deletion mutants 
after treatment ,,,ith A. UV. B. J\{MC, and C-terminal deletion mutants 
after treatment with C. UV, D. 1Hv[C, and E. cisplatin .• pUCPROMH-
1 (mass population) and. pSVL5E (single done) both containing the 
wild type ERCCI eDNA; '" ATG92 (mp); L',,\TG 103 (mp); • STOP293 
(sc); 0 STOP292 (sc); 0 HYBRID (mp)." the parental wildtype cell 
line CH09 (mp) and 0 the mutant '!3-3B (mp). The number of prolif-
erating cells \VJS measured as JH-thymidine incorporation. Points arc 
average values for duplicate wells (or four for the untreated cells) and 
the error bars represent standard errors of means. 
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C·terminal deletion mutants ofERCCl 
Previous studies have suggested that the strongly conserved C·terminal part of 
ERCCI is crucial for its function. pcDEAst in which the ERGCI cDNA contains a 
premature stop codon at amino acid position 214 coding for a 'Rad 1O-like' ERCCI 
protein (Fig. 1) could not correct MMC sensitivity. Neither could pcDEBgI, encod· 
ing a truncated protein of 287 amino acids with 17 unrelated C·terminal residues 
due to a frameshift mutation (van Duin et a11988) nor pcDEn, a splice mutant 
lacking exon VIII (van Duin et a11986) (Fig. I). 
~ , 
I 
'" 
0 ~ N 
'" 
:;; 
1;) ro OJ OJ OJ OJ 0 0 w 
U'i 
N N N N N ~ 1'2 
'" 
n. n. n. n. n. n. 
.J 
0 ~ 0 ~ 0 0 0 co > <.l bi bi f- :::J >- (f) c. (f) c. I c. 
kDa 
------- --
111-- ."~ ",-""" --,,~ ~--
74-
45-
___ -ERCC1 
29-
Fig. 3 Expression of wild type and EReCl C-terminal deletion mutant pro-
teins. Equal amounts (90 ~lg) of whole cell extracts were loaded 
(pcDEAst, STOP285, 290, 291, and 292. pSVLSE and HYTIRfD mass 
populations; 5'1'01'293 and pUCPRO/\ifH-l single dones). Blots were 
incubated with aftlnity-purified anti-EReCl antiserum. EReCt protein 
migrates at 39 kDa. Untransfected 43-3B is shown in Fig. 6, Note that 
this antiserum is specific for human ERCCI and does not recognize the 
endogenous Chinese hamster protein. 
To more preciselydetennine the extent of the C-terminal functional area, a prema-
ture stop codon was introduced at amino acid position 286 resulting in a C-tenlli-
nal deletion of 12 residues (STOP285). In addition, STOP290, STOP291, 
STOP292, and STOP293 were constructed (Fig. I). Of these C-terminal trunca-
tions only STOP293 was able to correct the sensitivity of 43-3B cells to MMC, 
whereas for UV only a partial correction was found (Fig. 2C and D). The normal 
survival of STOP293 transfected cells after exposure to cisplatin (Fig. 2E) showed 
that the observed resistance to MMC reflects correction of cross· link sensitivity in 
general and rules out the possibility of deficient drug uptake or metabolism. Thus, 
only four residues can be deleted from the C·tenninus without losing the cross-
link repair function, although the UV damage repair function is slightly affected 
already. The various truncated proteins in whole cell extracts from stable 
transfectants were analyzed by immunoblotting (Fig. 3). STOP291, STOP292, 
STOP293, and STOP290 (weakly) proteins could be visualized, indicating that 
they are stable ill l'il'O though, with the exception of STOP293, non-functional. 
Further shortening of the protein apparently induces instability as no ERCCI 
could be detected in STOP285 and pcDEAst (Fig. 3, note that the endogenous Chi-
nese hamster ERCCI protein is not recognized by our affinity-purified anti-
ERCCI antiserum, see also Fig. 6). 
To assess whether the sequence homology of the C-tenninus with the E. coli UvrC 
repair protein extends to the functional level, a hybrid construct was generated, 
with the human part substituted for its bacterial equivalent (Fig. I). This ERCCI-
UvrC hybrid protein is properly expressed (HYBRID in Fig. 3), however, failed to 
correct the sensitivity to UV and l\'IMC (Fig. land 2C). 
Missense mutations in ERCCI 
]0 further examine the presence of functional domains involved in one or both 
repair functions of ERCCl, specific amino acids were substituted in the region 
1110St strongly conserved between human EReCl, S. cerel'isiae RadIO, and 
S. pOlllbe SwilO (see Fig. 4). This part may contain the binding site for the human 
homology with: Rad10 UvrG 
Fig. 4 Homology beh\'een EReCl, SwilO and RadIO proteins in their most 
strongly conserved region. Identical amino acids arc in black boxes, 
physicochemically related residues are in gray boxes, and missense mu-
tations introduced arc indicated. Displayed part ofERCCI (297 amino 
acids) residues 120-159, SwilO (252 amino acids) residues 62-101 and 
RadIO (210 amino acids) residues 117-156 {numbers according to van 
Duin et a11986, Rodel eta11992, and Reynolds et (//1985). 
homolog of Radl (Bardwell ef aI1992) andlor it may harbor a DNA binding site 
(van Duin ef aI1986). The types of changes made and the effects on UV and MMC 
survival after transfection to 43-3B cells are summarized in Table 1. For a number 
ofERCClmutants we found a considerable difference in correction of the UV and 
!vI!vIC sensitivity. This was also observed in individual clones containing intact 
mutated eDNA. For instance, in clone PI50V(I) the UV sensitivity was comple-
mented only partially, whereas the extreme sensitivity to both MMC and cisplatin 
was almost fully restored (Fig. 5). In contrast, other mutant ERCCl transfectants 
retained the sensitivity to UV and showed partial or no correction of the MMC 
sensitivity. Immunoblot analysis revealed that Illost mutations gave rise to no or 
hardly detectable ERCCI protein (Fig. 6), suggesting that they cause protein insta-
bility. In those cases where protein was detected a partially corrected phenotype 
was seen ('Iable I), as shown for the PISOV and Ll41H substitutions (see also 
Fig. 6). These observations suggest that a reduced amount of (mutated) ERCCI is 
sufficient for the repair of MMC damage but not for the repair ofUV damage. This 
interpretation is strongly supported by the isolation of two clones carrying the 
same mutated ERCCl cDNA (PISOV), but which were found to express the en-
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10 
(ij 
> 1 .~ 
" (/) 
*' 0.1 
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UV (Jim') 
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<>43-38 
+pUCPROMH·l 
.P150V I 
0P150V I[ 
AS142V 
VL 141P 
a 1 2 
Cisplatin (~!g/m/) 
Fig. 5 Survival of 43-3B transfectallts containing missense mutants following A. 
U\~ B. lvL\'lC, and C. cisplatin treatment. 0 the mutant cell line 43-3B 
(mass population) and 43-3B transfected with \J L141P (single done); .... , 
SI42V (sc); II, PI50V(I) (se); D, PI50V(II) (sc); +, pUCPROMH-1 con-
taining the wildtype ERCCl eDNA (sc). The number of proliferating cells 
was measured as either CFA or oycrall JH-thyrnidillc incorporation. Points 
are a\,eragcyalues for duplicate wells (or four for the lmtreated cells) and the 
error bars represent standard errors of means. 
coded protein to a different level in repeated experiments. Clone PISOV(II) exhib-
its only partial correction of the lvlMC sensitivity and no correction of UV sensi-
tivity in contrast to PISOV(I) (Fig. SB and A). Immunoblot analysis revealed that 
the level of correction correlated with the amount of mutated ERCCI protein de-
tectable (Fig. 6, determined by copy number and site of integration, which differs 
in each transfectant). 
ERCCI expression was also analyzed at the single cellleyel by immunofluorescence. 
In rodent cells transfected with pUCPROMH-I, a human wildtype ERCCI con-
struct, ERCCI is e"pressed in the nucleus of every cell, but the expression level seems 
somewhat lower than in HeLa cells (Fig. 7). Although variation is seen in 
transfectants expressing mutated ERCCI protein (even in cells derived from one sin-
Missense Checked in UY· MMC· Protein expression level 
mutation 
C76W Illp 
Q107R mp 
A138D lllp not detectable 
Ll41H mp int ++ reduced 
Ll41P sc not detectable 
S142G mp 
SI42H Illp ++ 
SI42V sc int strongly reduced 
Ll43H mp int + strongly reduced 
Ll43P Hlp int 
Hl46P mp int strongly reduced 
Ll48R mp 
Ll48Q mp 
PISOV (I) sc int ++ reduced 
PISOV (II) sc int strongly reduced 
'\\'200S mp + 
Q2SIK mp + 
++ wildtype correction; 
+ correction dose to wildtype; 
no correction; 
int intermediate correction of the 43-33 'putant phenotype. 
For most mutants the CFA was determined as described b}' Westerveld et al (1984). (I) and (II) 
refer to two different populations containing the PISOV mutated eDNA. 
Table 1 Summary of ERCCl missense mutations, their expression and correct-
ing abilities 
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Fig. 6 E.xpression of wildt}'pe and missense mutated EReCl proteins. Equal 
amounts (90 ~lg) of whole cell extracts were loaded (pUCPROi'vIH-I, 
PISOV(I), PlSOV(fI}, Sl42V single clones and others mass populations), 
Blots were incubated with affmit}'-purified anti-EReCl antiserum. 
EReCl protein migrates at 39 kDa. Note that the antiserum does not 
recognize the endogenous Chinese hamster EReCl. (I) and (II) refer to 
two different populations containing the P ISOV mutated eDNA. 
gle clone), the overall expression levels are consistently lower than in cells containing 
the wildtype cDNA. As with immunoblot analysis, no ERCCI protein could be de-
tected in transfectant containing the Sl42V construct that failed to correct. 
Amplification and micro.injection 
The remarkable absence of ERCCI protein in most point mutants can be ex-
plained in two ways. Either the mutation renders the ERCCI mRNA or protein 
unstable or the mutation interferes with correct folding of the protein and pre-
vents it from proper association with the other component(s) of the complex. 
Uncomplexed (aberrant or wildtype) ERCCI protein is then rapidly degraded. To 
investigate these possibilities we assessed the fate of an excess of wildtype ERCCI 
protein obtained by DHFR-driven amplification of the wildtype gene and by mi-
cro-injection of purified ERCCI protein in primary fibroblasts. 
In an attempt to overproduce ERCCI protein a construct containing the DHFR 
gene and the wildtype human ERCCI cosmid (Fig. 8A) together with two domi-
nant selectable luarker genes, gpt and ngpt, as positive controls, was transfected 
into 43-3B cells. Transformants containing the different dominant markers and a 
functional ERCCI gene (as determined by wildtype UV and MMC resistance) 
were treated with stepwise increasing methotrexate concentrations inducing am-
plification of the DHFR gene together with its flanking sequences. Southern blot 
analysis and in situ hybridization to metaphase chromosomes revealed a massive 
(100- to more than a 1000-fold) amplification of the ERCCl gene in all stable 
transfectant clones analyzed (e.g. clone 41D in Fig. 8B and 8C, respectively). A cor-
43-38 transfected 43-38 transfected 43-38 transfected 
HeLa with pUCPROMH-1 with P150V with S142V 
Fig. 7 K':pression of (mutated) EReCl in single cells. Cells from transfectant 
P150V are dcriycd from clone (I). Immunofluorescence was carried out 
using affinity-purified anti-EReCl antiserum. HeLa mass population; 
pUCPROMH-l, PlSOV and S142V single clones. Like S142\~ mock-
transfected 43-3B cells displayed no fluorescent staining. 
responding dramatic increase in ERCCI transcripts was found as well (Fig. 8D, 
compare first lane with last lane). In contrast, ERCCI induction on the protein 
level was only approximately 4-fold as estimated by inul1unoblotting (Fig. SE). 
Two-dimensional protein analysis of the transfected cells clearly shows enhanced 
levels of DHFR and co-amplification of gpt and agpt (two genes not selected for), 
whereas no protein spot corresponding to ERCCI could be seen (Fig. SF). Similar 
results were obtained with a number of other transformants carrying the ampli-
fied functional ERCCl gene (data not shown). Apparently, it is not possible to 
overexpress human EReCl protein in Inammalian cells. 
To analyze the stability of wildtype ERCCI protein in another manner, purified 
full-length ERCCI protein and a ubiquitin-ERCCI fusion product (Koken et at 
1993), both overproduced in E. coli, were directly injected into the cytoplasm of 
human primary fibroblasts with the aid of a glass microneedle. Injection of rat 
serum albumin as a control, resulted in a clear cytoplasmic immunostaining 10 
min following injection, which remained fully stable for 1 hr at least. In contrast, a 
similar number of ERCCI molecules (representing more than five times the 
amount normally present in a cell) produced a very weak cytoplasmic staining 
early (within 10 min) after injection with occasional nuclear staining above back-
ground. No exogenous protein could be seen after 1 hr. These micro-injection re-
sults strongly suggest that an excess of free ERCCI is rapidly degraded in the cell. 
Similar results were obtained for the XPB and XPD repair proteins known to be 
part of the basal transcription factor TFIIH (our unpUblished results). 
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Fig. 8 Characterization of tCilosformant 41D. A. Construct used for the DHH~­
driven gene-amplification. Black boxes indicate the sequences derived 
from the ERCCI gene on (os34-3,1 and the pTCF plasmid (containing 
the (lgptgene), whereas open boxes represent regions deri\'cd from plas-
mid pHG (carrying the DHFR gene) and pSV3gptH (carrying the gpt 
gene). B. Southern blot analysis of EeoRI digested DNA (IS J1g) from 
various amplified transformants and I, 10 and 100 copies of the 
transfected construct per genome with a }lP-labeled HRCCI or DHFR 
probe (pHG) to quantify the amplification. C, 111 sitll hybridization on 
41D metaphase spreads with a DHH~ probe. 
D 
E 
0; 
"-
_ OJ 
a __ ~6 
.:s. 0) ..- ..... F + ::1. ____ 
« ..... + + >.-«« 
-->.>. R-5 oo (lJ_c..a. 
.......Jooo 
(l) .......... ,..... 
I,¢...q-'¢ 
----
iffitl 
-ERCCl 
kDa 
214-
111-
74-
45-
kDa 
43-
30-
20-
14-, 
" 
43-
30-
20-
14-
, 
"-
0> 
o ."l 
I " o I 
-
-
'" 
:lifo 
I-ERCCl 
., 
-'''"''''1 
pI-
1 
2 ........ 3 
/' -4 
-
D. Northern blot analysis of total and polyA t RNA from Bela and 41D 
cells. For hybridization a 32P-Iabeled ERCCl probe was used. 1.Jaturc 
EReCl transcript is indicated, but note that precursor and incompletely 
spliced EReC! transcripts hybridize as well. Compare the first and last 
lanes, both containing equal amounts of pol)'A + Ri\JA from Hcla and 
amplificant 41D. E. Immunoblot analysis of 43-3B, CH09, HeLa, and 
41D extracts (20 mg) using crude anti-EReCl antiserum. Full-length 
EReCl protein is indicated. F. Two-dimensional protein analysis of 43-
3B and 41D whole cell extracts. The 2-D gel was sil\Ter stained. (l) actin, 
(2) DHFR, (3) agp', (4) gpt. Note that (co-amplified) ERCCl (39 kDa), 
supposed to be present in the area between these indicated proteins, is 
not detectable. 
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Discussion 
ERCCI mutations were assayed for complementation of the UV sensitivity (NER 
defect) and MMC sensitivity (recombination defect) of the rodent group 1 mutant 
43-3B. In this mutant endogenous ERCCI protein is hardly detectable (Wood per-
sonal communication) and will not compete with the human counterpart for 
complex formation in the transfectants. By deletion analysis of ERCC1, the mini-
mal essential size of the protein for both of its repair activities could be deduced. 
From the N-terminus, one third of the ERCCI protein (91 amino acids) can be 
removed without loss of correcting ability. This finding indicates that this region 
(van Duin et (111986) is not required for the NER nor cross-link repair function of 
ERCCI. Consistently, this region is poorly conserved when compared with 
S. cerev;s;lIe RadlO (van Duin et III 1986) and largely absent in the S. pombe 
homolog SwilO (Widel et (111992). However, a cysteine to tryptophan substitution 
(C76W) within this nonessential part results in a nonfunctional protein (Table 1), 
pointing to a possible role in protein folding. Removal of 102 N-terminal amino 
acids fully inactivates ERCCI. This deletion may affect the transient association of 
ERCCI with the damage recognition protein XPA, since this interaction involves 
amino acids within the region of residues 93 to 120 of ERCCI (Li et (111994). In 
addition or alternatively, based on the homology between RadlO and ERCC1, re-
moval of the 102 residues may abolish the formation of a complex of ERCCI with 
the human homolog of Radl. The stretch of residues 90 to 210 in RadlO has been 
implicated in the binding of Radl (Bardwell et (111992). 
vVithin the central area, missense mutations 'were introduced affecting the best 
conserved part between amino acid positions 138 and 150. Most of these mutated 
ERCCI cDNAs produced reduced amounts of protein and could not fully comple-
ment the repair defect of the recipient cells. The most plausible interpretation of 
these findings is that all the different point mutations affect protein stability, prob-
ably by interfering with complex formation with ERCC4/ERCCll/XPF. Free 
ERCCI molecules are highly unstable inside the cell as was shown for an excess of 
wildtype ERCCI introduced transiently by micro-injection or by continuous 
overexpression in stable amplificants. In line with this observation, the alllount of 
ERCCI protein in human XP-F and rodent group 4 and I I cells is strongly reduced 
(Biggerstaff et 1111993, van Vuuren et (111995), whereas the ERCCI gene itself does 
not carry any mutation and is properly expressed at the mRNA level (our unpub-
lished observations). The transfectants expressing detectable (but lowered) levels 
ofERCCI protein showed a partial correction. This is consistent with the idea that 
this central area is needed for the interaction with ERCC4 and stability of the pro-
tein. Interestingly, the UV sensitivity of the S. cerev;s;lIe mdl-20 mutant is caused 
by a mutation in the Rad 10 binding domain of Radl and is partially corrected by 
overexpression of RadIO protein, presumably increasing the concentration of ac-
tive Radl-RadlO protein complex (Siede et (111993). 
In those cases where diminished amounts of 111utated protein were detected, the 
repair of UV damage (NER) was consistently more impaired than the repair of 
cross-links (recombination). No mutation was found that did affect cross-link re-
pair and not NER. It appears that lower levels of the ERCCI complex are required 
for cross-link elimination than for UV lesion removal. Either the number of 
interstrand cross-links is very low, such that small amounts ofERCCl complex are 
sufficient, the ERCCI complex is Inore active or not the rate-limiting step in cross-
link repair. Some exceptional rodent group 1 and 4 lllutants exhibit just a moder-
ate cross-link sensitivity combined with a full UV impairment (Busch et (1/1994). 
We have found the same for cells from XP-F patients (our unpublished results), 
explaining why XP group F presents a NEll. deficiency rather than a deficiency in 
cross-link repair. 
Several groups reported that increased levels of ERCCI transcripts correlate with 
increased cisplatin resistance of human cells (Gcleziunas et (1/1991, Dabholkar et 
(1/1992, Dabholkar ef (1/1994). However, we found only an approximately 4-fold 
increase in ERCCI protein, despite a massive increase of ERCCI transcripts 
(Fig. 8), and no elevated resistance to lvIlvIC in overproducing cells (Belt et (1/1991, 
our unpublished results). Thus, ERCCI protein levels should be determined, be-
fore conclusions can be drawn 'with respect to an involvement of this protein in 
cisplatin resistance. Consistent with this cautious note and with QUI' idea that small 
amounts of ERCCI complex are already sufficient for the cross-link repair nmc-
tion, no elevated EReCl protein levels were found in nitrogen mustard-resistant 
cells (Bramson ef (1/1995), indicating that increased ERCCI levels are not involved 
in resistance to this cross-linking agent. 
At the C-terminal end, no more than foUl' residues appear to be dispensable for 
both ERCCI functions. An ERCCI protein lacking the C-terminal five amino 
acids, although stable, failed to correct the UV and lvIlvIC sensitivity of 43-3B cells. 
Residue -5 is close to the point where the homology of ERCCI with the C-tenni-
nus of the E. coli UvrC repair protein ends (van Duin et (1/1988). Interestingly, the 
C-terminus ofUvrC itself is also essential for its endonuclease function (Lin and 
Sancar 1991), though residues that are thought to be directly involved in the inci-
sion acth'ity of UvrC may be located elsewhere (Lin and Sancar 1992). It was 
shown that the B(lcilllls slIbtilis UvrC protein can substitute the E. coli UvrC pro-
tein in the UvrABC excinuclease, despite their low homology (38%) (Lin and 
Sancar 1990). Interestingly, residues conserved between in these two proteins are 
also present in ERCCI and are therefore likely to be important for the nuclease 
activit)'. A database search revealed the presence of two S111a11 subdOluains h0111010-
gous to this essential C-terminal part in a large group of proteins implicated in 
either DNA break induction or scaling. Representatives of each class of proteins are 
aligned in Fig. 9. In addition to the known prokaryotic UvrC homologs, inducing 
the 5' (and possibly also the 3') incision during NER (Lin and San car 1991, Lin and 
San car 1992, Moolenaar et (1/1995), this group includes homologs of RadC, a pro-
tein active in recombination-dependent repair of DNA breaks (Felzenszwalb et (1/ 
1992), and NAD-dependent DNA ligases. Furthermore, residues within 
sub domain 1 were found to be conserved in a number of other nucleases among 
which the 5'nuclease domain of T(lq polymerase (Lawyer et (1/1989), the human 
flap-endonuclease FEN-I, equivalent to the 5'->3'endonuclease of E. coli DNA 
polymerase I (Robins et (1/1994), and many of the bacterial members of the 5'nu-
clease family described by Gutman and Minton (E. coli polymerase I amino acids 
188-212 Gutman and Minton 1993). The latter region constitutes the last part of 
the strongly conserved I-region in FEN-l shared with the XPG and S. cerel'isiae 
Rad2 nuclease (Harrington and Lieber 1994a) generating the 3' incision in the 
eukaryotic NER reaction. The crystal structure of Taq polymerase reveals that this 
area adopts a specific o;-heli.'<-turn-o;-heli.,< conformation followed by a long loop 
and two helices (Kim ef aI1995). Its role in the catalysis of the nuclease reaction has 
not yet been resolved. 
This evolutionary evidence strongly suggests that the UvrC-homologous domain 
is somehow involved in the activity of the ERCCI protein, supporting a direct role 
ofERCCI in the incision 5' of the DNA lesion. An ERCC1- Ul'rC hybrid gene, how-
ever, failed to complement the repair defect of the rodent group 1 mutant, indicat-
ing that the C-terminal regions of UvrC and ERCCI have diverged too much to 
allow domain swapping. In this regard it should be uoted that the C-terminus of 
UvrC stops at the -6 position in ERCCI (van Duin ef aI1986), i.e. just beyond the 
-4 residue critical for both ERCCI repair functions. The presence of detectable 
levels of the crucial C-terminally truncated proteins further supports the idea that 
this area is required for the catalysis rather than for stabilization. An ERCCI pro-
tein with two e),.-tra residues at position 208 (see pcDEMP2 in Fig. 1) is also stable 
in the cell and when strongly overexpressed it exerts a dominant negative effect 
(Belt ef aI1991). The poisoning of the ERCCI complex by this mutant protein 
suggests that the catalytic domain may e:}.'tend from the C-terminal end to residue 
208 at least. The conservation of the UvrC homology in mammalian ERCCI and 
S. pombe SwilO contrasts with its complete absence in S. cerel'isiae RadIO (see 
Fig. 4). Nevertheless, purified Radl-Rad10 is capable of incision (Sung ef ai1993b, 
Tomkinson ef 011993, Tomkinson ef aI1994). A possibility is that the Radl-RadlO 
nuclease can do without this d01nain. Perhaps 1110re likely, cryptic sequences £r0111 
the distinct N-terminal part of RadIO can provide this function, or alternatively, 
stretches in Radl that have no match in its S. pombe homolog Radl6. 
In conclusion, analysis of 111utatiollS introduced throughout the coding area of 
ERCCI has revealed dispensability of the poorly conserved N-terminal third of the 
protein, contrasting with a much more stringent need for the C-terminus. :tvIutant 
protein stabilities and local sequence conservation in many DNA break-processing 
proteins, suggest that the C-tcrminal domain is prill1arily required for enzymatic 
activity of ERCC1, presumed to be a structure-specific endonuclease. The central 
region of the protein appears to be involved in protein-protein interactions 
needed for protection against degradation. The repair of cross-links requires lower 
amounts of ERCCI than does NER, which could explain the cross-link resistance 
of XP-F cells and may indicate that the ERCCI-dependent step in this process oc-
curs outside the context of NER. To confirm these findings at the protein level the 
isolation of the other complex components is underway. 
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Fig. 9 Homology of the UvrC-like C-terminal domain ofERCCl with other pro-
teins. Shown is part of the human EReCl (297 amino acids) residues 236-
290, S. pombe $wilO (252 amino acids) residues 178-232, Pseudomonas 
fiuorescens UvrC (607 amino acids) residues 5S1-605, E. coli UvrC (588 
amino acids) residues 555-608, B. subtilis UvrC (598 amino acids) residues 
536-589, B. subtilis RadC (231 amino acids) residues 40-94, E. coli NAD-
dependent DNA ligase (671 amino acids) residues 511-565. an E. coli po-
tential 5'-...?3'e.'(onudease (251 amino acids) residues 176-230, Thermus 
aquaticus polymerase (832 amino acids) residues 190-244, and the human 
a-helix H' looph' a-helix I' a-helix J' 
FEN-1 protein (380 amino acids) residues 232-295 (numbers according 
to van Duin et a11986, Rode! et a11992, Gaffney et a11994, Sancar et al 
1984, Chen et aI 1989, Levin et a11992, Ishmo et al 1986, Shao and 
Newman 1993, Lawyer et al1989, and Murray et alI994). Identical amino 
acids are in black boxes and physicochemically related residues are in gray 
boxes. The consensus sequence is indicated. Symbol designation: X, any 
residue; O,L VI M;6,S TAG P; -,D E; +, KRH; 0, WY F. 
Materials and Methods 
Plasmlds 
The R. coli expression construct pETUbi .. ERCCl described earlier (Koken et al 
1993), encodes an ubiquitin-ERCCI fusion protein, in which the ubiquitin moi-
ety is thought to protect the N-terminus ofERCCl against proteol}1ic degrada-
tion. The N-terminal ubiquitin part can be cleaved off by the enzyme ubiquitin 
lyase (see Koken et al 1993). Plasmid pSVLS is a modification of the pSVI. 
eukarrotic expression vector (Pharmada) in which the EeaRI, SalI, KplIl, and 
HilldIn sites are removed. Subsequently, the ERCCl cDNA, isolated via PCR, was 
cloned behind the strong SV40 late promoter giving rise to plasmid pSVLSE (5.8 
kb). The PCR-derived ERCCI cDNA insert was verified by sequence analysis. 
Plasmid pUCPR01,lH-l (4.2 kb), containing the wildtype ERCCl cDNA under 
the control of its own genomic promoter, has been described previously (van 
Duin et a/ 1987). Plasmids pRSVneo and pSV3gptH respectively harbor the 
dominant selectable marker genes lIeo and gpt (Gorman et at 1983, Westerveld et 
aI1984). Plasmid pHG containing the DHFRgene (O'Hare et (/1981) was used 
to drive gene amplification in mammalian cells. 
Construction of mutant cDNAs 
Missense and C-terminal deletion mutations in ERCCl were introduced using 
site-directed mutagenesis (Kunkel et a/1987). The complete ERCCl cDNA to-
gether ·with its promoter region was inserted in J'v113mp18 (Pharmacia) giving 
rise to rvlp1 8PROl\,I. After mutation induction this insert was used to replace the 
wildtype ERCCI cDNA in plasmid pUCPROr"fH-l. 
The ERCCI-UvrChybrid construct consists of the ERCCI cDNA in which the C-
terminus, conserved between ERCC1 and the E. coli NER protein UvrC, is re-
placed by the C-terrninlls of U\'rC (ERCCI(l-708)-U\'rC(1600-1767)). The 
BUCCI part was amplified using a forward primer containing an optimal trans-
lation initiation sequence and a rC\'erse primer containing ERCCI (697-708) and 
UI'rC (1600-1617) sequences. The complementary oligonucleotide was lIsed (as 
forward primer) to amplify the C-terminus of U\'rc. The two amplified frag-
ments were used as template in a subsequent PCR to amplify the EUCCI-U\'rC 
hybrid gene. 
N-terminal deletion mutations were made via PCR using sense primers contain-
ing an optimal translation initiation sequence. The ERCCI-U\'rC hybrid gene 
and N-terminal deletion mutants were cloned into plasmid pSVL5E, replacing 
the wildtype ERCCI cDNA. 
All mutations were verified b}' sequence analysis. Furthermore, at least h\'o sepa-
rate cDNAs were used to assess the biological effects. 
DNA transfections 
Wild type and mutated ERCCI cDNAs were co-transfected with pRSVneo (in 
some cases after ill I'itro ligation). 43-3B (ERCCl-deficient CHO) cells (Wood 
and Burki 1982) were transfected using either the calciumphosphate DNA pre-
cipitation procedure (Graham and van der Eb 1973) or Iipofectin (BRL) as dc-
scribed (Troclstra et (/11992a). Stable transfectants (mass populations or single 
clones) selected on G418 (800 ~tglJlll, GIBCO) were checked for the presence of 
the intact human ERCCI cDNA by PCR as described earlier (Troelstra et 01 
1992b). 
Survival assays 
To determine the colony forming ability (CFA), DNA constructs (5 to 10 Jlg) 
were co-transfected with pSV3gptH (2 to 5 JIg) into 5'10s 43-3B cells in three 90 
nun dishes, as described previous!}' (Westerveld et aI1984). After 10-14 days of 
selection on mycophenolic acid (MPA, GIBCO) and mitomycin C (J\Uv[C, 
Kyoma) the cells were fixed, stained and colonies were counted, providing a 
rough estimate of the survival. To more precisely determine the correcting ability 
of the mutated ERCCI cDNAs, cells of 43-3B, its parental cell line CH09 and 
stable transfectants were plated at densities \'arying fro111200 to 1000 cells per 60 
mm dish. After attachment, cells were either rinsed with phosphate-buffered sa-
line (PBS) and UV irradiated at yarious doses (Philips TUV low pressure mer-
cur}' tube, IS W, 0.45 J per m2 per sec, predominantly 254 nm) or incubated with 
different doses of f ... H\'IC. The numbers of sun'iving colonies were counted in 
triplicate dishes. 
In some experiments the presence of non-proliferating giant cells hampered ac-
curate colony counting. Therefore, S phase-dependent 3H-thymidine incorpora-
tion, as a measure for the number of proliferating cells, was determined as well. 
To this end, 500 to 5000 cells were seeded in 30 mm wells and either rinsed and 
UV irradiated or incubated with 1U ... ,lC or cisplatin (cis-diamminedichloro-
platinum(II), Lederle) for 1 hr. Seven days later, before reaching confluency, the 
cells were incubated with 3H-thYll1idine (2 JlCi per ml) and 20 mM HEPES for 
I hr, rinsed twice with PBS and incubated for a further 1 hI' in unlabeled medium 
to deplete radioactiye precursor pools. Then, cells were lysed in alkali and radio-
actiyitywas quantified by scintillation counting. The two methods used to deter-
mine mutagen sensitivity, the classical CFA assay and the rapid and simple JH_ 
thymidine incorporation assay, gave essentially the same results. 
Immunoblotting 
Total cell extracts of stable transfectants (90 JIg) were checked for the presence of 
(mutant) ERCCl protein on im.ll1unoblots using affinity-purified anti-ERCCl 
antiserum (yan Vuuren et af1993). 
Two-dimensional electrophoresis was carried out as described by O'Farrell 
(O'Farrell 1975). The proteins were first separated according to their isoelectric 
point (pI) and subsequently at right angles en masse by SDS electrophoresis in a 
polyacrylamide gradient (7.5-20%) gel. 
ERCCl amplification 
Cosmid 43-34 carrying the ERCCI gene, the gpt and the agpt markers 
(\Vester\'Cld et af 1984) was ligated to pHG containing the DHFR-gene and 
transfected to 43-3B cells. Initially, the transfected cells were grown in medium 
containing MPA (25 ~lg per nu) and MMC (10-8 1'0 to sclect for the presence of 
the gptand the ERCCI gene, respectiyely. In parallel, part of the transfected cells 
was treated with UV-light and MPA. Both were followed bya selection on 10 Jlg 
per IllI methotrexate (MTX, Lederle). By stepwise increasing the MTX concen-
tration from 10 to 500 ~tg per ml amplification of the DHFR gene together with 
its flanking sequences was induced. Stably transfected clones were analyzed for 
amplification of the ERCCI gene, transcript and protein. 
Micro-injection 
ERCCI and ubiquitin-ERCCI proteins (0.1 pg), purified from oYerproducillg E. 
coli (Koken et af 1993), were injected into the cytoplasm of human primary 
fibroblasts (XP-G cells were used). Rat serum albumin (RSA) was used as a con-
trol. Cells were fixed 10 min or 1 hr after injection. Immunofluorescence was 
carried out using either the anti-RSA or anti-ERCCl antisera. 
In situ hybridization 
1'letaphase spreads of 41D cciis were used for ill sitll h),bridization with AAF-
modified pHG as a probe as described elsewhere (Landegent et ai 1984). Hy-
bridization was visualized using rabbit anti-AAF and peroxidase-conjugated pig 
anti-rabbit antisera. 
Immunofluorescence 
Cells grown on slides were rinsed with PBS and fixed in PBS containing 2% 
paraformaldehyde for 10 min and in methanol for 20 min. After extensh'e wash-
ing with PBS supplemented with 0.15% glycine and 0.5% BSA the slidcs were 
incubated ·with pre-immune or affinity-purified anti~ERCCI antiserum (1:100 
dilution in PBS) for 1.5 hr at room temperature, rinsed and stained with goat 
anti-rabbit-FITC antiserum (1:80 dilution) for 1.5 hr. Finally, the slides were 
rinsed and sealed in Vectasrneld mounting medium (Vector) containing 4;6'_ 
diamidino-2-phcllylindole and propidium iodide (DAPI) as a nuclear marker. 
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Nucleotide excision repair) which is defective in xerodern13 pigrnentosUlll, in-
volves incision of a DNA strand on each side of a lesion. We isolated a human 
gene homologous to yeast Radl and found that it corrects the repair defects of 
XP group F as well as rodent groups 4 and 11. Causative mutations and strongly 
reduced levels of encoded protein were identified in XP-F patients. The XFF 
protein was purified from mammalian cells in a tight complex with ERCC1. 
This complex is a structure-specific endonuclease responsible for the 5' incision 
during repair. These results demonstrate that the XPF, BRCC4, and BRCCll 
genes are equivalent, complete the isolation of the XP genes that fOl"m the core 
nucleotide excision repair system, and solve the catalytic function of the XPF-
containing complex. 
Introduction 
A coordinated interplay between multiple subunits is required to carry out NER in 
eukaryotes. The first steps of the process lead to lesion recognition and incision of 
the damaged strand on each side of a lesion. A 24- to 32-mer oligonucleotide is 
removed, followed by gap-filling DNA synthesis (Huang et a11992, Friedberg et al 
1995, Moggs et aI1996). In human cells, this repair pathway involves the xero-
derma pigmentosum (XP) proteins and associated factors. Individuals with XP 
show hypersensitivit}, to sunlight and a greatly increased incidence of skin cancer. 
Genes encoding the XPA, XPB, XPC, XPD, and XPG proteins have been isolated 
(Hoeijmakers 1994), and a factor defective in at least some XPE cells has also been 
identified, although it is not required for the core NER system (reviewed by Wood 
1996). XP-F is the only remaining NER-defective XP group for which a comple-
menting cDNA has yet to be identified. 
There is evidence that the two incisions made during NER are catalyzed by separate 
DNA cndonucleases. In humans, XPG endonuclease makes the 3' incision relative to 
the lesion (O'Donovan et al 1994a, Matsunaga et al 1995). XPG and its yeast 
homolog Rad2 specifically cleave near junctions of unpaired and duplex DNA, cut-
ting the strand in which the unpaired region moves from 3' to 5' away from the 
junction (O'Donovan et a11994a, Harrington and Lieber 1994a, Habraken et al 
1995). In S. cerevisiae, the Radl and RadIO proteins form a heterodimeric complex 
having a structure-specific endonuclease activity with a polarity opposite to XPG 
and Rad2, leading to the assumption that the Radl-RadIO complex makes the 
5' incision during NER in yeast (Bardwell et a11994, Davies et al 1995). ERCCI is the 
mammalian homolog of RadiO (van Duin et (11986) and has been found to associ-
ate with activities that correct human XP-F cell extracts as well as extracts [fOl11 Chi-
nese hamster cells of repair complementation groups 4 and II (Biggerstaff et a11993, 
van Vuuren et aI1993). A polypeptide of relative molecular mass of approximately 
115 kDa has been observed to co-puri~' with ERCCI by several assays and has been 
proposed as a candidate for a Radl homolog (Aboussekhra et al 1995, Park et al 
1995a, van Vuuren etaI1995). We decided to search directly for a human homolog of 
S. cerevisiae Radl and test it for possible correcting activity in XP-F and rodent group 
4 and II cells and extracts. 
Results 
Isolation of a human homolog of yeast Rad1 
A pair of approaches were combined to isolate a human homolog ofRadl. Degen-
erate primers designed on the basis of homology between S. cerevisiae Radl 
(Reynolds et al 1987), S. pombe Radl6 (Carr et al 1994), and Drosophila 
me/allogaster Mei-9 (Sekelsky et al 1995) were used in a reverse transcriptase-
polymerase chain reaction (RT-PCR). The amplified sequence was used as a probe 
to isolate a human eDNA clone coding for an open reading frame with sequence 
similarity to the C-terminal half ofRadl and its homologs. The N-tenninal half of 
the human gene was identified in a database search using S. cercl'isiae Radl and 
S. pOll/be Radl6, which detected two human expressed sequence tag clones encod-
ing an open reading frame that overlapped with the RT-PCR clone. RACE (rapid 
amplification of eDNA ends)-PCR confirmed the expressed sequence tag se-
quence. The compiled sequence of the assembled eDNA (shown schematically in 
Fig. lA) contains an open reading frame that encodes 905 amino acids (EMBL 
accession number U6431S for nucleotide sequence). The sequence conte,,'! of the 
first ATG in the clone at position 16 matches the consensus translational start site 
(Kozak 1987), although an initiation site slightly further upstream is not excluded. 
The predicted protein has a relative molecular mass of 103 kDa and pI of 6.35. 
Homology of the protein to Radl, Radl6, and Mei-9 is most pronounced between 
residues 699-758 (Fig. IB), a region located in the RadIO binding domain of/tadl 
(Bardwell etaI1993). In the N-terminal half, several leucine-rich repeats are con-
served that may be involved in protein-protein interactions (Schneider and 
Schweiger 1991). The relatively poorly conserved central area harbors putative nu-
clear targeting sequences (Dingwall and Laskey 1991). Motifs known to be in-
volved in DNA binding or endonuclease function were not found. In a protein 
sequence property search using the PropSearch algorithm (Hobohm and Sander 
1995), the only high scoring hits found with all four Radl family members were 
eukaryotic homologs of DNA mismatch repair proteins MutS and MutL, human 
Abr proteins, and Blouse Rh. 
By means of ill situ hybridization, the Radl homolog was localized to human chro-
mosome 16pI3.1-13.2 (Fig. 2A). This corresponds to the locus of a human repair 
gene complementing rodent NER mutants of group 4, identified using cell hybrids 
(Liu et a11993) and a genomic clone (Thompson etaI1994). 
= RACE -------PBSChhRad16 
----- Rad16026 
---------HGS238927 
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Fig. I Cloning of a human Rodl homolog. A. Schematic representation of the 
sources of eDNA used to assemble the functional gene. The open read-
ing frame is indicated by an arrow. 
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Fig. 1 Cloning of a human Rad] homolog. B. Alignment of residues 1 to 905 of 
the encoded protein with S. ccrcl'is;ac RadI, S. pombe Rad16, and 
D. melmlOgaster JVlei-9. The starting positions of two mutations in XP-F 
patient XPl26LO are marked with circles above the human sequence, 
and the position of a polymorphism is marked with a caret. 
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Correction o!XP·F and rodent group 4 and 11 cells by the human gene 
To determine whether the human homolog could correct one of the rodent UV· 
sensitive ll1utants, particularly of group 4, the eDNA in a mamnlalian expression 
vector (pcDNAhhRadI6) was transfected into UV41 (ERCC4-), UVSl (ERCCll-), 
and 43-3B (ERCCl-) cells. Stably transfected mass populations ofUV41 were ob-
tained that exhibited normal resistance to UV and the cross-linking agent MMC, 
to which rodent group 4 (and I) mutants are extremely sensitive (Fig. 2B). This full 
correction of UV 41 was confirmed by the protein expression studies described be-
low and indicates that the cloned cDNA encodes ERCC4. As expected, transfected 
43-3B cells did not survive UV selection (data not shown). However, 
pcDNAhhRad16 also conferred UV- and partial MMC-resistance on UVSl, the 
only representative of rodent group 11 (Fig. 2B), indicating that it is also the group 
11 correcting gene. This was surprising, since complementation between UVSl 
cells and two different group 4 mutants, UV47 and UV41, has been previously 
observed by independent laboratories (Hata ef 0/1991, Busch ef 0/1994). Tlms, the 
two rodent groups represent a unique case of intragenic complementation at110ng 
mammalian repair genes. The underlying Inechanis111 remains to be elucidated 
and requires cloning and sequencing of the hamster genes. Interestingly, there is a 
parallel in S. pOlllbe, in which the rad16.20 allele, which encodes the N-terminal 
45% of the protein, was complemented by a plasmid encoding the C-terminaI60% 
of the Rod16 gene product (Carr ef 011994). 
To study further the identity of the human gene product, we raised antibodies in 
rabbits against recombinant C-terminal fragment. The affinity-purified antiserum 
recognized a protein band lnigrating on gels at a relative molecular Inass of ap-
proximately 115 kDa in extracts from Chinese hamster and normal human cells 
(Fig. 3A). Chinese hamster mutant UV4I cells transfected with the complement-
ing cDNA regained a band of the same size (data not shown), showing that the 
cDNA encoded a full-length or near full-length polypeptide. The same protein 
band was strongly reduced in a HeLa extract depleted for ERCCI and present in 
the anti-ERCCI antiserum-bound fraction (Fig. 3B), confirming its presence in 
the ERCCI complex. 
As outlined in the Introduction, ERCCI and ERCC4 correcting activities are found 
in a complex that also harbors correcting activity for XP group F. Although we 
have previously found reduced levels ofERCCl protein in cells from XP-F patients 
(Biggerstaff ef a11993, van Vuuren ef 011995), ERGCl was explicitly excluded as 
the gene responsible for XP-F (van Duin ef aI1989). To determine whether the 
Radl homolog is involved in XP group F as well, we micro-injected 
pcDNAhhRad16 into the nucleus of fibroblasts from an XP-F patient. The repair 
defect was specifically and fully corrected to the level ofUV-induced unscheduled 
DNA synthesis in normal cells (see Fig. 2C, Table I). Moreover, injection of the 
ERCC4 antiserum into normal human cells caused specific and complete inactiva-
tion ofNER (Fig. 20) but had no effect on transcription (Table 1) or base excision 
repair (data not shown), two cellular processes distinct from NER. The inhibitory 
action of the antibodies was competed by pre-incubation with the C-terminal 
ERCC4 fragment but not by bovine serum albumin (data not shown). 
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Mutations in an XP·F patient 
To obtain direct proof that the Radl homolog is responsible for the xp. F repair 
defect, we searched for mutations in the gene. Restriction endonuclease finger-
printing (REF) indicated sequence alterations in the C·tenninal part of both 
alleles from patient XP126LO (Norris et n11988) (Fig. 3E) and in a second unre· 
lated individual with xp·F. RT·PCR clones (2) of each allele were compared by 
REF analysis with the original PCR mb:ture, and both were sequenced to rule out 
PCR-induced mutations. Sequencing both clones of one allele of XP126LO re-
vealed a 4-nucleotide deletion, TCTC, in a repetitive sequence (TTCTCTCTCA) at 
position 2281, possibly caused byreplication slippage, resulting in a frameshift and 
a truncated protein of 803 amino acids (Fig. 3D). Both clones of the other allele 
carried a C to T transition at nucleotide 2377, presumably due to deamination of a 
methylated cytosine at a CpG site, changing arginine residue 788 (conserved in 
S. pOlllbe, Drosophila, and human) into a tryptophan (Fig. 3D, R788W). In addi-
tion to these mutational alterations, two sequence polymorphisms were found. 
One at nucleotide 2090 (A to G) results in Asp or Gly in the human sequence, at a 
position coding for Gly in D. lIIelnllognster and S. cerel'isine and Asn in S. pOll/be. A 
preliminary analysis to estimate the frequency of this polymorphism showed that 
the Gly residue was present in more than 10 wildtype alleles examined. The second 
polymorphism at nucleotide 2487 (C to T) does not change the amino acid. 
We conclude that the Radl homolog is indeed responsible for the repair defect in 
XP group F. In accordance with nomenclature agreements (Lehmann et n/1994), 
the name XPF is recommended for this gene and XPF for its encoded protein. 
!'ig.2 The doned eDNA corrects the rodent complementation group 4 and 11 
and XP-F mutant phenotypes. A. (I) Chromosomes (blue) from a single 
cell showing hybridization to the p arm of each chromosome 16 (red. 
arrows), (II) E.xample of a single chromosome 16 with hybridization sig-
nal (left: G-band-likc diamidophenylindole pattern shown as an i1wcrse 
black and white image. right: diamidophenylindole-stained chromo-
some with gene signal). (III) Idiogram of chromosome 16 showing the 
assigned band position of the Radl homolog. B. S\tf"h'al of UV41 and 
UVS1 transfectanls after treatment with UV and l\U"IC. Bars represent 
standard errors of mean. C. Effect of micro-injection of the human 
Radl homolog on UV-induced unscheduled DNA synthesis in XP-F 
cells. D. Effect of micro-injection of anti-ERCC4 antiserum on UV-in-
duced unscheduled DNA synthesis in normal cells. Arrows point to in-
jected polynuclear fibroblasts, obtained by cell fusion of XP126LO (XP-
F) or repair-proficient normal fibroblasts, both containing three nuclei. 
Arrowhead indicates a cell in S-phase during incubation with 3H-thYIIli-
dine to monitor DNA repair synthesis. 
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Fig. 3 ERCC4(:A'"PP) protein. A. E.xpression of ERCC4 protein in UV41 com-
pared with normal Chinese hamster ovary CH09 cells. B. Immunoblot 
showing depletion of ERCC4 from a HeLa total cell extract using an 
anti-EReCl antiserum (HeLa-ERCC1) and retention on the antibody 
beads. The different Janes represent equal amounts of starting material. 
C. £::...-pression of ERCC4 protein in XPl26LO (XP-F) cells compared 
with SV40-transformed normal cells. The ERCC4(XPF) protein band is 
indicated. A similar reiatiyc difference in the amount ofXPF protein was 
found when total cell extracts of primar)' fibroblasts from normal and 
scwral other XP complementation groups were compared with three 
XP-F fibroblasts. Equal amounts of whole cell extracts were loaded, and 
blots were incubated with crude (B) or affmit}'~purified (A, C) antise-
rum. Both the hamster and the human XPF protein migrate at 115 kDa. 
D. Sequence showing mutations in the Radl homolog. E. REF analysis in 
XP-F patient XPI26LO. Shown is the C~terminal part after digestion of 
DNA from XP-I: cells (XPI26LO and XP42RO) or normal cells with 
Bad, Sad, and StilI. Aberrant migration is indicated. 
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Injected substance Injected cell line Cellular process Activity 
assayed (% of normal) 
no injection XPl26LO (XP-F) NER 15± 3 
peDNAhhRad16 (ERCOI eDNA) }''P126LO NER 105± 8 
pSVL5E (ERCCI eDNA) XP126LO NER 15± 2 
no injection XPCSlBA (XP-B) NER 7±1 
pcDNAhhRad16 (ERCC4 cDNA) XPCSIBA NER 8±1 
pre-immune serUIll CSRO (normal) NER lOO± 8 
anti-ERCC4 antibodies C5RO NER 4±1 
anti-ERCC4 antibodies C5RO transcription 104±4 
NER activity was determined as tN-induced unscheduled DNA s}'llthesis (see Fig. 2) and 
transcription was measured as 3H-uridine incorporation. Mean values pIlls or minus standard 
errors of the mean are in percentage of normal cells. 
'fable 1 1Hcro-injection of eDNA constructs and antibodies into human cells, 
Purification ofXPF protein in a complex with ERCC1 
To study the catalytic function of the ERCCI-XPF protein complex, we purified it 
Ii'om cells producing functional His-tagged ERCCI protein. ERCCI-defective 
Chinese hamster 43-3B cells were transfected with His-tagged human ERCCI 
eDNA, selected for repair competence, and extensively characterized to ensure sta-
ble e)q>ression and function of the His-tagged ERCCI. Immunochemical staining 
confirmed expression of His-ERCCI protein in the nuclei of transfected 43-3B 
cells (Fig. 4A to D), and il1lmunoblotting showed that normal amounts ofERCCI 
were produced (Fig. 4E). The transfected His-ERCCI fully corrected both the UV 
and Ml'vIC sensitivity of 43-3B cells (Fig. 4F and 4G). The usc of His-affinity cluo-
matography on chelated nickel columns in combination with five other purifica-
tion steps resulted in a preparation containing three major polypeptides revealed 
by silver staining, with relative molecular 111aSSeS of 42 kDa, 60 kDa, and 115 kDa 
(Fig. SA). Immunoblotting identified the 42 kDa band as His-tagged ERCCI and 
the lIS kDa band as XPF protein, respectively (Fig. SB). The ERCCI and XPF pro-
teins co-eluted at each step, and began to separate fi'om the 60 kDa protein and 
minor contaminants upon gel ftItration chromatography (Fig. SA, see different 
peak fractions for ERCCI-XPF and the 60 leDa band), glycerol gradient sedimen-
tation, or on Reactive Yellow 86 agarose (Fig. SC). These results indicate that the 
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ERCC1 protein complex is a heterodimer of ERCC1 and XPF, consistent with the 
suggestion of Park et at (1995a). Functional activity was shown by several criteria. 
The complex could correct the defect in dual incision exhibited by ERCCl and 
ERCC4 mutant cell extracts, as well as ex1:racts from UVS1 cells (Fig. GA). Human 
XP-F cell extracts were also corrected by purified complex, as shown in a repair 
synthesis assay for NER (Fig. GE) and in the dual incision assay. The complex did 
not contain correcting activity for other mutant cell extracts (Fig. 6B). In addition, 
the complex was active in a fully reconstituted repair system (Aboussekhra et at 
1995, data not shown). 
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Fig. 4 Functional expression of His-tagged EReC1 in Chinese hamster 43-3B 
cells. Nuclear localization of His-EReCl protein, detected by inllnUilO-
fluorescence microscopy using anti-EReCl antibody in A. 43-3B cells, 
B. 43-3B cells transfected with His-tagged or C. wildtype EReCl, and 
D. HeLa. E. Immunoblot with anti-EReCl antibody showing EReCt 
c.\:pression levels. Similar protein amounts were loaded. Note that the 
His-tag causes a mobility-shift on SDS-polyacrylamide gel electro-
phoresis and that the anti-EReCt antibody does not recognize Chinese 
hamster ERCCI. 
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Fig. 4 Functional eXl'ression of His-tagged EReCl in Chinese hamster 43-3B 
cells. F and G, Human His-EReCl protein full}' corrects the UV- and 
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Purified ERCCI-XPF complex. A. Fraction V was separated on G 
Superose 12 gel filtration column. Fractions were analyzed by SDS-poly-
acrylamide gel electrophoresis and silver-stained. EReCt and XPF are 
indicated. B. Immulloblot of Fraction V using an antibody raised against 
full-length ERCCI and an affinity-purified antibody raised against the 
C-terminal part ofXPF (see Fig. 3), C. Fraction VI after purification on 
Reacth'e Yellow 86 agarose. 
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Fig. 6 Repair-correcting activity of ERCCI-XPF complex. A. Autoradiograph 
of Southern blot. Platina ted DNA fragments corresponding to 
nonincised DNA (84 nl), uncoupled 5' incisions (61,64, and 65 nt), un-
coupled 3' incisions (42,48, and 49 nt), and dual incisions (24 to 32 nt) 
·were detected after hybridization with a .32P-Iabeled 27 mer probe com-
plementary to the DNA sequence surrounding the cisplatin cross-link 
(.t'vloggs et (/1996), as shown in the schematic diagram. Incision reac-
tions were incubated for 30 min using 200 ~lg of protein from the cell 
extracts indicated. The complementing factor added to UVSl 
(ERCCl!), UV4l (ERCC4),and 43-3B (ERCCl) cell extracts (lanes 3, 5, 
and 7. respectivel}') was ERCCI-XPF (fraction V, 1 ~Il, approximateiyO.l 
pmol complex). Cell extract (200 ~Ig of protein) from 43-38 cells ex-
pressing His-tagged EReCl was used for lane 8. XPG83 and XPG415A 
cell ex'iracts were complemented with 50 ng of purified XPG protein 
(O'Donovan et al 1994b, lanes 12 and 14, respectiveI}'), and XP-A 
(G~.J2345) cell extract was complemented with 90 ng of purified XPA 
protein (Jones and Wood 1993, lane 10). B. Assay for repair s}'nthesis, 
with human XP-F cell ex'iract, and ex'iracts from Chinese hamster UVSI 
cells and 27-1 cells (a hamster XPB/ERCC3 mutant). Repair synthesis is 
monitored by incubating cell extracts with a mixture of undamaged 
(-UV) and UV-damaged (+UV) circular plasmid DNA in a reaction 
mixture that includes a_J2P_dATP (Wood et aI1995). Lanes 1,2,4,5,7, 
and 8 had lOa ~Ig of the indicated extract (CFIT fraction). I.anes 3 and 6 
had 50 ~Ig of each CPU fraction. Purified ERCCl-XPF protein (fraction 
\~ 1 ~tI) was added in lanes 2, 5, and 8. 
ERCC1-XPF is a structure-specific DNA endonuclease 
To determine whether the purified ERCCI-XPF complex had structure-specific 
endonuclease activit)" we used a partially self-complementalY oligonucleotide to 
form a stem-loop structure consisting of a 22-nucleotide single-stranded loop and 
a duplex stem of 12 base pairs (Fig. 7A). This substrate was end-labeled on either 
the 3) or 5) terminus and reaction products were analyzed by comparison to DNA 
sequencing markers, to map the exact sites of cleavage. The ERCCI-XPF complex 
specifically cleaved the stem of this substrate 2, 3, and 4 phospho diester bonds 
away from the 5' side of the loop (Fig. 7 A lanes 2, 3, 6, and 7). These incisions co-
localized precisely with those catalyzed by yeast Radl-RadlO proteins (Fig. 7A 
lanes II, 12, IS, and 16). Conversely, human XPG protein cleaved the substrate on 
the 3' side of the loop, at the phosphodiester bond on the stem-loop border, and 
one bond into the stem (Fig. 7A lanes I and 8). No cleavage was observed when 
NIg2+ was Oll1itted from reaction mixtures. 
Several approaches showed that incision activity was intrinsic to the ERCCI-XPF 
complex. Structure-specific nuclease activity could be directly followed during the 
last steps (V and VI) of purification and always co-eluted with the ERCCI and XPF 
polypeptides. Furthermore, agarase beads coupled to anti-ERCCI antibodies 
could precipitate the nuclease in an active form on the beads, while beads coupled 
to pre-immune serum could not precipitate active complex (Fig. 7B). These find-
ings clearly demonstrate that incision activity is inherent to the ERCCI-XPF com-
plex. When DNA polymerase I (Klenow fragment) and deoA),nucleotides were 
added after cleavage of the stem-loop, the small DNA incision product was quanti-
tatively converted to approximately 36-mer, indicating the presence of an OH-
group at thc 3' terminus of the incision product (Fig. 7C). 
A "bubble" substrate containing a centrally unpaired region of 30 nucleotides 
(O'Donovan et at 1994a) flanked by duplexes of different sequence was also 
cleaved by ERCCI-XPF, near the 5' side of the junction between the duplex and 
unpaired region. However, we did note that ERCCI-XPF cleaved the stem-loop 
structure more readily than the bubble structure, while XPG preferred the bubble 
over the stem-loop (data not shown). Additional NER incision step factors such as 
XPA or RPA were not detectable in the purified preparation and are not required 
for the structure-specific nuclease activity of ERCCI-XPF with these substrates. 
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Fig.7 The ERCCI-A'PF complex is a structure-specific endonuclease. A. The 
structure of the stem-loop substrate is shown below the gel. Arrows 
indicate the sites of cleayage for the indicated enzymes, as determined 
from }."Iaxam-Gilbert sequencing ladders. For 5' labeling, Maxam-Gil-
bert products migrate approximately 1.5 nucleotides faster than the 
corresponding nuclease products. The 22 T residues are indicated by 
brackets. Lanes 1 to 5, 3' -labeled stem-loop with lane 1, XPG (50 ng)j 
lanes 2 and 3, ERCCI-XPF (purified fraction V, 1 and 2 gl, respec-
tively)j lanes 4 and 5, ~vlaxam-Gilbert G+A and C+ T sequencing lad-
ders. Lanes 6 to 10, 5'-labcled stem-loop with lanes 6 and 7, ERCCl-
XPF (purified fraction V, 1 and 2 ~d, respectively); lane 8, XPG (50 ng), 
lanes 9 and 10, G+A and C+T sequencing ladders. Lanes 11 to 14, 
3'-labeled stem-loop with: lane 11, Radl (100 ng) and RadIO (25 ng); 
lane 12, ERCCI-Xl)F (1 gI, fraction V); lanes 13 and 14, Maxam Gil-
bert G+A and C+ T sequencing ladders: Lanes 15 to 18, same as 11 to 1,1 
with 5' -labeled stem-loop. 
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Fig. 7 The ERCCI-XPF complex is a structure-specific endonuclease. B. Nu-
clease activit}' isolated on antibody-amnit}' beads. lane 1, 5' _32p_ 
labeled marker oligonucleotides. Lane 2, 5' -labeled stem-loop plus af-
finity-purified anti-EReCl antibody-beads (hum) pre-incubated with 
purified ERCCI-XPF. Lane 3, as lane 2 but with 3'-labeled stem-loop. 
Lane 4, as lane 3 but with pre-immune antibody-beads (Pre) pre-incu-
bated with purified ERCCI-XPF. C. Analysis of the 3' end of the cleav-
age product. Lane I, 5'-32P-labeled stem-loop plus purified ERCCl-
)''PF complex. Lane 2, 5' -labeled stem-loop c1eayed with ERCCI-XPl', 
followed by incubation with the Klenow fragment of E. coli DNA 
polymerase I (Pol I Kf) and unlabeled d1\TTPs.lane 3, unlabeled stem-
loop cleaved with ERCCI-XPF, and then extended with Pol I (Kf) and 
.l2P-labeled dNTPs. lane 4, control reaction in which unlabeled stem-
loop was incubated with Pol I (Kf) and 32P-Iabeled dNTPs. 
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These data demonstrate that the ERCCI-XPF complex is a structure-specific en-
donuclease cleaving one strand of DNA near borders between duplex and single-
stranded regions. The polarity of enzymatic cleavage of model substrates strongly 
suggests that the ERCCI-XPF protein complex makes the 5' incision during NER. 
This is indeed the case during repair, as shown in Fig. 6A. This assay simultane-
ously detected excision products resulting from dual incisions as well as uncoupled 
single incisions in DNA containing a specifically located cisplatin cross-link. SOll1e 
uncoupled 3' incisions (without the 5' incisions) can be observed in nannal cell 
extracts (see Fig. 6Alane I, see also Matsunaga et nI1995). In very strong reactions, 
some uncoupled 5' incisions also can be detected (Fig. 6A lane 14, see also Maggs et 
nI1996). XP-G extracts (defective in 3' endonuclease activity) or XP-A extracts 
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(missing the damage recognition protein XPA) were defective in incision (Fig. GA 
lanes 9, II, and 13). Although ERCCI- or XPF-deficient cell extracts were unable 
to generate 24-32-nucleotidc excision products, fragments corresponding to un-
coupled 3' incisions were still detected (Fig. 6A lanes 2, 4, and G). The ERCCI and 
XP-F cell extracts therefore specifically lack the ability to make the 5' incision. Ad-
dition of purified ERCCI-XPF complex to the extracts restored 5' incision activity 
and generated normal excision products (Fig. GA). 
Discussion 
Identification of the human XPF gene 
In this study, a single human eDNA was isolated that can fully correct the faulty 
repair in XP-F cells as well as in rodent group 4 and II cells. Although this has been 
suggested previously, based on indirect indications (Biggerstaff et n/1993, Reardon 
etnl1993b, van Vuuren et nl1993, Park et n11995a), this provides a unique demon-
stration that XPP, ERCC4, and the group 11 defects are allelic. Intriguingly, the 
correspondence between rodent groups 4 and II is the only known case of 
intragenic c01l1plemcntation between mammalian NER 111utants. The cloning of 
XPP completes the isolation of the set of XP genes that are required for the core 
process ofNER in mammalian cells. The gene is also the final one correcting the six 
original complementation groups of rodent repair 1l1utants that have been classi-
fied by Busch, Thompson, and coworkers (Busch et nI1989). 
We find that the encoded XPF(ERCC4) protein is intrinsic to an active ERCCI-
containing protein complex. The mutations located in the examined XP-F cells 
occur in the region expected to be involved in ERCCI binding, based on studies of 
the homologous yeast complex (Bardwell et n/1993). We have noted that ERCCI 
111utations interfering with complex fonnation result in rapid degradation of 
ERCCI and that the degree of sensitivity to UV-light and MMC depends on the 
amount of ERCCI complex expressed (our unpublished data). The reduced 
amount of XPF protein detected in extracts of XP-F cells (Fig. 3A), 43-3B, and 
UVSI rodent cells (data not shown) closely resembles the strongly reduced levels 
of ERCCI protein in these cells that we reported earlier (Biggerstaff et n/1993, van 
Vuuren et n11995) and suggests that complex formation is required for the stability 
of the XPF component as well. In rodent mutants, hypersensitivity to MMC occurs 
only at very low levels ofERCCI (our unpublished data). The residual amount of 
ERCCI-XPF complex present in XP-F cells may account for their moderate sensi-
tivity to MMC and the slow extended repair characteristic of XP-F (Zelle ef nl 
1980). 
XPF protein is a subunit of the nuclease that makes the 5' incision 
These studies with purified ERCCI-XPF show that the complex has an intrinsic 
structure-specific endonuclease activity. There are significant parallels with the 
homologous nuclease complex formed by the Radl-RadlO proteins in 
S. cerel'isine. The yeast complex consists of two subunits that are sufficient to per-
form incision (Sung et nl 1993b, Tomkinson et nl 1993, Bardwell ef nl 1994, 
Tomkinson ef aI1994). Our data, including the findings that the 115 kDa compo-
nent of the human is XPF and is equivalent to ERCC4 and ERCC11 , are completely 
consistent with an heterodiIlleric composition in mammalian cells as well. Moreo-
ver, the cleavage specificities ofERCCI-XPF and Radl-RadlO are identical, both 
on the stem-loop structure (Fig. 7 A) and on other substrates. The polarity of cleav-
age for these enzymes is the opposite of that mediated by XPG nuclease, and the 
incision sites of ERCCI-XPF are slightly further from the stem-loop junction than 
those mediated by XPG. Although it was known that XPG and Radl-RadlO 
cleaved near the border of single-stranded and duplex DNA, these data represent 
the only example in which cleavage sites have been definitively mapped at nucle-
otide resolution. 
In addition, experiments with a specifically placed cisplatin-DNA adduct showed 
directly that the structure-specific endonuclease activity ofERCCI-XPF is responsi-
ble for the 5' incision during the nucleotide excision repair reaction. Finally) it was 
determined that the product resulting from cleavage by the human enzyme has a 
3' OH group, so that gap-filling DNA synthesis can start at the 5' incision site without 
additional DNA modifications. The fragments produced by dual incision still retain 
a 5' phosphate (Moggs et aI1996), indicating that ERCCI-XPF makes the 5' nick 
without further processing. Since only the damaged DNA strand is cleaved during 
nucleotide excision repair, it is likely that lesion-dependent positioning of other inci-
sion components such as XPA, RPA, TFIIH, and XPC restricts the action of the two 
structure-specific repair endonucleases (XPG and ERCCI-XPF) to the damaged 
strand. 
In contrast to the above findings and to those in yeast, a purified preparation con-
tailling ERCCI and ailS kDa polypeptide from HeLa cells was reported to lack 
any structure-specific DNA endonuclease activity on a bubble substrate, acting in-
stead as a weak single-stranded endonuclease (Park et aI1995a). However, the ab-
sence of cleavage ill the single-stranded regions of the stem-loop or bubble struc-
tures in our assays shows that the ERCC1-XPF complex does not cut single-
stranded DNA indiscriminately. 
Consequences o!XPF-ERCC1 complex inactivation 
In the mouse, full inactivation of the ERCCI gene results in a severe phenotype 
causing early death (Mc'~~lir et al 1993, Weeda and Hoeijmakers unpublished 
data). This extreme phenotype suggests that the mammalian ERCCI-XPF com-
plex has a function ill addition to NER. In yeast, the homologous Radl-RadlO 
proteins are known to engage in a pathway of mitotic recombination by single-
stranded DNA annealing (Davies et al 1995, Ivanov and Haber 1995). The 
enzymatic activity demonstrated here for ERCCI-XPF suggests that this complex 
would also be suitable for such a recOll1billation process in mammalian cells. Im-
painnent of the recombination function of the ERCCI-XPF complex (which is 
presumably required for repair of MMC-induced DNA cross-links) may underlie 
the severe phenotype of ERCCI null mice. 
In contrast, the known XP-F patients have relatively mild clinical symptoms, and 
some are reported to survive into their sh"ties (Yamamura and Ichihashi 1989). It 
relllains to be seen whether all group F individuals with the sun-sensitive disorder 
xeroderma pigmentosum express a low level of ERCCI-XPF complex, and 
whether a complete absence of ERCC1-XPF is compatible with human viability. 
Materials and methods 
Isolation of the human XPF eDNA 
The 5' part of the gene was isolated by using the S. pombe Radl6 and S. cere\'isiae 
Radl sequences to search a database of human expressed sequence tag sequences 
(Adams et al1991, Adams et nI1995). Of two e~l'ressed sequence tag clones de-
tected, the longer (HGS238927) was from a human testis cDNA library. The in-
sert of approximately 2.1 kb encoded a polypeptide with homology to the 
N-terminal part of Rad16, Radl, and 1·[ei-9. The HGS238927 insert was used to 
screen a human testis cDNA library by hybridization, which identified a clone 
(RadI6026) with additional 5' terminal sequencc. RACE on multiple cDNA li-
braries confirmed the sequence of Rad16026 and the presumed AUG initiation 
codon. 
Tb isolate the 3' part of the genc, numcrous degcnerate primers were designed for 
regions in which the Radl,Radl6and D.melmlOgasterlHei-9gene products show 
sequence consen'ation. In positions where onc species differed from two others, 
the majority rule was followed. At positions where all three differed, the residue 
in the species most closely related to mammals was utilized. Conditions for PCR 
amplification were optimized using S. pombe cDNA as starting material. Prod-
ucts ·were evaluated further onl), if they corresponded to the predicted size. One 
appropriate primer pair was 5'-TIGTIGAT/CATGA/CGIGAAJGTT-3' and 
5' -CIGGIGTlAAJGLATAfGTAAfCTCICCLAC-3'. The protocol for this PCR am-
plification was 4 min at 94°C (hot start). followed by 35 cyclcs of 1.5 min at 94°C, 
1.5 min at 41°C and 1.5 min at 72°C. The final C}'cle was concluded with 10 min 
at n°C.Reaction mi~iurcs in 60 IlllvI Tris-HCI buffer (pH 8.5) contained 15 mM 
(l\TfI")2S0", 2.5 111M MgCI1• 0.2 mM dNTPs, 100 pmol primers, and SuperTaq 
(HT Biotechnology, ltd.) in a Perkin Elmer Cetus DNA thermo cycler. RNA from 
a non-XP-F primary fibroblast cell line or HeLa cells was used for random 
hexamer-primed RT-cDNA synthesis using standard conditions. Aftcr \'erifica-
tion that the amplified product was derived from a human gene with clear ho-
molog}' to Radl, the PCR product was used as a probe to identify a clone from a 
human testis cDNA library that encoded a polypeptide with homology to the C-
terminal part of the ycast and fly proteins. The insert was cloncd into 
pBlucscript, yieldingpBSChhRadl6. The 5' end of the pBSChhRadl6 clone over-
lapped by 338 bp with the 3' end of the HGS238927 sequence. 
To construct a complete cDNA, we first subcloned a 1636 bp BsaAI fragment 
from pBSChhRadl6 into the pBluescript vector carrying HGS238927, to obtain 
pBSHGSChhRadI6. A human fibroblast cDNA library (Kcyse and Emslie 1992) 
was used in a peR to obtain a fragment containing the most N-terminal se-
quence flanked by SarI and EngI sites. This PCR fragment was SacI-EagI-digestcd 
and separately subcloned into the pBluescript vector carrying HGS238927. An 
801 bp Ba111HI-XbaI fragment from the latter construct was inserted into 
pBSHGSChhRad16 to crcate a plasmid containing the complete coding se-
quence, pBShhRad16. The sequence of the assembled cDNA was determined on 
both strands and matched all partial cDNA clones and RACE sequcnccs. For ex-
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pression in mammalian cells, a 2940 bp NotI-ApllI fragment from pBShhRadl6 
was doned into pcDNA3 (hwitrogen), yielding pcDNAhhRad16. 
Mutation analysis 
The gene was amplified in two oyerlapping segments in an RT-PCR using total 
RNA isolated from Xlq; and normal cells. for REf analysis, the products were 
digested with different sets of restriction enzyilles in the presence of shrimp alka-
line phosphatase. Pooled digestions were 5' end-labeled with 32p by T4 polynu-
cleotide kinase, denatured, and single strands separated based on their confor-
mation, on a nondenaturing polyacrylamide gel containing 5% glycerol and run 
at 4°C (Lin and Sommer 1995). Fragments of the two alleles were subdoned and 
sequenced from XPI26LO, XP42RO (both XP-F cell lines), and normal primary 
fibroblasts (wildtype). 
Fh,orescence in situ hybridization 
The Radl homolog cDNA was nick-translated using Digoxigenin-dUTP 
(Boehringer ~vfannheim), and fluorescence ill situ hybridization was done as de-
tailed (Johnson et (/[1991). Individual chromosomes were counterstained with 
diamidophenylindole, and images were recorded using a charged coupled-device 
camera and analyzed using ISEE software (Inovision Corp.). Spreads (approxi-
matel)' 20) were analyzed by ere, and most had a doublet signal characteristic of 
genuine hybridization on at least one chromosome 16. Doublet signal was not 
detected on any other chromosomes. Individual chromosomes (10) were 
analyzed in detail using a combination of fractional length measnrements and 
fluorescence banding combined with high resolution image analysis. 
Selec.tion and characterization of 43-38 His·fRCC1 cells 
A tag sequence was introduced at the 3' end of ERCCI by PCR methods, to en-
code a fusion protein consisting of normal full-length human ERCCI cDNA fol-
lowed by Gly-Gly-Ser, a thrombin cleavage site, and sLx His residues. This con-
struct (pSVL-ERCCI-His) was transfected into 43-33 cells (Wood and Budd 
1982) and repair-competent transformants were selected after repeated UV irra-
diation (4.6 1 per m2). The number of cells surviving treatment with UV or 
JvH,,'IC (1 hr) was measured as 3H-thymidine incorporation 6 days after exposure. 
Proliferating cells were pulse-labeled with tritiated thymidine (l hr), followed by 
a chase (1 hr) to deplete radioactive precursor pools. Cells were lysed in 0.05 lv[ 
NaOH and transferred to scintillation-counting vials. Survival was calculated as 
the average ratio of incorporated radiolabel in treated duplicates to that in four 
untreated control dishes. 
Correc.tion of rodent mutants by transfection 
pcDNA3 (neo) and pcDNAhhRad16 were transfected into UV41, UVSl and 43-
33 cells using iipofectin, as described previollsi)' (Troelstra et aI1992a). Stable 
transfected mass populations were selected on G418 (800 ~lglml) and UV (UV41 
three times 8 J per m2 and UVSl three times 18 J per m2). Subsequently, 500 to 
5000 cells were seeded in 30 mill wells and either UV irradiated or incubated 
with the cross-linking agent Mi'viC for 1 hr. Survival was measured as JH-thymi-
dine incorporation 7 days after exposure. 
Micro.injection 
pcDNAhhRad16 or anti-ERCC4 antiserum was injected into one of the nuclei of 
- 66-
XP126LO {XP-F} homopol),karyons or into the cytoplasm ofC5RO (normal hu-
man primary fibroblasts) homopolykaryons. Repair activity was determined af-
ter 24 hr by UV-induced (15 J per ml) incorporation of 3H-thymidine and auto-
radiography as described (Vermeulen et alI994a). The number of silYer grains 
above the nuclei is a measure of the level of unscheduled DNA synthesis and 
reflects the cellular repair capacity. 
Immunological methods 
An E. coli ex 'Pression construct was made coding for a GST-ERCC4 fusion pro-
tein containing the 391 C-terminal residues present in pBSChhRad16. Antibod-
ies raised against fusion protein were isolated on a glutathione column and affin-
ity-purified. Immunofluorescence, SDS-polyacrylamide gel electrophoresis, and 
inullunoblotting were performed according to standard procedures (Sambrook 
et a11989), using polyclonal antibodies against human ERCCI and ERCC4. A 
HeLa whole-cell extract was depleted for EReCt using anti-ERCCI antiserum 
coupled to protein A beads. 
Isolation o!ERCCf-XPF protein complex 
ERCCI-XPF complex was isolated from 43-3B His-ERCCI cells, monitoringpu-
rification by immllnoblotting using an antibody against ERCCI and by repair-
correcting activity. A nuclear extract (lvlasutani et al1994) was prepared from 
1.4· 1011 frozen cells and dial)'zed against buffer A (20 mt-'f HEPES-KOH pH 7.5, 
0.2 mM EDTA, 2 mt.'1 MgCIl, 10% glycerol, 0.2 m1\'14-(2-aminoeth),l)benzene-
sulfonyltluoride,5 mM p-mercaptoethanol) containing 0.151\1 KCI and 10 ~{gI 
m1 of aprotinin. The extract (1.5 g) was loaded onto a phosphocellulose column 
(Whatman PI 1, 300 mt) equilibrated in the same buffer. The flow-through frac-
tion contains the incision protein RPA and proteins not needed for NER (Shhii 
et aI1992, Biggerstaff etalI993). 
Bound proteins (Fraction I, 600 mg protein) were eluted with buffer A contain-
ing 1.0 rvJ KCt, supplemented with 1 mr-.'l imidazole (Fluka), and applied directly 
onto a Nj2+ -NTA agarose column (Qiagen, 25 m1). The column was washed at 25 
m1/hr and eluted sequentially with bufter B (20 mM HEPES-KOH pH 7.5, 2 mZ,,1 
MgClz' 10% glycerol, 0.2 mM 4-(2-aminoethyl)benzenesulfonylfluoride, 5 mM 
p-mercaptoethanol, 0.5 M KCn containing 1 IIIlv!, 5 mM (pH 6.6), 20 mM (pH 
7.5), and 100 mM imidazole (pH 7.5). ERCCl was eluted in the last fraction 
(Fraction II, 35 Illg protein), supplemented with 0.02% NP-40 and 1 mt-,l potas-
sium phosphate, and loaded onto a hydroxyapatite column (Bio-Rad, 3 mI). The 
column was washed with buffer C {25 mM HEPES-KOB pH 7.8, 10% glycerol, 
0.2 mM 4-(2-aminoethy1)benzenesulfonylfluoride, 2 mM dithiothreitol, 0.02% 
NP-40} containing 5 mM potassium phosphate and 0.5 M KCl. ERCCI was 
eluted in buffer C containing 30 mM potassium phosphate and 0.5 M KCi (Frac-
tion Ill, 10 mg). The fraction was dialyzed against buffer C plus 1 111M EDTA and 
50 mM KCt, filtered through a 0.45 ~lm filter (.1Hllipore), and applied onto an 
FPLC J'.,.[ono Q HR 515 column (Pharmacia). A gradient of 50-300 m1'I KCI in 
buffer C was applied, and 0.5 Illl fractions were collected. ERCCl eluted at about 
0.2 jv[ KCi. ERCCI-containing peak fractions (Fraction IV, <1 m1) were pooled, 
diluted to 50 m1'! KCl with buffer C,loaded onto an FPLC Mono S column and 
eluted with a gradient of 50-300 mM KCl. Peak fractions (Fraction \~ 1.5 ml, 
approximately 0.1 pmol ERCCI complex/~ll) eluted at approximately 0.22 M 
KCl. A SMART system (Pharmacia) was used for the Superose 12 gel filtration in 
Fig. SA. For Fig. 5C, 20 I-ll of fraction V was diluted 1:2 in buffer C and added to 
10 Jll of swollen Reactive Yellow 86 agarose (Sigma) to give 50 ~ll in 25 mM 
HEPES-KOH pH 7.8, 10% glycerol, 2 nuv! dithiothreitol, and IOOmM KCI.After 
I hr at 4°C, the sllspension was centrifuged and 30 ~Il of supernatant loaded onto 
the gel. 
In vitro DNA repair and nuclease assays 
The assay for dual incision was as described (1vloggs et aI1996), except that the 
plasmid was cleaved with HilldIII and X/wI before detection by Southern hy-
bridization. Repair synthesis assays used CFII protein fraction from thc indicatcd 
cells, purified RPA, and purified proliferating cell nuclear antigen, as previously 
dcscribcd (Biggerstaff ct aI1993). Nucleasc reaction mixtures (15 Jll) contained 
0.2 to 0.5 ng stem-loop DNA and the indicated proteins in buffer as described 
(O'Donovan et a11994a) for Fig. 7A lanes 1 to 10, or in buffer D (50 m~vI Tris-
HCI pH 8.0, 10 m~\'I 1",IgC!2' 100 Jlglml bovine serum albumin and 0.5 m~\'I p-
mercaptoethanol) for lanes 11 to 18. After incubation at 25°C for 2 hr, 15 Jl190% 
formaldehyde was added, samples were heated at 95°C and loaded onto denatur-
ing 12% polyacrylamide gels. Products were visualized b}' autoradiography or a 
phosphorimager.J\'Iaxam-Gilbert A+G and C+ T reactions were carried out on 
the 3'- and 5' -labeled stem-loop substrates in order to locate the sites of 
enzymatic cleavage. For immunopredpitation, affinity-purified anti-ERCCI an-
tiserum (30 pI) ·was coupled to 10 Jll protein G beads, and beads were extensi\'Cly 
washed and incubated with the indicated amount ofERCCl-Xl)F complex in 20 
JlI of buffer D at 4°C. After 2 hr, beads were washed twicc·with 100 ~II of buffer D 
and added to nuclease reaction mh.1ure. Samples were then loaded on a denatur-
ing 20% polyacrylamide gel. For the end-labeling analysis in Fig. 7C, reaction 
mb .. 1ures containing 5' -labeled (lanes I and 2) or unlabeled (lanes 3 and 4) stem-
loop substrate were incubated for 16 hr at 16°C, with or without ERCCI-XPF 
complex (1 JlI of fraction V) as indicated. In lane 2, 1 JlI of 5 m!v[ dNTPs plus 1 U 
E. coli DNA pol I (KIenow fragment) was added for a further 30 min. I:or lanes 3 
and 4, 5 nmol dGTP, dCTP, and dTTP and 2 nn101 a_J2P_dATP were added for 30 
min, followed by a 90 min chase with 10 nmol unlabeled dATP. 
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CHAPTER 4 
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The second Caucasian xeroderma pigmentosum patient (XP42RO) belonging 
to complementation gronp F (XP-F) is described. Mild ocular photophobia was 
present from childhood, and acute skin reactions occurred upon exposUl'e to 
sunlight. Basal and squamous cell carcinomas developed after his twenty-sev-
enth year. In his late forties progressive neurologic symptoms emerged, which 
included intellectual decline, mild chorea and ataxia, and marked cerebml and 
cerebelar atrophy. Such neurologic abnormalities are very unusual in XP-F. 
Similar symptoms have been described in only one of 17 other XP-F individuals. 
His about 5-fold reduced activity of nucleotide excision repair in cultured cells, 
combined with moderately affected cell survival and DNA replication after UV 
exposure, are typical of XP-F. The recent cloning of the XPF gene allowed a mo-
lecular genetic analysis of this unusual patient. XP42RO, representing the sec-
ond case studied in this respect, turned out to be homozygous for a point muta-
tion in the XPF gene, causing an R788W substitution in the encoded protein. 
SUl'prisingly, this mutation had also been found in one allele of the other unre-
lated Caucasian XP-F case. The amount of mutated XPF protein is strongly re-
duced in cells from XP42RO, presumably due to a conformational change. Bio-
chemical, genetic, and clinical data all indicate the presence of considerable re-
sidual repair activity, strongly suggesting that the R788W mutation is leaky. 
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Introduction 
The autosomal recessive disease xeroderma pigmentosum is clinically manifested 
by photosensitivity of skin and eyes and early onset of freckling and other lesions 
on sun-exposed skin, culminating in a high propensity to neoplasms, especially 
carcinomas. Progressive neurologic degeneration occurs in SOlne XP patients, 
vaf}ring from central nervous system abnormalities to, in rare cases, additional pe-
ripheral nerve dysmyelination characteristic of Cockayne syndrome (Cleaver and 
Kraemer 1994). The photosensitivity of XP patients is due to defective NER, a 
process responsible for the removal of DNA damage induced by UV and diverse 
chemical mutagens. NER is a complex mechanism, requiring the correct interplay 
of about 30 different genes (Aboussekllfa eta11995, Mu et aI1995). Seven of these, 
named XPA to XPG, were found to be defective in XP patients. The XPA, XPC, and 
XPE proteins are probably involved in damage recognition, whereas XPB and XPD 
mediate subsequent local unwinding of the DNA helix. XPF and XPG are required 
for strand cleavage at either side of the DNA lesion. In the final stages of NER, the 
damaged patch is removed and replaced using enzymes from the DNA replication 
machiner),. 
Most NER-defective XP patients are affected in XPA or XPC, followed by XPD. XPF 
and XPG defects arc less frequent and only rare cases with XP-B and XP-E have 
been described. A patient with a mutated XPF gene, first identified in 1979 by ge-
netic complementation analysis (Arase et aI1979), showed relatively mild cutane-
ous symptOllls and no neurologic involvement. This picture is characteristic of the 
XP-F patients reported later on, all from Japan (Nishigori et a11986, Yamamura et 
a11989) except for one ti'OIll Europe (Norris et a11988) (see Chapter 61hble 1). 
One exceptional Japanese case was identified having neurologic abnonnalities 
(Moriwaki et aI1993). Here we describe a European XP-F patient with multiple 
carcinomas and other mild oculocutaneous symptoms, who developed marked 
neurodegeneration after his late forties. In view of this unusual clinical picture, we 
conducted detailed biologic and biochemical studies of his NER capabilities. After 
the recent cloning of the XPF gene (Chapter 3) molecular genetic analysis has also 
become possible. Here we report the second XP-F patient studied in this respect. 
To our surprise, we found a homozygous mutation, identical to one of the XPF 
alleles of the first patient. 
Results 
DNA repair studies 
The overall activity of NER was assayed in cultured skin fibroblasts as UDS, i.e. 
UV-induced incorporation of tritiated thymidine was measured byautoradiogra-
phy. In the patient, NER after exposure to 10 J per m' was reduced to 22% of nor-
mallevels (see Table 1, top panel) and varied between 15% and 30% on other occa-
sions (not shown). NER in the cells of the father was in the normal range (L1ble I). 
Genetic complementation analysis was performed to identify the gene defect. After 
fusion of XP42RO fibroblasts with one or two known representatives from all 
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seven XP groups A through G (for strains see materials and mcthods)) nonnal or 
near-normal UDS leyels were obtained in all cases except for the XP-F strain 
XP126LO where UDS remained low in the heterokaryons (data not shown). This 
result assigns the patient to XP group F. Cell suryiyal studies showed that the rela-
tiyely low NER activity resulted in only moderate UV cytotoxicity, much less 
marked than in XP cells from group A (Fig. IA). This behavior is characteristic of 
XP-F as shown here for XP2YO (Fig. IA) and for other XP-F patients elsewhere 
(Arase et a11979, Nishigori ef a11986) (Chapter 6 Table I). Also the consequences 
for the overall rates of DNA synthesis, measured 16 hr after UV exposure, were 
only moderate: the inhibition was much less pronounced than in XP-A cells, and 
similar to an XP-C strain (Fig. 113), known to be intermediate in this respect. The 
cells from the patient's fathcr showed a nonnal behavior in the latter two assays 
(only DNA synthesis is shown in Fig. 113). 
Case report 
Patient XP42RO,aged 62 years, is one of nine siblings from nonconsanguineous parents of Dutch 
origin. From about 10 years of age he developed irregularly pigmented macules and telangiecta-
sia on cheeks, temples and dorsa of hands. From his fifteenth to twenty-seyenth year he worked 
outdoors as a farm laborer, experiencing frequent acute sunburn reactions. Since his thirties,nine 
basal or squamous cell carcinomas haye been remoyed from sun-exposed areas. ~md photopho-
bia and occasional conjunctival vasoinjection were present from childhood. At age 47. his 24 hr 
and 72 hr MED were 0.08 and 0.04 J per cml ofUV-light. respectively, corresponding to the most 
sensitive type I skin individuals. 
After the age of 47. neurologic symptoms started to appear in the form of progressiye dysarthria. 
clumsiness, restlessness. and a mild chorea. Ataxia with unstead},gait,d),smetria of the limbs. and 
saccadic dysmetria of ocular moyement are now present. Nuclear magnetic resonance showed a 
corresponding marked atrophy of the cerebelum and cerebral cortex. Electroencephalogram, re-
flexes, and audiogram were normal. Signs of central nerve conduction impairment were noted in 
somatosensory and motor evoked potentials. Electromyography findings suggested mild 3..xonal 
pol)'lleuropath),. Neurophysiologic testing revealed deficiencies in attention. concentration, and 
recall as well as visuospatial and constructional deficits. l-chloro-2,4-dinitrobenzene testing 
(Bleumink et (1/1974) revealed a normal cell-mediated immune response. The patient is married 
without offspring, due to gonadal dysplasia. The family history revealed that sun sensitivity was 
also noted in the father. but without the development of severe skin lesions and neoplasms. None 
of the patient's siblings are known to have similar neurologic or cutaneolls problems. 
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Sample tested 
Standard NER assu}' 
XP42RO (patient) 
95RD28 (father) 
C5RQ (normal control) 
1licro-injection of "A'PF eDNA 
:x.'P1 26LO uninjected 
XPl26LO injected R788W eDNA 
Xl'126LO injected wt eDNA 
C5RQ uninjccted 
d mean ± SE1·1 (number of nuclei) 
b%ofnormal 
Grains per nucleusa 
12.9 ± 0.6 (50) 
55.4 ± 2.5 (50) 
58.7 ± 2.7 (50) 
5.5 ± 0.6 (24) 
12.0 ± 0.7 (27) 
22.9 ± 0.9 (27) 
20.6 ± 0.5 (29) 
Repair activityb 
22 
96 
27 
58 
Il2 
Table 1 Correction of NER activit}' in XP42RO 
A 
2.5 5.0 7.5 10 
UV flue nee (Jim') 
'" ·iii 
'" .c C 
» 
'" « 
z 
0 
~ 0 
100 
40 
20 
B 
• XP42RO (patient) 
.. 95RD28 (father) 
V XP2YO (Xp·F) 
o XP21RO (XP·C) 
A XP25RO (XP·A) 
o C~~O (normal) 
2.5 5.0 7.5 10 
UV fluenee (Jim') 
Fig. 1 Cellular responses to UV exposure. A. Survival assay. B. Inhibition of 
DNA synthesis measured 16 hr after variolls doses ofm~ All points rep-
resent averaged duplicate measurements. 
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Molecular genetic studies 
Recently, the XPF gene was cloned (Chapter 3), which allows mutational analysis 
of the affected gene in this patient. Initial REF analysis by single-strand conforma-
tion-sensitive gel electrophoresis indicated the presence of specific sequence ab-
normalities in the downstream end of cDNA amplified liOl11 XP42RO mRNA. 
These were partly similar to the ones observed in XP126LO, another XP-F indi-
A So eDNA genomic DNA ro~gJ §O:~ ~\ normal XP42RO XP42RO 95RD28 Ii< gxx G 
" 
G 
e err i< A 
I r 
c c 
,.~I AI patient father \ A 
,~l!'4 G G 
NLS ERCC1-BD 
l ~4 rmt! 1M I l"(' " ,1905 
tI~ R788W XPF in vitro D 
translates 
"' .... normal R788W 
kDa 
------
'W ."~~- ~-~. total cell extracts 106-
~. 69--- normal 95RD28 XP42RO XP126LO 
,,",.j .. 
-''''''''*'' 44-
Fig. 2 l...Iutational analysis ofXP42RO. A. REF analysis. The restriction enzyme 
fingerprint is shown of the 3' end of eDNA from normal, XP126LO, and 
XP42RO cells after digestion with EaeI, Sad and StilI. Aberrant bands 
arc indicated. B. Sequence showing C to T transition in eDNA and ge-
nomic DNA. C. Schematic structure ofXPl; protein with R788W muta-
tion. Domains shown in gray are highly conseryed; LRM, lellcine~rich 
motif; NLS, putatiYe nuclear location signal; ERCCl-BD, region re-
quired for ERCCl binding. D. J\{igration of XPF(R788\V) and normal 
XPF illl'itro translated proteins in a denaturing gel. Bands smaller than the 
full-length protein of 115 kDa represent N-terrninally truncated species 
caused by translational starts on internal AUG sites. Aberrant slower mobil-
ity of mutated XPF is more readily yisible in the shorter C-terminal prod-
ucts consistent with the mutation being situated in the C-terminal part of 
the protein. E. Immunoblot of equal amounts of cell-free protein ex-
tracts with anti-XPF antiserum (Chapter 3), 
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-XPF 
B 
C 
E 
vidual (Fig. 2A). XPI26LO had been shown earlier to carry a 4-nucleotide deletion 
in one allele coding for a truncated protein, 803 residues in length, and a C to T 
transition in the other changing amino acid residue 788 from arginine to tryp-
tophan (R788W) (Chapter 3). Subsequent sequence analysis of the region in 
XP42RO revealed that this patient is homozygous for the R788W mutation (Fig. 
2B). Investigation of genomic DNA verified the homozygous (or hemizygous) 
state of the patient and established the father as carrier (Fig. 2B). Material from the 
mother was not available for analysis. 
Consequences of the R788W mutation 
To determine the relevance of the observed change for ill !'ivo NER, an XPF cDNA 
carrying the mutation was cloned in a manlInalian expression vector with a strong 
promoter and micro-injected into the nuclei of XP-F strain XPI26LO. This 
overexpressed XPF species could correct the NER defect only very partially, 
whereas the nonmutated cDNA produces fully normal levels ofNER upon micro-
injection (Table I, bottom panel) (Chapter 3). However, significant residual activ-
ity was evident, which shows that the R788W substitution is not a null-mutation. 
On the protein level, the ll1utation causes an aberrant electrophoretic mobility de-
tected in denaturing sodium dodecyl sulfate-polyacrylamide gel electrophoresis of 
ill vitro translated polypeptides (Fig. 2D), indicative of a considerable conforma-
tional change. In XP42RO cell extracts, the amount of XPF protein is strongly re-
duced, as measured by immunoblotting (Fig. 2E). The levels were also low in 
XPI26LO but were intermediate in the father (Fig. 2E), in agreement with his het-
erozygous state. 
Discussion 
Patients with a mutated XPF gene are mostly found in Japan, where it is the most 
common form ofXP after XP-A. Outside Japan, XP-F is rare. This patient XP42RO 
represents only the second Caucasian case ever reported. The first case was an Eng-
lish patient XPI26LO (Norris et a/1988). Characteristic ofXP-F are mild cutane-
ous Iuanifestations, relatively late onset of cutaneous carcinomas, and the absence 
of neurologic abnormalities. Clinical, photobiological, and repair hallmarks of 
published XP-F cases are summarized in Chapter 6 (Table I). 
Acute sun sensitivity reactions 'were reported in 14 of 18 patients. The subnonnal 
!vIED peak at 24 hr in our patient corresponded with that in seven of 10 other 
XP-F patients, whereas it was low in only three. Delayed or morphologically abnor-
mal photosensitivity reactions have been reported in the majority of XP patients, 
consistent with the delayed reaction at 72 hl' seen in our patient. 
lVlalignant skin tumors first appeared between 27 and 47 years of age, which is 
relatively late for XP patients in general, but early among the nine of 18 XP-F cases 
where tumors have arisen. The prevalence of only basal and squmnous carcinomas) 
characteristic for XP-F, is also lower than in XP-A and XP-D patients. Obviously, 
tumor risk also depends on total UV exposure and medical care. Our patient, who 
had been extensively exposed to sunlight for at least twelve years, contrasts with 
nine tumor-free patients of whom four were still vel")' young (Chapter 6 Table 1). 
Residual repair activity is similar to the other XP-F patients. This four to sLx times 
reduction of overall NER rate seems to be in contradiction with an only moderate 
UV cytotoxicity and nucleic acids synthesis inhibition, a unique feature typical for 
the XP-F group also found in our patient. This behavior is thought to be caused by 
a partially impaired NER activity which proceeds longer and is less reduced at later 
times after exposure (Zelle et a11980, Arase et aI1990). The rather mild cutaneous 
and ocular manifestations of XP-F are in line with these repair characteristics. 
Whereas the UV-sensitive phenotype of our patient is rather typical of XP-F, the 
neurologic abnormalities that started to develop in the patient's late forties are 
unusual and have been reported in only one exceptional Japanese case so far 
(Moriwaki etaI1993), with a type and onset of neurologic symptoms grossly simi-
lar to our case. Five of the other patients 'were much younger at the time of report) 
but in three aged 50 to 73 there was no evidence of neurologic problems. In gen-
eral, central nervous systenl dysfunction is not unconllnon in XP. However) usually 
only cases with the most severe photosensitivity are affected, such as those in 
groups A and D (Andrews et aI1978), where the problems develop at an early age. 
Robbins et al (1993) reported neurologic degeneration in a mildly sensitive XP-C 
patient who was in her forties. However, in our case with comparable Illild NER 
impairment the origin may be distinct and specifically related to the XPF defect as 
the course of the neurologic disease was different from that of the XP-C patient. 
Peripheral nervous system problems such as dysmyelinatio111 which afC not present 
in our case) are found in another repair disorder Cockayne syndrOIne and in rare 
cases that combine the features of XP and CS (Nance and Berry 1992). Such pa-
tients occur in XP groups B, D, and G only (Hamel et a11996, Vermeulen et al 
1997). Therefore, these abnormalities were proposed to be associated with subtle 
disturbances in basal transcription, a process requiring the proper functioning of 
the XPD and XPB proteins (Vermeulen et aI1994b). 
The nonstandard clinical picture of our patient prompted us to perform a more 
detailed molecular genetic analysis. The assignment to group F by complemen-
tation analysis was confirmed on the molecular level by the identification of a ho-
mozygous mutation in the XPF gene. A C to T transition (probably due to 
deamination of a methylated cytosine at a CpG site) at nucleotide 2377 changes 
the basic arginine residue 788 of the encoded protein into a hydrophobic tryp-
tophan. This mutation is physiologically relevant and most likely responsible for 
the patient's NER defect, because overexpression of micro-injected mutated cDNA 
cannot fully correct UDS in XP-F cells. Surprisingly, the same R788W mutation 
had been found earlier in one of the alleles of the unrelated English patient 
XPI26LO (Chapter 3). Both this point mutation and the C-tenninal truncation 
encoded by the second allele ofXPI26LO affect the region of the XPF protein that 
is required for stable physical interaction with another repair enzyme called 
ERCCI (Chapter 5, Fig. 2C). Uncomplexed free XPF and ERCCI proteins are un-
stable ill vivo (Chapter 2). Therefore, the strongly reduced levels of XPF protein 
that we observed in both patients' cells (Chapter 3) and the deficiency ofXP-F cells 
in ERCCI protein (Biggerstaff et a11993, van Vuuren et a11995, Yagi et a11997) 
would be readily explained by this interaction failure. However, ill I'itro the R788W 
protein could still bind ERCCI (our unpublished data). It follows that the appar-
ent XPF protein instability ill I'il'o is related to the conformational changes that we 
detected in a denaturing gel. 
In the process ofNER, the ERCCI-XPF protein complex catalyses strand incision 
at the 5' side of the DNA lesion (Chapter 3, Bessho et al1997b). Because this stn!C-
ture-specific endonuclease activity is essential for reconstitution of NER in vitro 
(Aboussekhra et al1995, Mu et al1995), the presence of significant residual repair 
in the XP-F cells suggests that in most patients the mutations are leaky. Intrinsic 
residual activity in the R778W mutated protein was apparent from its capability to 
partially restore repair in micro-injected XP-F cells that overexpress it. 
In conclusion, a homozygous R788W mutation in the XPF gene underlies the NER 
defect of patient XP42RO. The mutation causes strongly reduced but still detect-
able levels of XPF protein. The biochemical defect results in clinical and cellular 
UV-responses that are mild and typical of other XP-F cases reported so far. 
Whether the R788W substitution is also responsible for the unusual late-onset 
neurologic symptoms in the patient remains to be seen) because the other Euro-
pean XP-F patient with the same mutation and showing no neurologic symptoms 
(Norris et al1988) was still young (22 years old) at the time of report. Moreover, 
extended case finding and mutational analysis, currently in progress, will also shed 
light on the possibility that R788W represents a Caucasian founder mutation. 
Materials and methods 
Cell strains and culture 
Primary skin fibroblasts were cultured routinely in Ham's FlO medium supple-
mented with 15% fetal bovine serum and antibiotics. Cell strains used were 
X1'42RO (patient), 95RD28 (patient's father), XP25RO (XP-A), XPIIBE (XP-B), 
XP20RO, XP2lRO, and XP3MA (XP-C), XPIBR, and XP2CS (XP-D), XP2RO 
(XP-E), XP2YO, and XP I 261.0 (XP-F),XP3BR (XP-G),and CSRO (normal con-
trol). 
DNA repair studies 
The UV SOUTce was a standard germiddalmercUTY tube emitting UV-C rars of 
predominantly 25,1 nm. NER activit}'was assayed in cultured fibroblasts as UDS, 
by measuring UV-induced incorporation of tritiated thymidine in 
autoradiograms, as described elsewhere (Vermeulen et (/1 1994a). The number of 
grains above the nuclei represents the cellular repair activity. The short-term ef-
fect ofUV on nucleic adds synthesis was similarly assayed by 3H-thymidine in-
corporation 16 hr after irradiation (Hamel et (/[1996). A simplified assay was 
used for cellular survival (Hamel et (/[1996). In short, sparsely seeded, 2-day-old 
cultures were e;'\-posed to graded UV doses. Three to five days after irradiation, 
the number of proliferating cells was estimated by liquid scintillation counting 
of tritiated thymidine incorporated during a 3 hr pulse. For complementation 
analysis, XP cells were fused using Semiai virus and assayed for UDS after 24 to 
,18 hr, as described (Keijzer et a/1979). 
General biochemical procedures 
Nucleic acids purification, restriction enzyme digestions, gel electrophoresis, and 
immunoblot analysis were performed according to standard procedures 
(Sambrook et aI1989). Coupled ill \'itro transcription and translation reactions 
using the TNT reticulocyte lysate system were performed as described by the 
manufacturer (Promega). Labeled translation products were analyzed by stand-
ard sodium dodec}'l sulfate-polyacrylamide gel electrophoresis. 
Mutational analysis 
The XPF gene was amplified in two overlapping segments by PCR from cDNA 
prepared from total cell RNA isolated from cultured fibroblasts using random 
hexamers. Products were digested with different sets of restriction enzymes and 
5' end-labeled with 32p-phosphate (Chapter 3). Labeled single strands were sepa-
rated based on conformation in nondenaturing polyacrylamide gels containing 
5% glycerol and run at 4°C, as described (Uu and Sommer 1995). Amplified 
genomic or cDNA fragments were directly sequenced. 
Micro-injection 
XPF cDNA subcloned in a mammalian expression vector pcDNA3 was 
microneedle-injected into one nucleus of XPF-deficient XPl26LO homopoly-
kar}'ons. After a 24 hr expression period, UV-UDS was measured in the injected 
cells (Vermeulen etaI1994a). 
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ERCC!-XPF is a heterodimeric protein complex involved in nucleotide excision 
repair and recOInbillationaI processes. Like its homologous complex in 
S. cerevisiae, RadlO-Rad!, it acts as a structure-specific DNA endonuclease, 
cleaving at duplex-single-stranded DNA junctions. In repair, ERCCI-XPF and 
RadlO-Rad! make an incision on the 5' side of the lesion. No humans with a 
defect in the ERCCI subunit of this protein complex have been identified and 
ERCCI-deficient mice suffer from severe developmental problems and signs of 
prematUl'e aging on top of a repair-deficient phenotype. Xeroderma 
pigmentosum group F patients carry mutations in the XPF subunit and gener-
ally show the clinical symptoms of mild DNA repair deficiency. All XP-F pa-
tients examined demonstrate reduced levels of XPF and ERCCI protein, sug-
gesting that proper complex formation is required for stability of the two pro-
teins. To better understand the molecular and clinical consequences of muta-
tions in the ERCCI-XPF complex, we decided to map the interaction domains 
between the two subunits. The XPF-binding domain comprises C-terminal 
residues 224 to 297 of ERCCI. Intriguingly, this domain resides outside the re-
gion of homology with its yeast RadiO counterpart. The ERCCI -binding do-
main in XPF maps to C-terminalresidues 814 to 905. ERCCI-XPF complex for-
mation is established by a direct interaction between these two binding do-
mains. A mutation from an XP-F patient that alters the ERCCI-binding domain 
in XPF indeed affects complex formation with ERCCI. 
Introduction 
Nucleotide excision repair is a cellular process that guards the integrity of the ge-
nome. It removes a wide variety of lesions from the DNA, including bulky DNA 
adducts and the most prominent UV-induced damages. During NER, a dual inci-
sion is Illade asymmetrically around a lesion to allow its release as part of a larger 
(24 to 32 nucleotides) DNA fragment (Huang et a11992, Mu et a11995, Moggs etal 
1996). The remaining gap is filled by DNA synthesis and ligation (Aboussekhra et 
al 1995, comprehensively reviewed in Friedberg et al 1995). The mammalian 
heterodimeric protein complex ERCCI-XPF is a structure-specific endonuclease 
that catalyzes incision on the 5' side of the lesion during NER (Chapter 3, 
Matsunaga et a11995, de Laat et aI1998a). Like XPG, which makes the 3' incision 
(O'Donovan et aI1994a), ERCCI-XPF is thought to be positioned through pro-
tein-protein interactions with other repair factors ,Hound a partially unwound 
DNA intermediate (Evans et a11997a, 1997b, Mu etaI1997b). Defects in one of the 
XP factors (XPA-G) involved in the incision stage of NER can cause the typical 
UV-sensitive) cancer-prone phenotype observed with xeroderma pigmentosum 
patients. 
Chinese hamster cell lines defective in either ERCCI or XPF show not only sensi-
tivity to UV-light, but are also extremely sensitive to DNA interstrand cross-link-
ing agents, a phenomenon not observed with any other NER-deficient cell line 
(Busch et aI1989). Mutational analysis of the ERCCl gene ill vivo showed that 
indeed 1110st mutations affecting its NER function also disrupt its presumed func-
tion in the repair of interstrand cross-links (Chapter 2). Moreover, severe symp-
toms like liver and kidney abnormalities, developmental delay, reduced life span, 
and signs of premature senescence are typically observed with ERCCI knock-out 
mice and are absent in NER-deficient XPA and XPC knock-out mice (McWhir et al 
1993, de Vries et a11995, Nakane et a11995, Sands et a11995, Weeda et aI1997a). In 
S. cerel'isiae, strains defective in the homologs of ERCCI and XPF, RadIO and 
Radl, fail to complete recombination between direct repeated DNA sequences 
(Fishman-Lobell and Haber 1992) and mutations in the homologous proteins of 
S. pall/be, SwilO and Radl6, can affect mating-type switching (Gutz and Schmidt 
1985). An additional engagement of ERCC1-XPF and their homologs in 
recombinational pathways might commonly underlie these non-NER-related phe-
notypes. 
There is limited knowledge of structural and functional domains within the 
ERCCI-XPF complex. Protein-protein interactions have been reported with the 
putative damage recognition protein XPA (Robins et a11991, Li et a11994, Park et 
a11995a) and with the single-stranded DNA-binding protein RPA (Matsunaga et 
al1996,Bessho et aI1997b), which may stabilize the opened DNA complex (Evans 
et a11997b, J'>'Iu et aI1997b). The interaction with XPA occurs through residues 93 
to 120 in the ERCCI protein (Li et aI1994). Recently, we demonstrated that RPA 
can modulate ERCCI-XPF incision activity such that cleavage is restricted to the 
damaged strand (de Laat et al 1998b). It is as yet unknown which region in 
ERCC1-XPF is responsible for the interaction with RPA. At the C-terminus of the 
ERCCI protein, a region of 53 residues shows extensive homology to the C-termi-
nus of the E. coli NER protein UvrC (Doolittle ef 011986, van Duin ef 011988). In 
UvrC, this region was found to be essential for its endonuclease activity (Lin and 
Sancar 1991) and deletion of this region specifically disrupted the 5' incision dur-
ing NER in E. coli (Moolenaar ef 011998). Possibly, these residues are required to 
position the active cleavage site correctly onto the DNA (Moolenaar ef 0/1998). In 
agreement, the region comprises a so-called helix-hairpin-helix (HhH) motif, 
which has been implicated in non-sequence specific DNA binding and was found 
to be present in many DNA break processing enzymes (Chapter 2, Doherty ef 01 
1996), including the structure-specific DNA nucleases FEN-l and XPG 
(Harrington and Lieber 1994b, Lieber 1997). The 20 amino acids long HhH motif, 
present twice in this C-terminal part of ERCC1, is the only domain that 
ERCC1-XPF shares with other structure-specific nucleases. Intriguingly, the S. 
cerevisioe Radl-Radl0 complex lacks this UvrC-like domain, including the HhH 
motifs, but incises DNA at exactly the same positions as ERCC1-XPF (Chapter 3). 
A more detailed map of functional domains within the ERCCI and XPF protein 
might provide insight into the relevance of sequence motifs within this complex. 
Also, it would allow a 1110re accurate interpretation of the phenotypical conse-
quences of mutations in the encoding genes. Here we report the mapping of the 
interaction domains between ERCCI and XPF and we demonstrate directly that a 
naturally occurring XP-F mutation affects complex formation. 
Results 
ERCC1 and XPF efficiently reconstitute a protein complex in vitro 
In mammalian cells, endogenous ERCCl and XPF arc associated in a stable 
heterodimeric protein complex (Chapter 3, van Vuuren ef 011993, Biggerstaff ef 01 
1993, Park ef 011995a) and complex formation ill vivo was also observed when 
recombinant ERCCI and XPF proteins were overproduced together in insect cells 
(Bessho ef 01 1997b, de Laat ef 01 1998a) or E. coli (unpublished observation). To 
determine whether EReCl and XPF associate illl1itro, immunoprecipitations were 
performed on ill vitro translated gene products. For this purpose, affinity-purified 
polyclonal antibodies against ERCCI and XPF were used that had previously been 
shown to be able to deplete the complex from whole cell extracts (Chapter 3, van 
Vuuren etoI1993). III vitro translation ofXPF in a reticulocyte lysate-based tran-
scription-translation system resulted not only in the 115 kDa full-length gene 
product but also in a series of truncated polypeptides which could be precipitated 
with an anti-XPF antibody (Fig. I, lane 4). Consistent with their molecular weight, 
these fragments appeared to originate from in-frame alternative start co dons. 
\~11en XPF protein was incubated with anti-ERCCI antibodies alone, no signifi-
cant XPF-prccipitation was observed, showing minimal cross-reactivity with the 
anti-ERCCI antibody (Fig. 1, lane 2). However, addition of ill vitro translated 
ERCCI (Fig. I, lane 1) resulted in efficient XPF precipitation with anti-ERCCI 
antibodies (Fig. 1, lane 3), demonstrating complex formation between ERCCl and 
XPF. Similarly, precipitation of wildtype ERCCI with anti-XPF antibodies was de-
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tected only in the presence of XPF protein (Fig. I, compare lanes 5 and 6). In all 
these tests, the corresponding pre-inul1une antiserum and an unrelated antisenml 
raised against XFA protein were not able to precipitate any complex. Patterns were 
not different from the beads-only controls (Fig. I, lanes 2 and 5 and data not 
shown). We conclude that ERCCI and XPF efficiently reconstitute a protein com-
plex in vitro. As this assay detects binding of snlall mllounts of proteins amidst a 
vast excess of reticulocyte lysate-derived proteins, it has to be considered a strin-
gent binding assay, detecting high affinity interactions only. As such, it wiII provide 
a conservative estiInate of the domains responsible for complex formation. 
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Fig. 1 111 vitro translated ERCCI and XPF reconstitute a complex. Autoradio-
gram of (antibody bead-bound) 35S-labeled proteins separated on an 
11% SDS-polyacrylamide gel. Input is indicated abo\'C each Iane. 
EReCl and XPF ii/vitro translates directly analyzed on gel show identi-
cal products as obserwd in lanes I and 4, respectiYely. The molecular 
weights of the full-length proteins are indicated. 
The XPF-binding domain is localized to the C-terminal region ofERCCl 
Localized protein-protein interaction domains were previously assigned in Radl-
RadIO, the homologous counterpart of the ERCCI-XPF complex in S. cerel'isiae 
(Bardwell et aiI992, 1993). Almost two thirds of the RadIO protein, stretching 
from residue 90 to 210 at the yery C-terminus, was shown to be required for Radl 
binding. This region corresponds to amino acids 98 to 214 in ERCCI, i.e. the mid-
dle part of this protein. In order to identify the XPF-binding domain in ERCCI, 
initial truncations from both sides of the ERCCI protein were based on this puta-
tive interaction domain. 
The first 92 amino acids at the N-terminus ofERCCI were found to be dispensable 
for XFF binding and, in contrast to RadIO, deleting the N-terminal 103 residues 
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Fig. 2 N-terminal truncations of EReCl. Autoradiogram of (antibody bead-
bound) JSS-labeled proteins separated on a 16.5% SOS-polyacrylamide 
gel. Note that only the EReCl protein fragments carry an HA epitope 
tag. The lower band synthesized along with ERCCl-ATG174 (lane 2) 
originates from the in-frame alternative translational start at position 
224 in EReCl and also carries an HA epitope tag at the C-terminus. 
Production and visualization of the \'cry small (6 kDa) ERCCI-ATG245 
fragment was difficult. Co-precipitation ofXPF with this fragment was 
performed in a separate experiment and is shown as a distinct panel 
(lane 4), The altered migration pattern of XPFgene products (compared 
with Fig. I) is due to different percentage of gel. The molecular weights 
of the proteins are indicated. 
(ERCCI-ATGJ03) and 118 residues (ERCCI-ATGI18) did not seem to affect com-
plex formation either. Even subsequent truncations from the N-terminus did not 
abolish the XPF binding capacity of ERCCI and, much to our surprise, we found 
that an ERCCI peptide lacking the complete region of homology to RadiO 
(ERCCI-ATG224) still bound to XPF (Fig. 2, lanes 2 and 3). This interaction was 
observed with both an anti-XPF antibody (data not shown) and with an antibody 
directed against an HA epitope tag introduced at the C-terminus of the ERCCI 
fragments (Fig. 2). The latter had to be used because the anti-ERCCI antibody 
failed to precipitate such small C-terminal ERCCI peptides. Deleting the N-terIni-
nal 245 residues of ERCCl, yielding a peptide with a molecular weight of only 6 
kDa, abolished the affinity for XPF (Fig. 2, lane 4). We conclude that the N-termi-
nal border of the domain responsible for initial and stable binding to XPF resides 
between residues 224 and 245 in the ERCCI protein (Fig. 4). 
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Fig. 3 C-terminal truncations of ERCCI. Autoradiogram of (antibod)' bead-
bound) J5S-JabeJed proteins separated on an 11% SDS-polyacrylamide 
gel. The odd lanes show non-specific binding of EReCl fragments to 
anti-XPF antibody beads. Interaction with XPF is scored positiyc if the 
amount of precipitated EReCl is significantly more in the presence 
(even lanes) than in the absence (odd lanes) ofXPF. In each precipita-
tion (lanes 1 to 8), similar amounts ofERCCl products were used. Note 
that ERCCl-STOP293 specifically binds to XPF, but with reduced affin-
ity compared with full-length EReCl (compare lanes 4 and 2), The 
molecular weights of the proteins are indicated. 
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In agreement with this conclusion, a C-terminally truncated ERCCI protein con-
taining only the first 215 residues (ERCCI-STOP215) was deficient in XPF bind-
ing. The same was found for the proteins ERCCI-STOP235, ERCCI-STOP257 
(data not shown) and ERCCI-STOP282 (Fig. 3, lanes 7 and 8). Even ERCCl-
STOP292, lacking only five amino acids from the C-terminus of full-length 
ERCCl, did not show XPF binding (Fig. 3, lanes 5 and 6). Interestingly, the addi-
tion of residue Phe293 to ERCCI-STOP292, yielding ERCCI-STOP293, 
reproducibly restored partial affinity for XPF, possibly demonstrating a direct in-
volvement of this phenylalanine in XPF binding (Fig. 3, lanes 3 and 4). However, 
ERCCI-STOP293 never co-precipitated with XPF as efficiently as did full-length 
ERCCI, showing that even the last four residues contained sequence information 
required for optimal XPF binding. We conclude therefore that the C-tenninal bor-
der of the XPF-binding domain in ERCCI is located between residues 293 and 297, 
which is the last amino acid of full-length ERCCI {Fig. 4). 
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Fig.4 Schematic presentation of the XPF-bindillg domain in EReCl. A. Over-
view ofXPF interactions obtained with truncated EReCt fragments. At 
the top is shown full-length EReCt with the domain that corresponds 
to the Radl-binding domain (BD) in RadIO. +, interaction with XPF; 
+/-, intermediate interaction with XPF; -, no specific interaction with 
XPF. B.i\:lapping of XPF-binding domain in EReCl. A summar)' of re-
ported interaction domains in ERCCI. The dotted line represents Radl-
liD in RadIO. Note that Radl and EReCt do not physically interact (see 
discussion), 
The ERCC1-binding domain is localized to the C-terminal region o!XPF 
Figure 1 shows that a complete series of truncated XPF fragments originating from 
alternative translational start sites co-precipitate with wildtype ERCCI when an 
anti-ERCCI antibody is nsed (Fig. I, lane 3). This indicates that the C-terminal 
part ofXPF is responsible for ERCCl binding, which would be in agreement with 
the RadIO-binding domain in Radl, which was Inapped to a region corresponding 
to residues 662 to 827 in XPF (Bardwell ef nll993). To identify the ERCCI-inter-
acting region in the XPF protein, initially a set of N-terminally truncated XPF 
cDNAs was made by systematically removing coding DNA on the 5' side of in-
frame ATG codons. In this way we obtained the constructs XPF-ATG629, XPF-
ATG677, XPF-ATG711 and XPF-ATG737. On polyacrylamide gels, the ill vitro 
translated products of these constructs co-migrated exactly with the truncated 
fragments that were synthesized along with full-length XPF. Precipitation studies 
with full-length ERCCI showed that not only XPF-ATG629, lacking the N-termi-
nal 629 residues, but also the other N -terminally truncated XPF fi-agments were 
fully capable of binding ERCCI (data not shown, but see below for further trunca-
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Fig. 5 N-terminal truncations of XPF. Autoradiogram of (antibody bead-
bound) J5S-1abeled proteins separated on a 15% SDS-polyacrylamide 
gel. Arrowheads (lanes 1 and 4) indicate XPF products originating from 
the alternatiYe starts at position 844 and 856. Note that these two trun-
cated XPF fragments do not co-precipitate with EReCl (lanes 3 and 6), 
confirming the mapping of the N-terminal border of the ERCCl-bind-
ing domain in XPF. Lanes 2, 5, and 8 show non-specific binding ofXPF 
fragments to anti-ERCCl antibod}' beads. Input is shown in this figure 
to demonstrate that although some XPF-ATG833 specifically co-pre-
cipitates with ERCCt (compare lanes 9 and 8) the ERCCl-affinity of 
this Xl'F fragment is strongl}' reduced (compare lanes 9 and 7 with lanes 
6 and 4, and 3 and 1). The molecular weights of the proteins are indi-
cated. 
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Fig,6 C-terminal truncations of XPF. Autoradiogram of (antibody bead-
bound) }5S-1abeled proteins separated on a 15% SDS-polyacrylamide 
gel. Odd lanes show non-specific binding of XPF fragments to anti-
EReCt antibody beads. Equal amounts of XPF products were used in 
each precipitation (lanes 1 to 6). Note that although the XPF-677-87S 
(lanes 3 and 4) and XPF-677-84S (lanes 5 and 6) are larger than XPF-
758-905 (lanes I and 2). thcydo not precipitate with EReCl, due to C-
terminal deletions. The molec~tlar weights of the proteins arc indicated. 
tions). This demonstrated directly that, like Radl, XPF contains a large N-terrninal 
region that is dispensable for complex formation, but it also showed that the inter-
action domain in XPF is located more towards the C-terminus. By Ineans of peR, 
we further truncated the XPF protein and found that ERCCI affinity was unaf-
fected even when almost 90% of residues were missing fro111 the N -terminus of the 
XPF protein. The peptides XPF-ATG758 (Fig. 6, lanes 1 and 2), XPF-ATG785 (Fig. 
5, lanes 1 to 3), and XPF-ATG813 (Fig. 5, lanes 4 to 6) all bound strongly to the 
ERCCI protein. However, ERCCI binding capacity was severely reduced when 20 
more residues were deleted from the N-tenninus ofXPF (XPF-ATG833) (Fig. 5, 
lanes 7 to 9). Thus, the N-terminal border of the ERCCI interaction domain is 
located between residues 814 and 834 in XPF. 
To map the C-terminal border of the ERCCI-binding domain in XPF, premature 
translational stops at positions 845 and 875 were introduced into the binding-pro-
ficient XPF-ATG677 construct, reducing its length by 60 and 30 amino acids, re-
spectively. This yielded the peptides XPF-677-845 and XPF-677-875. Unlike a 
(smaller) peptide that contained the very C-tenninal residues ofXPF (XPF-758-
905), neither XPF-677-845 nor XPF-677-875 showed specific binding to ERCCI 
(Fig. 6), demonstrating that the C-terminal border of the ERCCI-binding domain 
in XPF resides between the amino acids 875 and 905 (Fig. 7). 
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Fig. 7 Schematic presentation of the EReCt-binding domain in XPF. A. Over-
view of EReCl interactions obtained with truncated XPF fragments. At 
the top is shown full-length XPF with the domain that corresponds to 
the RadIO-binding domain in Hadl. +. interaction with EReCl; -, no 
specific interaction with EReCl. B.lvlapping ofERCCI-BD in XPF, and 
schematic presentation of the XP126LO alleles, The arrow indicates the 
position of the R788W substitution. The triangle indicates position of 
the frame shift resulting in a truncated protein. 
Direct interaction between the binding domains of ERCC1 and XPF 
The minimal domain required for initial and stable XPF binding spans residues 224 
to 297 inERCCI, whereas residues 814 to 905 in XPF were found to be necessary and 
sufficient for stable binding to ERCCl.lb find out whether these domains physically 
interact, we mixed the HA-tagged peptide ERCCI-224--297 with XPF-813-905 and 
precipitated them with an HA-antibody. Since these two peptides migrate similarly 
on SDS-polyacrylamide gels, radiolabeled methionines were only incorporated into 
XPF-813-905. XPF-813-905 was found to co-precipitate with ERCCI-224--297 (Fig. 
8,lane 2), but not with the smaller ERCCI-245-297 fragment (Fig. 8, lane 3, compare 
with lane I), demonstrating that ERCCI-XPF complex formation is established by a 
direct interaction between residues 224 to 297 of ERCCI and 814 to 905 of XPF. 
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Fig. 8 Direct interaction between the binding domains of EReCt and XPF. 
Only EReCl fragments contained an HA epitope tag at the C-terminus. 
Precipitations were performed with an anti-HA antibody. No radiolabel 
was incorporated into EReCl fragments. The molecular weight ofXPF-
813-905 is indicated. 
Naturally occurring XP·F mutations affect complex formation 
Mutational analysis of an XP-F patient, XPI26LO (Norris et al 1988), demon-
strated sequence alterations in the C-terminal part of both XPF alleles, one being a 
point mutation resulting in an amino acid change at position 788 (R788W) and 
the other being a 4-nucleotide-deletion causing a frameshift at residue 759 (759fs) 
and a preIllature truncation at position 803. Strongly reduced protein levels of 
both ERCC1 and XPF were observed in cells of this patient, apparently as a conse-
quence of these XP-F u1utations. Previous observations indicated that EReCl and 
XPF molecules residing outside the complex are rapidly degraded in the cell. We 
therefore hypothesized that these mutations would interfere with stable complex 
formation (Chapter 2). To test this directly, cDNAs encoding the two XP126LO 
-88 -
alleles were cloned into expression vectors and in vitro translated. Co-
precipitations with wildtype ERCCI translates revealed that the amino acid substi-
tution R788W did not alter the ERCCI binding capacity of the XPF protein (Fig. 9, 
lane 3), whereas the product of the other allele had completely lost it (Fig. 9, lane 
4). Thus, one of the alleles of this XP-F patient indeed carries a mutation that af-
fects ERCCI binding ill vitro. However, under the conditions used here, no altered 
ERCCI affinity was obsen'ed for the gene product carrying the point mutation at 
position 788. 
kDa 
115-
anti-ERCC1 
w! wt R788W 759fs XPF 
- + + + ERCC1 
== ::=::: 
---'!III!' 
-XPF 
40- •• __ ERCC1 
~ '. *' 
2 3 4 
Fig.9 A naturally occurring XP-F mutation affects complex formation with 
ERCCl. Autoradiogram of (antibody bead-bound) 35S-labcled proteins 
separated on an II % SDS-polyacrylamide gel. Similar amounts of XPF 
were used in each precipitation (lanes 1 to 4). The molecular weights of 
the proteins are indicated; '\1, wild type XPF protein. 
Discussion 
In this study we mapped the interaction domains between two polypeptides by 
performing immunoprecipitations on ill vitro translated proteins. In such assays, 
small mnounts of both proteins are mixed in the context of a huge excess of unre-
lated, reticulocyte lysate-derived, proteins. Co-precipitation, therefore, requires 
that proteins bind each other with relatively high affinity. A well-established inter-
action between ERCCI and XPA for example, with a dissociation constant of 
2.5.10.7 !vi (Saijo et 011996), cannot be visualized with this procedure and co-pre-
cipitation of ill vitro translated XPA is only detected with an excess of 
(recombinantly overproduced) ERCCI on antibody beads (our unpublished ob-
servation, Bessho ef 011997a). Thus, our binding assay is a conservative one that 
will only reveal domains required for initial and stable complex formation, but 
fails to show residue stretches of minor importance for protein-protein interac-
tions. We define residues 224 to 297 in ERCCI and residues 814 to 905 in XPF as 
the regions responsible for initial and stable complex formation between ERCCI 
and XPF. 
Comparison between ERCC1-XPF and Rad1O-Rad1 
Radl-RadlO from S. cerel'isine and mammalian ERCCI-XPF not only display ex-
tensive (lInino acid sequence homology) but are also functionally very similar. Both 
complexes interact with the DNA damage-binding NER protein XPA, which is 
known as Rad 14 in S. cerel'isine (Li ef n11994, Park and Sancar 1994, Guzder ef nl 
1996). Also, both display identical incision patterns on stem-loop substrates 
(Chapter 3) and require similar DNA structural elements for nuclease activity 
(Bardwell ef n11994, de Laat ef nI1998a). Interaction domains responsible for com-
plex formation have previously been assigned to the Rad1-Rad10 complex, using a 
two-hybrid system and immunoprecipitation assays similar to those described in 
this report (Bardwell ef nI1992, 1993). The binding domains in both Radl and 
RadiO appeared to map to protein regions that are well conserved between the 
yeast and mammalian h0111ologs. Surprisingly, however, we fInd that the interac-
tion domains in ERCCI and XPF locate elsewhere. 
The location of the Rad I-binding domain in RadlO corresponds to residues 98 to 
214 in ERCCI (Bardwell ef nI1993), but theXPF-binding domain in ERCCI com-
prises a stretch of amino acids (224 to 297) that resides outside the region of ho-
mology with RadiO (Fig. 4B). This C-tenninal extension in ERCCI is predomi-
nantly composed of a double ]-IhH motif (residues 236 to 289). HhH motifs have 
been found in many DNA break processing enzymes, including the E. coli NER 
protein UvrC, and are thought to be involved in DNA binding. Previous mutagen-
esis studies showed that a 'RadIO-like' ERCCI protein, with a stop at residue 214, 
was functionally inactive (van Duin ef nI1988). This can now be explained by the 
inability of this protein to [onn a c0111plex with XPF. However, addition of a dou-
ble HhH motif alone is not sufficient to restore XPF-binding capacity. A hybrid 
protein containing the first 236 amino acids of ERCCI fused to the double HhH 
motif of bacterial UvrC, composing a peptide of 291 amino acids, failed to bind 
XPF (data not shown). Similarly, the ERCCI-STOP292 peptide containing the 
complete double HhH motif of ERCCI did not bind XPF (Fig. 3). Apparently, the 
double HhH motif in ERCCI is not directly involved in XPF binding. Our data 
demonstrate that residues 293 to 297 in ERCCI are important for XPF binding. 
Interestingly, an as yet unobserved homology exists between the C-tcnninal 
residues 293 to 296 in ERCCI, comprising the amino acids Phe-Leu-Lys-Val, and 
the final four residues of RadlO (207 to 210), which are Tyr-Leu-Asn-Leu. Al-
though the Radl-binding motif in RadlO was reported to extend to residue 210 
(Bardwell efnI1993), to our knowledge no subtle truncations from the C-tenninus 
of RadIO have been made. Hence, it is not dear whether these particular four 
residues ofRadlO are indispensable for Radl binding, but it is possible that the two 
motifs in ERCCI and RadlO fulfil similar roles in binding the complexing protein 
partner. Along this line of argument, the double HhH motif present in ERCCI may 
support correct structural positioning of the very C-terminal residues of ERCCI. 
The functional relevance of an additional, putative DNA-binding d01nain in this 
part of ERCCI still has to be resolved though. It is worth mentioning that also 
S. pOll/be SwilO (Rodel et 011992) and plant homologs of ERCCI (Xu et 011998) 
also contain a UvrC-like C-terminal domain, which suggests that S. cerevisioe 
RadIO is an exception in lacking this region. 
XPF and Radl use partially different domains for binding their respective 
complexing partners as well. The RadIO-binding domain in Radl has homology to 
residues 662 to 827 in XPF, butwe fInd that residues 814 to 905 in XPF are required 
for actual ERCCI binding. Motifs with a putative function have not been found in 
this region (Chapter 3). The poorly conserved localization of interaction domains 
between S. cerel'isioe Radl-RadlO and human ERCCI-XPF explains why neither 
ill vivo nor ill vitro an interspecies protein-protein interaction was observed be-
tween Radl and ERCCI (Bardwell et 011993). 
Interpretation of ERCC1 and XP·F mutations 
Recently, we reported a mutational analysis of the ERGCl gene in which a series of 
truncated ERCCI proteins were tested for repair capacity ill vivo (Chapter 2). The 
N-tenninal92 amino acids were found to be dispensable for ERCCI to function in 
repair ill vivo. Disruption of the N-tenninal103 residues of ERCCI, however, com-
pletely destroyed the repair capacity of this peptide. As in our precipitation assay 
this protein fragment is capable of binding XPF, affects on ERCCI-XPF complex 
fonnation Seell1 not to be involved. Rather, a reduced affinity for XPA, whose bind-
ing domain maps to residues 93 to 120 in ERCCI, may underlie this phenotype. C-
terminal ERCCI truncations demonstrated a direct link between complex forma-
tion ability and repair capacity. A deletion of five anlino acids fr0111 the C-tenllinus 
of ERCCI (ERCCI-STOP292) completely destroyed both the protein's ability to 
bind to XPF (Fig. 3) and to support repair ill vivo (Chapter 2). However, addition 
of only one residue to this peptide, Phe293 in ERCCI-STOP293, not only partially 
restored XPF binding (Fig. 3), but was also suffIcient for partial restoration of the 
ill vivo repair capacity of ERCCI (Chapter 2). Apparently, Phe293 in ERCCI is 
crucial for XPF affInity and complex formation is a prerequisite for ERCCI to 
function in repair. 
Reduced protein levels, not only of XPF but also of ERCCI, are frequently ob-
served in XP-F patients (Yagi et 011997, personal observation). The instability of 
these proteins is thought to be caused by the lack of a stably bound partner. A 
similar phenomenon has been observed with other tight protein complexes, for 
example with Ku70-Ku80 (Chen et 011996). XPI26LO is an XP-F patient with 
such reduced XPF and ERCCI protein levels whose mutations have been mapped. 
One allele carries a framcshift at rcsidue 759, which leads to a prelnature stop in 
front of the ERCCI-binding domain, and in agreement, we fInd that the encoded 
protein does not interact with ERCCI. The R788W point mutation in the other 
allele resides outside the ERCCI-binding region in XPF and we fInd that this mu-
tated XPF protein binds normally to ERCCI. However, as residual XPF and ERCCI 
protein levels in this patient are less than 50%, this mutation is also anticipated to 
affect complex formation. Apparently, additional low affmity interaction domains 
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not picked up in our conservative assay can still be of significant relevance for ill 
vivo complex stability. Of course, the possibility that R788W makes XPF 
proteolytically unstable by itself cannot be dismissed here. Either way, the residual 
complexes observed in this patient must contain XPF molecules carrying the 
R788W substitution. This mutated form of XPF is responsible for the phenotypic 
features of the XP126LO patient, which is supported by our recent finding of a 
homozygous R788W defect in another XP-F patient with similar responses to UV 
(Chapter 4). Residual ERCC1-XPF protein amounts are likely to be required for 
normal development and viability, since mice carrying a hOlll0Z}rgous null muta-
tion in ERGCl show developmental delay, severe liver and kidney abnormalities, 
reduced life span and signs of premature senescence (McWhir et a11993, vVeeda et 
aI1997a). As most XP-F patients tested have reduced ERCCI and XPF protein 
levels (Yagi et al 1997, unpublished observations), we expect that partially dis-
rupted ERCCI affinity fi'equently underlies the XP-F phenotype. 
Materials and methods 
Construction of mutant cDNAs 
N-terminal truncations were made via PCR using sense primers containing (5' to 
3') a T7 polymerase recognition sequence, an optimal translational initiation se-
quence and 18 to 24 nudeotides complementary to the sequence of insertion. 
Exceptions were the constructs XPF-ATG629, XPF-ATG677, XPF-ATG71I. and 
XPF-ATG737. Here) the restriction sites HindITI) RsaI) FokI and Eag! were used, 
respectivciy, to remove upstream coding cDNA in front of these in-frame ATG 
co dons. HA epitope tags were introduced as described previously (de laat et til 
1998a). C-terminal truncations were made via PCR using anti-sense primers 
containing (3' to 5') 18 to 24 complementar}' nudeotides, a translational stop 
sequence and 6 to 9 random nudeotides. cDNA from the two alleles ofXP126I.o 
was amplified, subc10ned and sequenced as described (Chapter 3). 
In vitro translations and immunoprecipitations 
ERCCI and XPF constructs were transcribed and translated separately ill )'itro, 
following the instruction manual of the TnT coupled transcription-translation 
system of Promega. PCR products were phenol exiracted and ethanol precipi-
tated. 2 to 10 ~{g DNA were added per 50 ~ll ill vitro transcription-translation 
reaction mix. The polyclonal antibodies against ERCCt and XPF (affinity-puri-
fied) used for immunoprecipitations ha\te been described before (Chapter 3, van 
Vuuren et 1111993). For imlllunoprecipitations, (truncated) ERCCt protein and 
(truncated) XPF protein were mixed with 5 ~d NE'rr buffer (l00 cl.l NaCl, 5 
n11\1 EDTA, 50 Illl",! Tris pH 7.5, and 0.5% Triton-XIOO) (total volume 15 to 20 
Jll) and incubated for 30 min at 30Ge, Antibody was added and after 2 hr at 4°C, 
100 J.ll NE'lT buffer containing 10% protein A-sepharose beads were added. In-
cubation proceeded for another 2 hr at 4°C (with tumbling), then the beads were 
washed four times with 0.5 m] NE'lT and suspended in sample buffer. Samples 
were boiled and protein fragments were separated on SDS-polyacrylamide gels, 
which varied between 5 to 16.5% acrylamide, depending on the size of the 
peptides studied. In the case of 15 and 16.5% gels, 0.1 M NaAc was added to the 
lower running buffer for optimal separation of small protein fragments and the 
dre m-cresol purple was added to the sample buffer instead of coomassie 
(Christ)' et aI1989). Dried gels were analyzed by autoradiography or with a 
phosphorimager. 
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CHAPTER 6 
General discussion 
Considerable progress has been made in recent years in understanding the roles 
of the XP and ERCC factors in NER and the molecular basis of xeroderma 
pigmentosum. Insights into the NER pathway began through complementation 
studies. Yeast as well as rodent repair mutants and cells from XP patients have 
been of great importance for the analysis of NER. To date, most of the genes 
complementary to these mutant groups have been cloned and their role is being 
elucidated. The cloning of the XPF gene, presented in this thesis, completed the 
isolation of the core NER factors. The XPFgene product was found to constitute 
an endonuclease together with ERCCI. The XPF and ERCCI proteins and their 
role in DNA repair and xeroderma pigmentosum are further discussed in this 
chapter. 
ERCC1-XPF complex 
Composition 
The ERCCl gene is the first human repair gene cloned. The gene was isolated after 
transfection and correction of an UV-sensitive rodent group I mutant (Westerveld 
ef a11984, van Duin ef aI1986). It encodes a protein with homology to the yeast 
repair protein RadIO. III vitro complementation studies with mutant cell extracts 
had demonstrated that ERCCI resides in a complex together with the ERCC4, 
ERCCII, and XPF-correcting activities (Biggerstaff ef a11993, Reardon ef a11993b, 
van Vuuren et a11993), Information on the horl101ogous complex in S. cerel'is;ne 
has been of great help for the characterization of the ERCCI-containing complex. 
The yeast complex consists of two proteins: the ERCCI homolog RadiO, and Radl 
(Bailly ef aI1992, Bardwell ef aI1992). Homologs ofRadl had already been identi-
fied in S. pOll1be and the fruitfly, Rad16 and Mei-9, respectively (Carr ef a11994, 
Sekelsky ef a11995, Araj and Smith 1996). On the basis of the homology in their 
protein sequences, the human homolog was isolated. Interestingly, the gene could 
restore the repair defect not only in XP-F cells but also in rodent ERCC4- and 
ERCCll-deficient cells, suggesting that only one and the same gene is involved in 
these different mutant cells. About the same time, the isolation of the ERCCI-
containing protein complex using a histidine-tagged ERCCI protein was accom-
plished. Analogous to the complex in yeast, the mammalian complex appeared to 
consist of only two proteins, ERCCI and XPF, which supports the idea, that the 
encoding genes XPF, ERCC4, and ERCCl1 are equivalent. Complementation stud-
ies, however, had previously assigned the ll1utants to distinct groups, 4 and 11 re-
spectively (Hata efa11991, Riboni efaI1992).Apparently, the mutated ERCC4 and 
ERCCl1 genes, or better: the mutated XPF genes of Chinese hamster groups 4 and 
11, can cOlnpensate each others defect, a phenomenon known as intragenic 
complementation. Interestingly, there is a parallel in S. pombe, in which the 
md16.20allele, encoding the N-terminal half of the protein, was complemented by 
a construct encoding the C-terminal half of the Rad16 gene product (Carr ef nl 
1994). 
However, no Illutations have been found in the open reading frame of the )(PF 
gene of UVS I, the Chinese hamster group II mutant (Hayashi and Yasui personal 
communication), Furthermore) fusion of group 4 mutants with the group 11111U-
tant seems to restore the expression of the XPF transcript. These results would 
suggest that UVSI represents a distinct gene that may encode a transcriptional 
regulator (Hayashi and Yasui personal communication). This might also explain 
the fact that overexpression of the XPF eDNA could correct the UV-sensitivity of 
UVSI, whereas transfection of the genomic sequence could not (Brookman ef nl 
1996). Overexpression of the complex partner ERCCI could not restore the 
ERCCll mutant phenotype, excluding the possibility that addition of (ERCCl-
)XPF stimulates an alternative repair pathway, 
On the other hand, it is possible that ERCCII is needed in an auxiliary way, per-
haps to stabilize the complex. In that case, an excess ofXPF might overcome a lack 
of (functional) ERCCII supporting complex formation. A similar phenomenon 
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has been observed with the donble-strand break repair-deficient md55 and md57 
mutants. Their X-ray sensitivity could be suppressed by the overexpression of 
RadSl and/or RadS2 (Hays ef nll99S). The exact mechanism remains to be elnci-
dated. 
ERCC1 
XPA 
1:lOIl1I1297 
XPF-BD 
Fig,l The ERCCI-A'FF complex. Schematic representation of functional do-
mains within the EReCt and XPF proteins. HhH, helix-hairpin-helix 
motif; Uti ... !, leucine-rich repeat; LZ, leucine zipper; NtS, nuclear locali-
zation signal; 3D, binding domain. 
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Fig. 2 Alignment of human ERCCI with its homologs. Displayed arc human 
ERCCI (297 amino acids), its mOllse homolog (298 amino acids), the 
Lililll11 IOllgij1ortllll homolog (fragment of 278 amino acids) residucs 1-
272, S. pombe SwiIO (252 ammo acids) and S. (erew'siae RadIO (210 
ammo acids). Identical amino acids are in black boxes and physico-
chemically related residues are in gray boxes. Indicated are the XPA- and 
XPF-binding domain (BD) including the two HhH motifs (numbers 
according to van Dum et all986, 1988, Xu et al1998, Radel et a1I992, 
and Reynolds et aI1985). 
- 96 -
Functional domains 
ERCCI and XPF form a tight complex with structure-specific endonuclease activ-
ity. The ERCCI-XPF endonuclease performs the 5' incision during NER.lt specifi-
cally recognizes branched DNA structures with 3' single-stranded DNA ends. 
ERCCI-XPF cuts near the transition of double-stranded to single-stranded DNA 
(Chapter 3). The nuclease is also required for removal of nonhomologous DNA 
from 3' single-stranded ends of recombining DNA, which structure resembles the 
damage-containing DNA substrate cut by ERCCI-XPF during NER (Sargent ef al 
1997). A close examination of the protein sequences and the study of mutated pro-
teins revealed several domains important for their function (Fig. I). 
In ERCCI, the N-terminus is the least conserved part of the protein (Fig. 2). Ac-
cordingly, up to one third of the protein can be deleted without loss of function. 
The region contains a putative nuclear location signal sequence, which is appar-
ently not essential for nuclear transport of the protein. Instead, the putative bipar-
tite NLS in XPF (Dingwall and Laskey 1991), located in the middle of the protein, 
may be responsible for transport of the complex to the nucleus. The central region 
in ERCCI is the best conserved (van Duin et aI1986).lt contains the XPA-binding 
site (Li ef al 1994, Park and Sancar 1994, Li ef al 1995b, Saijo ef al 1996). In 
S. cerel'isiae, the Radl and RadIO proteins together interact with the XPA homolog, 
Radl4, much stronger than each protein alone (Guzder ef aI1996). Accordingly, 
the presence ofXPF may enhance the affinity ofERCCI for XPA. The complex also 
interacts with RPA and with DNA, interactions not found with the ERCCI subunit 
alone (Saijo ef a11996,de Laat ef aI1998b). So far, no other interacting proteins 
have been reported, neither for ERCCI nor for XPF. 
The N-terminal half of XPF contains a large number of leucine residues that may 
form two structural motifs involved in protein binding (Fig. 3). At the very begin-
ning, the sequence starts with a repeat of leucine-rich motifs (or leucine-rich re-
peats). These LRMs are short sequences of22 to 30 residues with hydrophobic amino 
acids at conserved positions. Leucine-rich motifs have a degenerate consensus se-
quence as they contain gaps, and vary in length and in amino acid cOIl1position. 
LRMs are found in a large variety of proteins and arc inlplicated in tight and highly 
specific protein-protein interactions, such as receptor-ligand binding (Schneider ef 
a11988, Windisch ef aI1995a). The three-dimensional structure of the ribonuclease 
inhibitor protein (RJ) revealed the structural properties ofLRMs responsible for the 
binding function. The buried leucines in LRtVIs playa structural role and are not 
directly involved in protein-protein interactions. The sequence of RI consists of 15 
LRMs. All repeats adopt very similar structures, consisting of a short ~-strand and an 
a-helix approximately parallel to each other, resulting in a flexible, arch-shaped 
binding surface suitable for strong and distinctive interactions with ligand proteins 
(Fig. 4) (Kobe and Deisenhofer 1993). One of the three motifs in the extracellular 
domain of the neurotrophin receptor TrkA was found to specifically bind to nerve 
growth factor, indicating that LRMs can represent independent TImctional entities 
(Windisch efaI1995b). LRM structures arc also present in the yeast homologs Radl 
and Radl6 and resemble the motifs found in yet another yeast repair protein Rad7 
(Schneider and Schweiger 1991). The protein(s) that can bind to the LRMs in XPF 
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SpoRad16 253 
SceRadl 317 
HsaXPF 313 
MfTlJJXPF 324 
DrneMei·9 305 
NcrMus38 269 
SpoRad16 323 . . . . . . . . . . . . 
&eRadl 388 ............. 
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SpoRad16 375 
SceRadl 431 
HsaXPF 444 
MmuXPF 455 
Drnetlei·9 414 
NcrMus38 373 
SpoRad16 442 
See Rad1 494 
Fig. 3 Alignment of XPF with its homologs. Displayed are human XPl: (905 
amino acids), its MilS /lllIswllls homolog (917 amino acids), D. 
melallogaster j\:lei-9 (946 amino acids), N. (rassa lvfus38 (892 amino ac-
ids), S. pombe Rad16 (892 amino acids) and S. Lwel'i5iae Radl (1100 
amino acids) residues 76-1100. Occasionally, stretches of residues 
present in only one of the peptides were deleted for optimal alignment. 
Identical amino acids are in black boxes and physicochemically related 
residues arc in gray boxes. Indicated arc the ERCCl-binding domain 
(liD) and leucine zippers (LZ) in XPF as well as the leucine-rich motifs 
(LRMs) in Radl. Additional residues (italic) upstream of human XPF 
were reported by Brookman et (/I (1996) (numbers according to Chapter 
3, Lamerdin unpublished results, Sekelsky et {//1995, Hatakeyama et (/I 
1998, Carr et a/ 1994. and Reynolds et a/1987). 
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remain to be identified. Further downstream, the N-terminus contains several leu-
cine-zipper motifs (Brookman et aI1996). The only similarity between LRMs and 
leucine zippers is the conservation of ICllcines at particular spacings. Leucine zippers 
are built of heptad repeats with leu cines present at every seventh position. These 
leucines form a hydrophobic ridge on one side of a helL" that interacts with a com-
plementary helix. The leucine residues in leucine zippers participate in dimerization 
(Landschulz et aI1988). Dimerization mal' occur within the XPF polypeptide. Alter-
natively, an ERCCI-XPF dimer-dimer could be formed by association of leucine 
zipper motifs of two separate XPF peptides. It is not known, however, whether 
ERCCI-XPF is active as a 1110nomeric complex or acts in lllultimeric form. Separa-
tion of a cellular protein e.x'iract 011 a size fractionation column revealed that most 
ERCCI-XPF eluted in the fractions with a molecular weight corresponding with the 
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size of a monomeric ERCC1-XPF complex, whereas a small amount of ERCC1-XPF 
eluted in fractions corresponding to a much higher molecular weight (van Gool et al 
1997), indicating that ERCCI-XPF can be part of a larger complex. 
Complex formation involves the C-tenninal domains in both proteins (Chapter 5). 
Also in yeast, the domains in Radl and RadlO required for their mutual interaction, 
are located in their C-terminal regions (Bardwell et aI1992, Bardwell et aI1993). The 
ERCCI-binding domain in XPF, however, resides, different from the RadlO-interac-
tion domain in Radl, in the very C-terminal end (see Chapter 5 for further details). 
Similarly, the XPF-binding domain in ERCCI is located in the very C-terminal end, 
a region that is even lacking in the yeast RadlO protein. The ERCCI C-terminus 
shows some homology with the C-terminal part of the E. coli NER endonuclease 
UvrC (van Duin et aI1988). The homologous region contains two putative helix-
hairpin-helix motifs. HhH motifs are found in a large variety of DNA break-generat-
ing and processing enzymes (Chapter 2, Doherty et aI1996). These motifs are impli-
cated in non-sequence-specific DNA binding and it is likely that the I-IhH-contain-
ing proteins recognize a specific structure of the DNA helix rather than a specific 
nucleotide sequence. Six crystal structures of predicted HhH motifs are currently 
known: a series of two in rat and in human DNA polymerase P (Sawaya et a11994, 
Pelletier et al 1996) and one each in Endonuclease III (Thayer et aI1995), AlkA 
(Labahn et al 1996), and in the 5'nuclease domain of Taq polymerase I (Kim et al 
1995). Superposition of polymerase p, Endo III and AlkA HhH three dimensional 
structures reveals remarkable similarity in the type II p-tUl'Il that bridges the helices 
and their crossing angle. The HhH motifs bind DNA via the formation of hydrogen 
bonds between protein backbone nitrogens and DNA phosphate groups. The 20 
residue-long motif contains several positions with high propensities for hydropho-
bic residues at positions 3, 6, 9,14,17, and 18 (Fig. 5). Residues at positions 3,17, and 
Fig. 4 Structure of ribonuclease inhibitor. Ribbon diagram of the RI structure 
(adapted from Kobe and Deisenhofcr 1995). 
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Fig. 5 The helix-hairpin-heli.x (HhH) motif. A. Alignment of the two HhH 
motifs from ERCCI with the motifs from other HhH-containing pro-
teins. Identical amino acids are in black boxes and physicochemically 
related residues arc in gray boxes. B. Shown are the second HhH motif in 
human ERCC1 (darkgra}') on top of the second HhH motif in rat DNA 
polymerase p (31 kDa domain) (light gray) together with the DNA 
molecule. The three dimensional structure of the ERCC1 HhH was 
modeled with help of the HhH structure in rat DNA polymerase p using 
the SwissModel program. Hsa, H. sapiells; Spa, S. pombe; Eca, E. coli; Hm, 
n, slIbtilis; Taq, T. aqllaHCII5; Rllo, Rattlls lIorl'egiCIIS; h, hydrophobic resi-
due (numbers according to van Duin et (1/1986, Rodel et a/1992, Sancar 
et a/1984, Chytln et a/1994, Le\'in et a11992, Asahara et a11989, Itoh et a1 
1996, Lawyer et (1/1989, J'\'furra)' et (1/1994, and Kumar et a/1990b). 
-101 -
A 
B 
18 stabilize helical packing, whereas residues at positions 6 and 9 stabilize the p-turn 
and the hairpin. Glycines at positions 8 and 10 form important elements of the hair-
pin loop. Glycine HhH position 8 is important for the formation of the type II 
p-turn, whereas glycine HhH position 10 contributes to a pronounced e"c(ended sur-
face that mediates DNA-binding. A high propensity for lysine at HhH position 12 
and threonine or serine at HhH13 suggests that these interact with DNA phosphate 
groups. An alanine or small hydrophobic residue is preferred at HhH position 14. 
The HhH motif in the 8 kDa domain of polymerase p is implicated in the short-
gap filling activity of the enzyme. This domain has been shown to bind single-
stranded DNA (Kumar efaI1990b). The second HhH motif occurs in the 31 kDa 
domain that binds only to double-stranded DNA (Kumar ef a11990a, Pelletier ef al 
1996). The putative HhH motif in endonuclease III is associated with thymine gly-
col binding (Kuo ef aI1992), whereas uracil-DNA glycosylase has a DNA-binding 
groove and an adjacent pocket with HhH-configuration that tightly fits a 
deoxyuridine residue flipped-out liOln the damaged DNA (Roberts 1995). The 
HhH motif in Taq polymerase I protrudes into a major cleft in the 5'nuclease do-
main adjacent to metal binding sites. In this way, DNA bound to the motif is pre-
sented to the nuclease active site. 
Like ERCC1, most HhH proteins contain (multiples of) two copies of the motif. 
The presence of two motifs probably enables the protein to bind DNA twice; to 
structures that contain transitions from double-stranded to single-stranded DNA, 
such as loops, hairpins, flipped out bases, and cruciforms, generated during proc-
esses like DNA repair and recombination, as illustrated by the B. slIbfilis RecR pro-
tein. RecR contains two HhH motifs. The protein is involved in postreplication 
repair and homologous recombination. It binds ssDNA and dsDNA. In fact, it is a 
sequence-independent DNA-binding protein that shows some preference for 
damaged DNA (Alonso ef aI1993). Recently, it was found that RecR can bind two 
DNA molecules at the same time with preference for the cross over of two helices 
(Ayora ef aI1997). Because of these HhH motifs, ERCC1 is likely to be responsible 
for DNA binding. 
Like other structure-specific nucleases ERCCI may also harbor the nuclease do-
main. In comparison with FEN-I and XPG, however, the positions of the possible 
active site residues (conserved acidic amino acids D and E) relative to the HhH 
motif seem not to be conserved in ERCCI (Mueser ef al 1996, Shen ef aI1997). 
Intriguingly, the yeast Radl-RadlO complex appears to lack the HhH-containing 
UvrC-like domain, but incises DNA at the same positions as ERCC1-XFF (Chap-
ter 3). Insight into the function of the HhH motifs in ERCCI will have to come 
from structural and detailed mutation analysis. 
Triple function 
Nucleotide excision repair 
Mutations in the ERCCI and XFF proteins result in UV-sensitivity, which reflects 
their role in NER. However, ERCC1 and XFF are involved in the repair of a wider 
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range of DNA damage. The rodent complementation groups I and 4 are also ex-
tremely sensitive to DNA cross-linking agents while the others are not (Hoy et al 
1985). Intrastrand cross-links arc easily removed via NER. The damaged 
nuclcotides arc rC1110ved and replaced with normal ones, using the complementary 
undamaged strand as a template. However, in the case of interstrand cross-links, 
both strands are damaged. The repair of these cross-links probably requires an 
additional step that involves homologous recombination. 
Cross· link repair and homologous recombination 
In E. coli, the removal of interstrand cross-links is thought to involve first dual 
incision in one strand around the cross-linked base. In this way, the NER 
excinuclease UvrABC produces an oligonucleotide cross-linked to an intact DNA 
strand (van Houten et aI1986). Following excision, a 5'exonuclease activity (DNA 
polymerase I) probably generates a single-stranded DNA region to allow strand 
invasion of a homologous sequence (Sladek et a11989) (Fig. 6). Subsequent new 
DNA synthesis using the homologous sequence as a template and ligation result in 
a triple-stranded DNA structure. Finally, the cross-link is eliminated in a second 
excision reaction (Cheng eta11988, Sladek eta11989, Cheng etaI1991). In E. coli, 
interstrand cross-links are completely repaired by the NER proteins with help of a 
5'exonuclease and RecA. A different model has been proposed for the repair of 
interstrand cross-links in mammalian cells (Bessho et aI1997a). With a substrate 
containing a defined interstrand cross-link, the initial incisions i111,itrowere found 
in one of the two strands, both 011 the same side of the cross-linked basco Remark-
ably, the oligonucleotide excised, does not contain one of the cross-linked bases. In 
the model, at least two more rounds of excision will be required to complete the 
repair reaction. Moreover, the excision reaction seems to depend on NER proteins 
other than ERCCI and XPF, which is not expected from the NER mutants' pheno-
types. The role ofERCCl-XPF in cross-link repair, which seems to occur outside 
the context of NER, remains to be determined. Their function may resemble the 
role of ERCCI-XPF during homologous recombination, which is better under-
stood. 
In yeast, two distinct homology-dependent pathways are initiated by a DSB: ho-
mologous recombination and single-strand annealing. In both pathways, the ends 
of the DSB are processed by a 5' -,>3'exonuclease to expose long 3' single-stranded 
tails. During homologous recombination, the Rad5l, assisted by R1'A and Rad52 
(all single-stranded DNA-binding proteins), mediates the search for homologous 
sequences and annealing of these single-stranded DNA ends to a homologous du-
plex (Ogawa et aI1993). During SSA, annealing occurs within repeats and these 
intermediates may have protruding nonhomologous 3' ends. Such DNA structures 
are substrates for the NER endonuclease Radl-RadlO (Fishman-Lobell and I·laber 
1992, Bardwell et a11994, Davies et all995, Ivanov and Haber 1995). Accordingly, 
the Radl-RadlO proteins, in contrast to other NER proteins, are involved in mi-
totic recombination between direct repeats (Klein 1988, Schiestl and Prakash 1988, 
Schiestl and Prakash 1990, Saffran et a11994, Ivanov and Haber 1995). Likewise, 
ERCCl-XPF seems to be involved in SSA between direct repeats in human cells 
only if nonhomologous ends are present (Yao ef aI1997). 
The analogous complex in S. pOlllbe, SwilO-Radl6, is required for the resolution of 
DNA intermediates during mating-type switching. Mating-type switching is a 
process related to homologous recombination. Switching is initiated by a site-spe-
cifically induced double strand break. Subsequent strand exchange generates a 
heteroduplex DNA molecule, but does not produce a Holliday junction (Egel ef al 
1984, Gutz and Schmidt 1985, Formosa and Alberts 1986, Nassif ef al 1994). 
S. pOlllbe SlI'ilOand Rad16 (allelic to SlI'i9) have been assigned to the class II mat-
ing-type switching genes (Ege11989, Fleck ef aI1992). In class II switching mutants 
the reduced frequency of mating-type switching is caused by aberrant resolution 
of recombination intermediates. Interestingly, the human ERCCI gene was found 
to correct the switching defect of a slVilO mutant (Widel et a11997), which points 
to a role of ERCC1-XPF in homologous recombination. Remarkably, also sIVi4, a 
mismatch repair protein MutS homolog, belongs to the class II mutants. 
In S. cerel,isiae, the removal of nonhOlllologous ends in recOlnbination intcnnedi-
ates not only depends on Radl-RadlO, but also on the mismatch repair proteins 
Msh2 and Msh3 (Saparbaev et al1996, Sugawara ef aI1997). Mutations in Msh2 
reduce spontaneous rnitotic recombination with certain direct repeat substrates to 
the same extent as mutations in Radl. A siInilar reduction is seen with the double 
mutations IIlsh2radl and IIlsh3radl, suggesting that Radl, Msh2 and Msh3 func-
tion in a single pathway (Saparbaev ef aI1996). Only Msh2 and Msh3, and no 
other mismatch repair proteins appear to be involved. The requirement for Msh2 
and Msh3 differs with the different DNA structures formed during homologous 
recombination and SSA. In SSA, Msh2 and Msh3 are especially required for struc-
tures with short homologous regions. '\Then the annealing sequences arc long, 
Msh2 and Msh3 have only little effect, while Radl and RadIO are still required. In 
contrast, Msh2 and Msh3 are as necessary as Radl during homologous recombi-
nation, independent of the length of flanking homologous sequences. Msh2 and 
Msh3 may recognize and stabilize the branched recombination structure. In addi-
tion or alternatively, the heterodimcr may load Radl-RadlO onto the recombina-
tion site. Either way, Msh2 and Msh3 may act to facilitate Rad I-RadIO-dependent 
removal of nonhomologous ends Ii-OIll double-strand breaks. The proteins have 
no subsequent role in mitotic DSB-induced recombination (Sugawara et a11997), 
although lvlsh2 has been shown to bind Holliday junctions (Alani et aI1997). 
Interestingly, S. cerel,isine exoI Illutants are defective in recombination between di-
rect repeats (Fiorentini et aI1997). ExoI, which interacts with Msh2, is a double-
stranded DNA-specific 5' -73'exonuclease active in the Msh2 pathway of mismatch 
repair (Tishkoff ef aI1997). It probably degrades the newly synthesized strand 
from the initial nick towards the mismatch during mismatch repair. ExoI may have 
a similar function in mitotic recombination in concerted action with the mis-
match repair proteins and the Radl-RadlO complex. 
It is likely that ERCCI-XPF resides in a large complex, different from the 
'repairosome' involved in NER, with other proteins such as Msh2 and Msh3 and 
the human homolog of Exol. An intriguing speculation would be that the mis-
match repair factors Msh2 and Msh3 might be suitable partners for dimerization 
with ERCC1-XPF. They were high scoring proteins in the protein sequence prop-
erty search PropSearch (Hobohm and Sander 1995) with XPF, indicating that they 
resemble the XPF protein. Moreover, Msh2 and Msh3 playa role in mismatch rec-
ognition as heterodinlcrs. By way of dimer formation, the availability of 
ERCCI-XPF in the NER, SSA, and homologous recombination pathways could be 
regulated. As discussed below, there arc indications that the NER and mismatch 
repair pathways interact with one another as well. 
Interstrand cross-link 
~: I I II I I I I I I 'PI, I I I I I I~: 
! Incision UvrA, UvrB, and UvrC 
I I I II I I)' I 'PI, I," I I ! 5'->3' Exonuclease 
llIl23' I I 'PI, I I I I I I 
I RecA-mediated strand exchange t Repair synthesis 
~:5~; ; ;' ;' ~';' ; ;~:: ! Resolulion of crossovers 
! Excision of cross-link UvrA, UvrB, and UvrC Repair synthesis 
IIIIIIIIII~lllm 
IIII ""'"'''' III 
Fig. 6 i'vIodel for interstrand cross-link repair in E. coli. 
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Mismatch repair 
The Msh2 factor is involved in the repair of mispaired bases and small loops that 
arise by replication slippage and during recombination between related but di-
verged sequences. The various Msh-dimers have distinct but partially overlapping 
substrate specificity. While, the yeast Msh2-Msh3 heterodimer primarily recog-
nizes small loops, the Msh2-Msh6 dimer prefers single basepair mismatches 
(Alani 1996, Johnson ef al1996, Marsischky ef alI996). Mismatches also occur in 
heteroduplexes formed during meiotic recombination (Modrich and Lahue 1996). 
Repair of these mismatches either restores the sequence originally on that chroma-
tid or replaces it with the sequence of the homologous chromatid. When a mis-
match within heteroduplex DNA is not repaired through meiosis, both sequences 
become fixed in the first round of DNA synthesis, an event also known as post-
meiotic segregation (PMS). Along with Msh2, Radl specifically affects the repair 
of large DNA loops formed during meiotic recombination (Kirkpatrick and Petes 
1997). The Drosophila XPF homolog Mei-9 is involved in meiotic recombination 
(Baker and Carpenter 1972). Mei-9 mutants are sensitive to UV and ionizing ra-
diation due to a defect in the NER and DSB repair pathways (Dusenbery ef al 
1983). In addition, these mutants are defective in the repair of mismatches within 
meiotic heteroduplex DNA, apparent from high levels of PMS, suggesting that 
N[ei-9 has a function in a 111ismatch repair homologous recombination pathway 
(Romans 1980, Carpenter 1982).ll'loreover, Mei-9 has been shown to be required 
for certain types of DNA mismatch repair throughout the Drosophila life span 
(Bhui-Kaur ef alI998). Thus, Mci-9 is involved in NER as well as mismatch repair. 
1vIismatch repair proteins can also bind to intrastrand cisplatin cross-links, which 
are normally repaired via the NER pathway (Duckett ef a11996, Mello ef alI996). 
This could explain the cellular resistance to cisplatin in Inismatch repair mutants 
(Aebi ef a11996, Drummond ef alI996). Binding of human MSH2 may shield the 
damaged bases from repair. Alternatively, IVISH2 may provoke incomplete, and 
therefore lethal, mismatch repair. Mismatched cisplatin lesions, produced by post 
replication repair DNA synthesis past the damaged base, are also bound by mis-
match repair proteins (Yamada ef aI1997). These compound lesions are substrates 
for NER too (Hess ef al1997, Moggs ef alI997). Probably, the increased structural 
alteration enhances damage recognition. Repair synthesis after excision of the 
cross-link, however, will copy the former mismatch, fIxing a mutation in both 
strands. The non-complementary residues opposite the intrastrand cross-link en-
hance ill vitro nucleotide excision repair of the lesion, which is, however, inde-
pendent of the MSH2-MSH6 proteins (Moggs ef alI997). Thus, no functional 
overlap between the Inismatch and nucleotide excision repair pathways for the re-
pair of these lesions has been observed il/vifro (Moggs ef al1997, Mu ef alI997a). 
Repair interplay 
In short, the ERCCI-XPl' proteins seem to be involved in at least three different 
repair pathways: NER, recombination and Inismatch repair. The means of repair) 
for which the ERCCI-XPF endonuclease activity is required, will be regulated by 
different protein-protein interactions. So far, only one association has been dcter-
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mined, the interaction with the damage recognition protein XPA. Other candidate 
factors are MSH2 and MSH3. Especially the XPF protein contains a large region 
with several motifs implicated in protein binding that will be interesting for fur-
ther analysis of the role of ERCC1-XPF in the different repair processes. 
ERCCl and xeroderma pigmentosum group F 
XPgroup F 
Xeroderma pigmentosull1 is associated with a defect in one of the XP factors in-
volved in NER. As rllcntioned before, XP is characterized by severe photosensitiv-
ity, pigulcntation abnonnalities and predisposition to skin cancer. The median age 
of 830 reported XP patients, reviewed iu 1987, was only twelve years (Kraemer et al 
1987). Between one and two years of age on average, XP patients begin to show 
sun-sensitivity and freckling. At the moment of recording, half of the patients had 
developed skin cancer, predominantly basal and squamous cell carcinomas, alillost 
exclusively in sun-exposed areas of the skin. The average age of onset was eight 
years. Ocular abnormalities were reported in 40% of the cases, whereas neurologi-
cal signs appeared in nearly 20% of the patients. Progressive mental retardation, 
hypo- or areflexia and/or deafness appeared in nearly all these cases before the age 
of five. Neurological degeneration may be caused by an accull1ulation of 
unrepaired endogenous oxidative damage leading to premature death of nerve 
cells (Satoh eta11993, Reardon etal 1997). DNA damage is likely to be produced in 
extra large amounts in neurons due to their high metabolic activity, and may 
therefore contribute to progressive neurodegeneration in XP. XP group F patients 
show a rather mild phenotype. Their clinical features are summarized in Table 1. 
XP-F patients are only moderately sensitive to sunlight and the average age of onset 
of skin cancer was 40 years. Only three out of 25 individuals had ocular problems. 
Mild neurological signs, also detected in three patients, appeared in two of the 
patients much later in life (after their forties). Compared with other groups, the 
clinical features of group F XP patients are relatively mild. 
XP-F mutations 
The number of patients with group F xeroderma pigmcntosum is relatively low 
(Cleaver and Kraemer 1989). To date, 18 cases with XP-F have been reported 
(Table I). As the clinical features in most XP-F individuals are relatively mild, these 
may often remain unnoticed. :Mutational analysis revealed that only two mutations 
reside in the N-tenninal region ofXPF. Similarly, only few mutations affect the C-
terminal part close to the ERCCI -binding domain. In an English patient 
XPI26LO, both mutations reside in the C-terminal part of the )J'F gene. The 
frameshift mutation, 759fs, codes for a truncated XPF protein lacking the ERCC1-
binding domain. The R788W point mutation resides outside the binding domain, 
however, alters the protein structure and is therefore thought to affect ERCCI 
binding (Chapter 4). Nevertheless, the mutated XPF protein could bind ERCCI ill 
vitro and has been shown to have residual activity ill vivo, which can explain the 
mild clinical features. The R788W mutation has also been found one Dutch and in 
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Japallese 
XP230S F 45 + (6) 
XPlOlOS F 49 +d low + 1 MF (30), 2 Bee, 1 KA (47) 
XP2yoa F 64 + 1 sse (62), BDe (, 65) 
XP3yoa M 29 + 1 KA (26) 
XP25KO F 8 + low 12<1h + (1.5) 
XP27KO" F 11 + nor 124h + (3) 
XP28KOb F 8 + + (3) 
}"'P41KOb M 5 + + (3) 
XP38KO F 44 + nor 124h + 
XF46KO F 61 + nor 124h + (14) 
XP7KA F 42 + low 1 24+72h + (4) 2 Bee (40) 
XP90TOc M 42 + nor 148h + (10) 6 Bee (42) 
XP92TO' F 41 + nor 148h + (5) 1 Bee (41) 
XPI07TO' I' 73 + low I 48+72h + (5) 2 Bee, 1 TF (72) 
Kps6 F 18 ± + (11) 1 Bee (18) 
XP24Kyl 1'1 48 + (6) 1 BDC (, 50) 
Npsl M 34 
Nps8 M 63 
European 
XP126LO F 22 + nor 124h + (10) 
XP42RO M 62 + nor /24+72h + (10) 8 BCC, 1 sce, 1 KA (27) 
XP7NE M 28 low/48h + 
Xl)24BR F 29 + low /24 + 
XF26BR F 20 + low /24 + 
XP32BR M 7 + + 
96RD239 M 15 + + (15) 
I also known as XPlTS 4 (Takebe el a11980) 10 (Itoh ela11995) 
2 also known as l\'fNNH 5 (Fujiwara et a11985b) II (Moriwaki el a/1993) 
a, h.c Family relationship 6 (Yamamura and 12 (ltoh et ai1994) 
d not after UV 1chillashi 1989) 13 (Norris et a/198B) 
1 (Arase et al 1979) 7 (Fujiwara et a11985a) 14 Chapter 4 
2 (Nishigori et(11986) 8 (Arase eta/198B) f Jaspers personal 
3 (Nishigori et (11991) 9 (Kondo el a11989) communication 
Table 1 Overview of XP-F cases 
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2.3 20·25 6,7 
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4.3 19 E491K 1518T 6,8 
± 3 12 9 
3 12 9 
2.3 19 594del 594dcl 3 
1.3 20.5 10 
+ 3.1 7 R443W 525f5 11 
12 
17 12 
13 R788W 7591's 13 
± + 2 15·30 R788W R788W 14 
possibly 20·30 P368S Ild · f 
3 20·30 R788W RS77\V · f 
2 IS R788W R788W 
2 10 
+ + 5 <5 1U42P R142P · 
f 
Bee basal cell carcinoma BDe bile duct cancer 
sec sqamous cell Ild not determined 
carcinoma 
KA keratoacanthoma 
']'F trichofolliculoma 
MF mammary 
fibroadenoma 
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other English XP-F patients. Most patients carry the point mutation in at least one 
allelc, which suggests that the mutation originates [1'0111 a common ancestor (Fig. 
7). In contrast, variolls unique mutations were found among the Japanese XP-F 
patients (Matsumura ef aT1998). Different from the European mutations, these are 
concentrated in the central part of the XPF protein (Fig. 7). 
XP-F 
Fig.7 XP-F mutations. Sites of mutations in the XPFgene product. Gray boxes 
indicate best conserved regions. 
Except for the XP230S cells, all examined XP-F cells contain at least one allele 
coding for a mutated, though, full-length XPF protein. Although, these mutations 
did not affect transcript stability, the mutant proteins were hardly detectable 
(Matsumura ef aT 1998). Like R788W, small amounts of these mutated proteins 
may still be able to interact with ERCC1 and as such responsible for some residual 
repair activity. In XP230S cells, only one mutated transcript has been found, 
which produces a truncated protein lacking the entire C-terminal half including 
the ERCC1-binding domain. Despite this severe mutation, the patient's phenotype 
is as mild as described for all other group F patients. The mutation, however, has 
not been verified at the level of the gene, and it is therefore still possible that also in 
this patient a small amount of full-length (mutated) XPF is expressed from the 
other allele. 
ERCC1-XPF residual activity 
The residual amount of complex present in XP-F cells probably accounts for slow 
but long-lasting repair (Zelle ef aT 1980). Previous mutational analysis in rodent 
mutants revealed that the degree of sensitivity to UV-Iight and MMC depends on 
the amount of ERCCI (-XPF complex) expressed (Chapter 2). The residual repair 
activity may, therefore, account for the 1110derate UV-sensitivity associated with 
XP-F, contrasting with the extremely low cellular repair activity, immediately after 
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UV. Moreover, small amounts of ERCCI-XPF are probably required for normal 
developll1cnt and viability, since mice carrying a homozygous null-illutation in 
ERCCI are severely affected. 
ERCC1.syndrome 
A human syndrome associated with a defect in ERCCI has not yet been identified. 
ERCCI is not involved in any of the known XP, CS or TTD complementation 
groups (van Duin ef al1989 and unpublished results). It is possible, though, that 
an ERCCI defect leads to a different phenot)'pe, not represented among existing 
XP groups. Candidate diseases could be Fanconi's anacIuia or Roberts syndrOIllc, 
both associated with severe cross-link sensitivity (Burns and Tomkins 1989). Mu-
tations in ERCCI ma)', on the other hand, interfere with viability because of its 
additional function in recombination. 
Mice with an XPA defect show many of the characteristics ofXP. They are photosen-
sitive and predisposed to UV-induced skin cancers. These mice are viable, develop 
nonnally and have a normal life span. In contrast, mice carrying non-functional 
ERCCl alleles show a more severe and complex phenotype. The)' have a markedly 
reduced life span, severely runted phenotype, abnormalities in liver nuciei, and re-
duced liver functions (McWhir ef a11993, Weeda ef aI1997a). No pathological ab-
normalities arc noticed in the heart, lung, brain and eyes, nor obvious neurological 
abnormalities (Weeda ef aI1997a). Sexual development seems normal, although 
1110St mice die before the reproductive age and no mice have been shown to be fertile. 
Fig. 8 Individual with the unusual severe form ofXP-F at the age of8 (left) and 
16 (right) years old. Courtes), of l'vleinecke. 
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The mice have a thin skin and lack subcutaneous fat. Theil' kidneys contain dilated 
tubules associated with renal dysfunction. Nuclear abnormalities were found not 
only in liver, but also in kidney (increased octaploidy, coarse chromatin and promi-
nent nucleoli with abnormal organization) nuclear invagination and intranuclear 
inclusions, abnormal nuclear size), Primary fibroblasts showed no increase in duo-
mosomal instability nor programmed cell death. 
Case report 
The proposita is a 16-ycar-old Afghan boy (Fig. 8). His parents are cousins. His two younger 
brothers are normal. 1·iaternal age was 17 years. A5 reported by his parents, his birth measure-
ments were quite normal and early dcYclopment was 001)· slightl)' delayed. At age 8 months, he 
was treated for a hepatitis A infection. Several rears later, he again suffered from recurrent fevers 
(possibly tuberculosis) and was treated with rifampicin for 2 to 3 years, Already in his first years 
of Hfe, he showed marked sun-sensitivity, 
From the age of 10, his parents noticed his oldish appearance, narrow face and loss of subcutane-
ous fat, and not before the age of 12, his failure to grow. He was examined in India for growth 
hormones. In the following years, he lost weight and suffered from dizziness. He needed assist-
ance with dressing. but could eat himself. After consumption of milk products he had intermit-
tent diarrhea. According to his father. he made water frequently during day and night. He had 
learning difficulties and hearing loss. 
At the age of 15, he was evaluated for short stature and de\'Clopmental delay. He presented at 
Altonaer Kinder-Krankenhaus (Germany) with dystrophy. dwarfism (height of 120.2 Clll. weight of 
17.6 kg), microcephaly (head circumference of 46.9 on), birdlike face, normal hair. and an overall 
prematurely aged appearance. He had no carries, but enamel dysplasia. His skin was dry and 
atrophic with irregular pigmentation, after severe sun burn. mainly in face and neck, and no skin 
callcer. Secondary sexual characteristics were present with descended testis. According to his par-
ents he was mentally- delay-ed. Furthermore, mild neurological impairment with disturbed coordi-
nation and mild ataxia were observed. The electroencephalogram (EEG) demonstrated mild gener-
alized slowing. He had a high pitched yoice. Ophthahnologic examination revealed optic atrophy 
and narrow retinal \'Cssels (from age 6, he wear glasses.). Results of examination of the lungs were 
unremarkable, whereas the heart was enlarged. Spleen and liver were not dearl}' separated. Liver 
malfunctioning (not due to an infection) was apparent from ele\'ated serum liver enZ}'llle le\'cls (AP 
1288 UII, y-GT 76 UII, GPT 29 WI), an elevated blood ferritin b'el. pointing to chronic liver cell 
injury. as well as low levels of serum phosphate and calcium. He also suffered from severe kidney 
insufficiency with secondary- osteopenia (bone reduction). anemia. acidosis. Both kidneys were 
relatively- small and condensed with limited glomerulus filtrate due to reduced leyels of serUlll albu-
min. Blood pressure was 160/110 .111m Hg (hypertension). Sonographic studies revealed not only 
the presence of ascites but also pleural fluid. His fibroblasts showed a complete loss of cellular repair 
activit), (UV-induced UDS was less than 5% of normal), normal karyotype and no increased spon-
taneous chromosomal breakage. Complementation analysis assigned the patient to xeroderma 
pigmentosllm group F. Due to progressive kidney problems (increasing leyels of creatinine) and a 
pneumonia. he died from a multi-organ failure at the age of 16. 
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Features 
Cliuieal 
Growth 
Pigmentation abnormalities 
Skin cancer 
Lack of subcutaneous fat 
Prematurely aged appearance 
Renal dysfunction 
Liver malfunction 
- alanine aminotransferase 
-,,(-glutamyl transferase 
- alkaline phosphatase 
- bilirubin 
- serum albumin 
- serum iron 
Hemolytic anemia 
Hypertension 
Optic atrophy 
Neurological abnormalities 
Reduced life span 
CeH"far 
Nuclear abnormalities 
Chromosomal instability 
IN-sensitivity 
M~vlC-sensitivit}' 
Repair activity 
(UV-induced UDS) 
I indicative ofli\'er cell injury 
New XP-F patient 
retarded 
+ 
+ 
+ 
+ 
elevated (76 U/I) 
elevated (1288 U/I) 
reduced (22.0 gil) 
elevated' 
+ 
+ 
+ 
+ (mild impairment) 
+ (16 yr) 
ud 
5x 
3x 
<5% 
2 illdicatiw of reduced liver excretory functions 
od not determined 
Table 2 Comparison XP-F patient with ERCCI-deficient mice 
ERCC1-deficient mice 
retarded 
+ 
+ 
+ (dilated tubules) 
IS-fold increase l 
2-fold increase 
2-fold increase1 
7-fold increase1 
reduced (20.5 gil) 
+ 
+ (3 wk - 6 mnd, 
depending on genetic 
background) 
li\'Cr and kidney 
+ 
+ 
4% 
The mutant mice have an increase in Howel Jolly bodies (granular structures 
within erythrocytes) in peripheral blood, pointing to hemolytic aneluia, as well as 
an elevated ferritin deposition in spleen, which is indicative of an increased turno-
ver of erythrocytes. SOlne of the features point to premature senescence. 
The UV-induced repair activity in their fibroblasts was eAiremeiy low (4% of nor-
mal). These cells were hypersensitive to UV irradiation and MMC treatment as 
well and showed early seizure in proliferation (replicative senescence) (Weeda et nl 
1997a), Furthermore, ERCC1-deficient mouse embryonic stem cells carry a defect 
in gene targeting by hOll1ologous recombination when targeting constructs con-
tain heterologous ends (Weeda personal communication). 
Liver, kidney and brain are luetabolically very active. The involvement of liver and 
kidney suggests that ERCC]-XPF is important in the repair of some endogenous 
damage associated with high metabolism. Candidates for endogenous metabolites 
are carbonyl compounds, which are found in the liver and can produce DNA 
interstrand cross-links, such as malondialdehyde, a side product of the fatty acid 
metabolism (Smith and Pereira-Smith 1996). The absence ofERCC] or XPF prob-
ably results in the accumulation of interstrand cross-links giving rise to carly onset 
of cell cycle arrest and polyploidy, explaining the runted phenotype, the poor and 
delayed development and early death associated with ERCC]-XPF deficiency. 
Novel repair syndrome 
Recently, we have come across an exceptional XP-F patient, whose clinical and cel-
lular characteristics strikingly resemble those of the ERCCI null mutant mice (see 
case report and Table 2), In addition to the severe sun-sensitivity and neurological 
degeneration normally associated with XP, and developmental retardation rClui-
niscent of CS, this XP-F patient has severe liver and kidney abnormalities. The 
patient is homozygous for a point mutation in the N-tenninus of the XPF protein. 
A conserved arginine residue present in one of the leucine-rich motifs is changed 
into a proline (R142P in Fig. 7). The mutation results in an undetectable amount 
of ERCC]-XPF. The additional symptoms not associated with XP, such as the kid-
ney and liver problems might be due to the absence of the possible recombination 
function of ERCCI-XPF. 
These new features associated with a defect in ERCCI-XPF may be of help identi-
fying ERCC] and XP-F patients in the future. 
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Summary 
DNA is continuously under threat of numerous naturally occurring and man-
made agents producing a wide variety of DNA lesions. These can cause cell death 
by blocking essential cellular processes, whereas persistent DNA lesions may bring 
about mutations in the DNA. Accumulating mutations play an important role in 
the development of tumors and processes like aging. It is clear that removal of 
DNA damage is of vital importance to the cell. Different repair pathways have 
evolved to protect the cell against DNA damage. These are summarized in Chapter 
one. 
One of the main repair systems is the nucleotide excision repair (NER) pathway. A 
coordinated interplay between multiple proteins is required to carry out NER in 
eukaryotes. The fIrst steps of the process lead to lesion recognition, local opening 
of the DNA double helix and incision of the damaged strand on each side of a 
lesion. A 23 to 32-mer oligonucleotide containing the lesion is removed, followed 
by gap-ftlling DNA synthesis. In human cells, this repair pathway involves thexero-
derma pigmentosum (XP) proteins and associated factors. Individuals with the 
repair disorder xeroderma pigmentosum show hypersensitivity to sunlight, a 
greatly increased incidence of skin cancer, and in S0111C cases neurological disease. 
Genes encoding the XPA, XPB, XPC, XPD, and XPG proteins have been isolated, 
and a factor defective in at least some XP-E cells has also been identifted, although 
it is not required for the core NER system. 
The two incisions made during NER are catalyzed by separate DNA 
endonucleases. In humans, XPG endonuclease makes the 3' incision relative to the 
lesion. In Saccharolllyces cerel'isiae, the Radl and RadIO proteins form a 
heterodimeric complex having a structure-specifIc endonuclease activity with a 
polarity opposite to XPG, leading to the assumption that the Radl-RadlO com-
plex makes the 5' incision during NER in yeast. The Radl-RadlO complex has an 
additional engagement in a mitotic recombination pathway, probably employed 
for the repair of DNA cross-links. Like RadIO, its mammalian homolog ERCCl is 
involved in both NER and cross-link repair. Mutational analysis revealed that the 
poorly conserved N-terminal9l residues ofERCCl are dispensable for both repair 
functions in contrast to a deletion of only four residues from the C-terminus. 
These fIndings are reported in Chapter two. A database search revealed a strongly 
conserved motif in this C-terminus sharing sequence homology with many DNA 
break-producing and processing proteins, indicating that this part may be re-
quired for the presumed structure-specific endonuclease activity of ERCCI. Most 
rnissense mutations in the central region give rise to an unstable protein ((0111-
plex). Accordingly, we found that free ERCCl is very rapidly degraded, suggesting 
that protein-protein interactions provide stability. It seems that the removal of 
cross-links requires less ERCCl than UV-damage repair. 
ERCCI has been found to associate with activities that correct human XP-F cell 
extracts as well as extracts [1'0111 Chinese hamster cells of repair complementation 
groups 4 and II. Furthermore, a polypeptide observed to co-purify with ERCCI 
by several assays has been proposed as a candidate for a Rad I homolog. We isolated 
a human gene homologous to yeast Radl and found that it corrects the repair de-
fects of XP group F as well as rodent groups 4 and II. These results demonstrate 
that the XPF, ERCC4, and ERCC11 genes are equivalent and complete the isolation 
of the XP genes that form the core NER system as reported in Chapter three. The 
XPF protein was purified from mammalian cells in a tight complex with ERCCI. 
The complex indeed is a structure-specific endonuclease responsible for the 5' in-
cision during repair. Causative mutations and strongly reduced levels of encoded 
protein were identified in XP-F patients. 
Xeroderma pigmentosum group F patients generally show the clinical symptoms 
of a mild DNA repair deficiency. All XP-F patients examined demonstrate reduced 
levels of XPF and ERCCI protein, suggesting that proper complex formation is 
required for stability of the two proteins. No humans with a defect in the ERCCI 
subunit have been identified, and ERCCI-deficient mice suffer from severe devel-
opmental problems and signs of premature aging on top of a repair-deficient phe-
notype. To better understand the molecular and clinical consequences of muta-
tions in the ERCCI and XPF proteins, their mutual interaction domains were 
mapped (CI",pter five). The XPF-binding domain comprises the final 73 C-termi-
nal residues of ERCCI, whereas the ERCCI-binding domain in XPF maps to the 
last 91 C-tenninal residues. Formation of the ERCCI-XPF complex is established 
by a direct interaction between these two domains. The frame shift mutation 
found in one allele of the first Caucasian XP-F patient described (XPI26LO) re-
sults in a protein lacking the ERCCI-binding domain, which is shown to affect 
complex formation with ERCCI. 
The identification of a second Caucasian XP patient belonging to complemen-
tation group F (XP42RO) is described in Chapter four. Mild ocular photophobia 
was present from childhood and acute skin reactions occurred upon exposure to 
sunlight. Basal and squamous cell carcinomas developed after his twenty-seventh 
year. In his late forties) progressive neurological symptolllS emerged, which in-
cluded intellectual decline, mild chorea and ataxia and marked cerebral, and 
cerebelar atrophy. Such neurologic abnormalities are very unusual in XP-F. Similar 
symptoms have been described in only one of 17 other reported XP-F individuals. 
His approximately 5-fold reduced activity ofNER in cultured cells combined with 
moderately affected cell survival and DNA replication after UV exposure are typi-
cal ofXP-F. The patient turned out to be homozygous for a point mutation in the 
XPF gene, causing an R788W substitution in the encoded protein. This mutation 
had also been found in one allele of the other unrelated Caucasian XP-F case. The 
amount of mutated XPF protein is strongly reduced in cells from XP42RO, pre-
sumably due to a conformational change. However, biochemical and clinical data 
indicate the presence of residual repair activity. 
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We have only recently identified an exceptional XP-F patient who strikingly resem-
bles the ERCCI -deficient mice (Chapter six). His UV-sensitivity is very severe and 
his cells appear to have lost all excision repair activity. His homozygous point mu-
tation results in an undetectable amount of ERCCI-XPF, which probably inter-
feres with the possible recombination function of the endonuclease. The recombi-
nation defect may explain the additional symptoms not associated with XP, such as 
the kidney and liver problems found in the patient. The new repair syndrome de-
scribed here is more reminiscent of a cell cycle arrest or premature aging disorder 
than ofXP. 
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Samenvatting 
VOOR DE LEEK 
AIle levensvormen zijn opgebouwd uit eellen. Bacterien en gistcn zijll eencellige 
organismen, terwijI planten, dieren en menscn uit een groat aautai cellen bestaan. 
In elke levende eel bevindt zich DNA dat er uit ziet als twee OIll elkaar gewikkelde 
strengen. Het DNA is de drager van de erfelijke informatie vall een organisme. Het 
DNA van de mens bevat ongeveer 100.000 genen. Een gen is een stukje DNA dat 
informatie bevat voor een erfelijke eigenschap. Het vonnt als het ware een recept 
voar het maken van een eiwit dat helpt die eigenschap tot stand te brengen. Deze 
recepten worden gespeld met vier letters: A, C, Ten G, die op aile mogelijke manie-
ren achter elkaar kunnen staan. In de twee strengen van de dubbele DNA keten 
vormen de letters tegenoverliggende paren en dat kan maar op een manier: A paart 
met T en G paart met C. 
Helaas kan dit kostbare erfelijkmateriaal schade oplopen door gebeurtenissen bin-
nen in de eel, maar oak door invloeden van buitenaf, zoals chcmische en radioac-
tieve stoffen of de UV-straling van de zan. UV-straling kan bijvoorbeeld T's die 
naast elkaar zitten in de DNA streng met elkaar verkleven. Rontgenstraling kan de 
DNA strengen breken en sOI11Illige Illedicijnen tegen kanker knopen ze juist ver-
keerd aan elkaar. Doordat deze schades belangrijke processen in de eel blokkeren, 
kunnen de cellen afsterven en ais ze dan tach overleven blijven er permanente ver-
anderingen in de recepten aehter, die men mutaties noemt. Een opeenhoping van 
nlutaties speelt een belangrijke rol in het ontstaan van kanker en veroudering. 
Deze problemen kunnen enigszins worden ondervangen als schade tijdig kan wor-
den gerepareerd. 
Dat DNA-reparatie erg belangrijk is kan men zien bij patienten die lijden aan de 
erfelijke ziekte xeroderma pigmentosum (XP). Ze kunnen de beschadigingen ver-
oorzaakt door UV-licht niet repareren. Hun huid is extreenl gevoelig vaal' de zon 
en dam'door erg droog (xeroderma) en vol onregelmatige pigrnentvlekken 
(pigmemasum). Dc gevoeligheid voor UV-licht gaat bij deze patienten vaak ge-
paard met een sterk verhoogde kans op huidkanker. In somrnige gevallen is er oak 
sprake yan ernstige problemen yan het zenuwstelsel. In Nederland heeft minder 
dan een op de 200.000 mensen deze erfelijke ziekte. Verspreid over de wereld kun-
nen we op dit moment 7 verschillende typen xeroderma pigmentosulll (A tot en 
met G) onderscheiden die berusten op afwijkingen in verschillende DNA-repara-
tie-genen. Dat zijn dus de genen die zelf het recept voor de reparatie-eiwitten dra-
gen. 
De reparatie-eiwitten (XPA, XPB, XPC etc genoemd) zorgen er samen voor dat de 
schades uit het DNA verwijderd worden. Dit proces, nucleotide excisie reparatie 
genoenld, on1vat vijf stappen: 
Herkel/Ilillg l'nIl de DNA schade. De reparatie-eiwitten XPA, XPC, en mogelijk ook 
XPE, zoeken naal' schades in het DNA, waar zc vervolgens op gaan zitten en andere 
reparatie-eiwitten naar de beschadigde plek lokken. 
Opellillg I'all de DNA dubbel helix. Rondom de beschadiging worden vervolgens de 
twee strengen van het DNA nit elkaar gehaald door een combinatie van eiwitten, 
waar XPB en XPD onderdeel van uitmaken. 
Kllippell l'nIl het DNA. Dam'door krijgen XPG en een eiwitpaar (met dam'in het 
reparatie-eiwit ERCCI) de rllimte om elk aan een kant van de schade een knip te 
zetten in de beschadigde streng. 
Schade I'erll'ijderillg. Vervolgens wordt het deelmet de schade lIit het DNA gewipt. 
Het is nog niet predes bekend hoe dat laatste in z'n werk gaat. 
Opl'ullillg. Uiteindelijk wordt het achtergebleven gat gedicht met nieuwe letters 
door DNA-prodllcerende enzymen. 
De inleiding van dit proefschrift beschrijft een aantal verschillende soorten van 
DNA-reparatie, maar gaat dieper in op nucleotide exdsie reparatie (NER). NER 
van de mens lijkt sterk op NER van insekten en zelfs van eenvoudige gisten. Het 
mcchanisme vall hers tel is dus gedurendc de evolutie weinig veranderd. Aan de 
hand van cen bekend gen Vaal' een reparatie eiwit in gist hebben we het vergelijk-
bare gen in de mens gevonden. Het bleek overeen te komcn met het gen dat verant-
woordelijk is 1'001' de ziekte xeroderma pigmentosum type F (beschreven in hoofd-
stuk drie). Het eiwit (XPF genoemd) vonnt een vast koppel met een ander repara-
tie-eiwit ERCCI. In hoofdstuk vijf wordt beschreven op welke manier ERCCI en 
XPF aan elkaar vastzitten. Het ERCCI-XPF paar zet cen van de knippen in de 
beschadigde DNA-streng tijdens het reparatieproces. Behalve hun rol bij het her-
stel van UV-schade, zijn ERCCI en XPF ook betrokken bij het losmaken van knris-
verbindingen tussen DNA-strengen. Het feit dat ERCCI en XPF betrokken zijn bij 
het repareren van DNA-kruisverbindingen voorspclt dat ze oak een 1'01 spelen in 
andere reparatieprocessen die schades op een andere manier uit het DNA verwij-
deren dan NER, bijvoorbeeld via re-combinatie van stukken DNA die erg op elkaar 
lijken (hoofdstuk zes). We hebben de delen van ERCCI die belangrijk zijn voor het 
goed functioneren van het eiwit in kaart gebracht. Dit is beschreven in hoofdstuk 
twee. Het blijkt dat ERCCI en XPF elkaar beschennen. In ongebonden toestand 
worden ze snel door de cel afgebroken. In cellen met een te kleine hoeveellleid 
(minder dan normaal) van het ERCCI-XPF paar wordt UV-schade heellangzaam 
verwijderd (NER), terwijl kruisverbindingen tussen DNA-strengen normaal gere-
pareerd worden (re-combinatie). 
Om de relatie tussen de erfelijke veranderingen in het XPF gen (het 'genotype' van 
de patient) en het daaruit volgende ziektebeeld (het 'fenotype') te begrijpen, heb-
ben we van een aantal patienten de afwijkingen in de XPF genen bepaald. Ieder 
Inens beschikt over twee kopieen van het XPF gen, een van de vader en cen van de 
nweder. Bij een van de onderzochte patienten mist de ene kopie vier letters. Hier-
door wordt een korter dan normaal XPF eiwit geprodllceerd. Dc andere bevat een 
een-Ietter verandering die waarschijnlijk een andere opbouw van het eiwit tot ge-
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volg heeft. Die mutatie werd ook gevonden in een andere Europese XP-F patient 
die wordt beschrcven in hoofdstuk vier. Hoewel beide gemuteerde eiwitten van 
deze patient snel worden afgebrokcl1) kan er tach een kleine hoeveelheid van het 
XPF eiwit in zijn cellen worden aangetoond. Ze hebben dan oak cen klein deel van 
de oorspronkelijke reparatieactiviteit behouden. Dit verklaart het relatief milde 
ziektebeeld dat karakteristiek is voor aile XP-F patienten die we tot nu toe kennen. 
In tegenstelling tot IVat we verwachtten, hebben nog geen patient gevonden met 
een genetische verandering in het ERCCl eiwit. Anders dan de milde verschijnse-
len veroorzaakt door een mutatie in XPF bij de mens, blijkt dat muizen met een 
ERCCI Illutatie een zeer ernstig fenotype hebben. Behalve een reparatiedefect en 
UV -gevoeligheid, hebben deze Illuizen lcvcr- en nierproblclncll en vertraagde 
groei. De muizen gaan binnen enkele wekenna de geboorte dood. We hebben re-
cent een uitzonderlijke XP-F patient gevonden, ,vaarvan het ziektebeeld veellijkt 
op dat van de ERCCI-Illutante muis (hoofdstuk zes). Door de mutatie is er geen 
aantoonbare hoeveelheid ERCCI-XPF en nauwelijks nog reparatieactivitcit aa11-
wezig in zijn eeHen. Vye verwachten daaroIl1 dat flU oak de eventuele flll1ctie in het 
recombinatie herstel van kruisverbindingen is verstoord. Dit laatste zou de s)'mp-
tomen die niet karakteristiek zijn voor XP) zoals de nier- en leverproblemen, kun-
nen verklaren. Deze nieuwe 'reparatieziekte' heeft meer weg van voortijdige verou-
dering dan van XP en l110gelijk helpt dit nieuwe ziektebeeld in de toekomst bij het 
vinden van ERCCI patienten. 
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